INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136497, 33935, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, NULL, X'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', NULL, X'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', 'NCBI', 1768159717, 1768159717, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136498, 33935, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'789c0dc8b11183300c05d09e29fe0414144cc008e972297446847f275b201b2ede3e94efbd7645f27c1893347a816fb8d924b36041f31f135b4748a87598ca5a9f456811c326b42bf4d1793158bed835fb4ab15e59c7e13dcd9f3fefce23e0', NULL, X'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', X'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', NULL, X'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', 'NCBI', 1768159717, 1768159717, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136499, 33936, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'789c6d523d6f1b310cddfd2b38a6807169dc34c8dea543daa563e08127d1774229d290281b975f1feae2244ddb418020f2f17d503f7012aaa9654815104ec99081988215e5c5086c468323e3d2cba1b490bcc16b044920a32c30260d33e5147a81305852a9bd6a33c1dcbc07468dcb16f070f0b9492608c4dc180b1c9aacfd5b102a2782a012dbe5052582fa8ce2358a75809f5ab273542a2e37bf09673a11bbba4230929d89046e86dbbb15bf1beeee214fd7f16180efcb515f502e1657bff2c16a4cd55a1951820bc15629c2b8b86bd6f3ff49410f7ea9b58774215db95ecd8fac1a9d58cfde5db6fee6a4dd62ea0ebb025b8e3d37769abae4a3b9404b019a58fad7a8230389157c45ffc9bdbb505f7d1ebe42cecad70f9f86cde3cd7eb3f93617159feafe082b79b21c745606b7d81fb5c4ae6ec2ea492431aabe240f9ab5d6adaff4fdfebe9237176ea82f9800cd4a1a9b796aa6307f087b805f6992bae22f3e6b0f6ffe6b2512b845829cd88714ca5a5e3013f9f7404e4f3efc4cf85b56e3ead425260c9ec5fa03716d8e8436bbf5dd7ef3f8c5cfedfe1956cd0a63', X'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', X'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', NULL, X'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', X'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', NULL, X'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', 'NCBI', 1768159717, 1768159717, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136500, 33936, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', NULL, NULL, NULL, NULL, X'789c558f316e03410845fb9c8203ac2c1739411a77be40e482996137280cac18c6966f93b3e464c64a1377f005bcc7798673b0290aece8d829c8078c2f9bd2a01074530e736ae0b44d41973be09a4350d01973bbc298be91df1760ad321beb061f70e5c0ce3a327553406d108e9580843a698c039c48c9132c586ee6dfffa8ab89d82da1a83a51e4e5b6f035f1ebd4fa1487a01149a9d677497b2862d6b29d1a4b4a8e14ccafb09864b5a3922c4f9bdf1fe19ddb5f7278fb7c3f5e1e831a6454', NULL, NULL, X'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', 'Hybrid', 1768159717, 1768159717, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136501, 33936, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', NULL, X'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', 'NCBI', 1768159717, 1768159717, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136502, 33940, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', 'NCBI', 1768159717, 1768159717, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136503, 33940, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'789c7d8f314e44310c44fb9cc217581ab8c172001aaad516feb1c937cab7232791369c9e64c5d220d18ec7336fde5d147d002a81b36286e8a336cc599481a49a137b057486cd0d290f88d83899cb17136c03ba4e471ea209b889654b03449bc1877587033fcd21b9f5529fc2e5f91a2e2fd710ce98a3f403ec8679c6ddfbe38f5676ab655fea83c50ab67d8437742c6e8d27db2178725ebff4b00171b12a9341173963e51ace7f6f95a329add513f2e0869b65897704d19d5d56e6eff4f0ea3d9d44a9c77fabbe0124da7c9f', NULL, X'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', 'NCBI', 1768159717, 1768159717, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136504, 33940, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'789c6d55cb8edb3810bcfb2bfa033cc6cc606776730cb213e49453904be0439b6c498da54881a4ec78bf26df922fdb6aca72c6b3010c5be6a3bbaababaf5f98e9dd47370e75245a390e3480721f6a346c55a164f297308e72d69ac998f12d35cec2f474f354dea6c179bc414e53007fd1777ba94c71d7d19d2dc0f5407594f524e73154a5dd742db0efb23c7cabdad12bbaa47ae1afbb637ce2e390dcaf94c2e08678e0eabe20606bc9138249c3c691d00c0cfceee31b996354b17e4fbb6c5310aaf53178b3c80690545600b92f9803cf5bcdb7cfb6bbff93268217cbc1637976284e68c4099e6e8f10dcc0822c86180532c3b7a1f972c3e95c6e4f1fe1e81e9193f634f9ed5442ab8e1d2380aa2349116961c411f8bd52e1ae7bb742835cf268618889491b500db3bc32654b843d94cf4294b1fa11f75327290d2cae2060d3e4ba4810b48e2e124219094ca87a065108f500ff7fb4d0bf61a52436fb87cca91f1cca163c3fdb87b321e37c640fadb8ad3c3cf1fe0fc4855478302dae7166d424941af2ca532b7a9a34e0f3915355acffbcdcb51bd5875cbdcf7406a4c48c729a7e3220db27dfcfaa1f1fbf8f2f58140ada414edb70e59c492e152671505c6aa571b659ece6646c4aeb8ced95f5615200dde1b405b0afa0fa8c7aa074dd85955052c9a8673c1e212754b05160fde7ac6259c8f33a478e54a2bafcf730f7f50d15103e745630bb81af2aa6a663313aa86aab7b2bd75cbb5b0760915b5aee911665a10b287938b33a577f4c219967b135aedd371accb85739a81f41ad52bf73199dd7f57a72dc9d1ac34e02b26f423025b4b17ed6381f9a99cc7a9a6b118ba465c8b340f65319f16e0da364b42b493cd99289d56b3e2c37ef33ed4ebb4c079582e40af6a9ee4ca50a247ddd6b970f13ff2fc7de3d36b3f3894061805cdeed05511ed510115824350a1135b274e29d7c5c69826e81e1a9397d07a54f468b9502a487c991683f636012a66cfa56dbfeb388f37451a663473abf06eb3f9c0f980f17519ad6074d33ddc1cde6606404fbc5468bb48bf26c6c0eb0d4897d3487f3eb559524f8a36599a0bddf6073ab307c5750d95ff5f2b0173c5ee8581b3c371b5c43a75cdc1e30443f8d2f461d80205f774544cf6e4ea0ca5c35b43ada5368f6fbe3d62a4bc6480ff3de5f54dd25e1d760b3a95f6ce319ed258fefcf1bc4cce776d72eee8533a0146de5e6fbceab9aa8603911d3cd6cd971791044c4b3cbe993a434e302c6c8568bfbcb9cc99e8b2fdf534052e23df4ab40016f3635c3b347477413bb9e9d55f7e02d4622f53d0832a4ffbff0002f7aff6', X'789c6d54bd72133110eefd14dba4331e028481921928288086190ac6c55adabb13c8da43d2d91c4f9367c993f1ad2ed80e49753f9276bfbfd5d74168afa55297e5d724a9c699b28c9aab78627f905c84a4ebc4d542da91668ef4f9193ba9737473a912921067a183ee430da9274e9e7ce09c07e10dbdebaa64ba7e7d775b95aedf90e7b9157a54632ab2a60a3821b9e02539b16d4f56b52d59b800e26ea69be75777b7b6fceae5e6e66a7d779ba58cc01b0e12e7cdeafbdbedeafbf58bedeae3f95054f534625f9932bada8190b96a9ed1a3545b58931b04ba8c1cd29a3a8112b6d155f0df45110f506b0218cfd888b779d42aa904c5f62875e0dccfeb06bbfc0c893846c19f93b8d0599d9b32b8607b29a0ce896eae8cb403ca02e9246bd118fe00f223b942a15135a34c555466f3cb4f822f0ab02ae41c2aa77aef5dc3c1041233753a4552afd95a56344bc0e02777b610ad6908fdf0d00a4e3c0e736428eb40c39e9a8a01d15d917c00007019b906c4a8500ffdad72cd8c179dca230ef0e6fae576f5f55f049deef79a9e0ae0b9db31d481de6b4e90089a76dcb21739cfa90776d876d0e06ca99a28cd0de39eb90cd660c4766f228d20223bddd017642e2f1694d0a7d00567bafd6b7d14d41f878b0697b9b0d24ed38f2959de6c7d43e063d8fe9b9d56c7689a63991114498b2d49eb993190ed848ac50d67211b5cc03fc7180f9c13ae7b3b6732f8cc4784113edae8867c49ba98155e4b331380b038c006d4862749effb95c5d6a79db5b6fe5268fb46cc36f40dcd9744b7792d75f241200cef74aaf4a24dfaab16e453181a72d06bf63da8ea4135ea88356468da034b0d3bb582d6d0eafb3cf5cbcde0624870275e18b544f3380437581267a9f712628e9de4241e297bbd5d7d0ad153cf986d50b435dd7750607dfa3745f720305df86d1385de045ce322ea59c393618d91e3bc53174eb1c66df3610cad34c73ef0e545811104973d2f6d9219cb4f15be9c25dc3b827825c302575b9b4592c8d5eed77ad4b30e71c9d1392d8d2f744d5323088037dbbf89ee305a', NULL, X'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', X'789c75564b6edc4610ddcf296a134002660691edc440768265230662c548826c8c5934c9e6b0e16637d39f91e8d3e80c39820e9033e555b1498e207937e47455bf7af5ea153fe5dadb31993a52634ea6d1645cf294ee3cc55c1d83cf43fc65b3b9dad33bab6234357d5a22369b577bfaac87c461e7af9f1f458a1b13b36df968e55d134905fccac636c61da9b2befe1ac9b7d42b373e3ed4be1facbea721f8a48d8b5bc0aa6d96b37dae73dcd3ed4ed53a8d967edbd563e4539a2e6eafdf5d6e29755a227d1a074d4dc847ce9c3a13a96668dbc787a0a30e270d181474936b4eac2a634d1a49b986ee7c009e6a945c88f476d72c0580221dea4eb9a3a65ef30f13fbfde3c35f38db732e1a5077af43a44e9d342df870ab69326e4d1d983d763e27bec0048a29e43ae5a0f7c4599a17c852aeee3cc092771c14cfd3791a8db60dd5c1c7688dfbcaf548cd7ac652f0b541978248ba8b62e4d40280c3402375631310f94dd0be80282555774083bb9fd5c74580eca0559d0ce02218a9ab29d3ebdd0d50a85e33c7d2726e2873bd74828ffdb9fb53aee20b94c3e3af74c11018d7682fe53f69a46b74e0209358246a5095952226bee674b3a29ed4390b05e0f79b2f57878dc09e855f34a7a1e85bdad1b5c86dae75b3b9b61eb9ef4cea248faafc49ef7aedb862f0d2cfe2a78984eda2d8852e65a3874240268276c6b556f5bd4a3e4c1ae4b7fede342a9993e01c7448666297dbaf8eb80c12d37698a8d30264621d11fe7ec4098a83ae0d2b1d299fdcd1ebc6f02f6e8b4a54ab1ca70c18b86c994d6ee860428164c29d1ae31ef3ad42e557229e3c4e458139c088453b276f732f84c721a7dccb8406dd42cd5cd63c7e8e54d318e64a59d2f7808d7ba7e275dbe2694f1f812ad249034e54ad969aa6fff81400ab983a94c77e065e2189c60384f3880bc12495668ed6ba52005f68ffabc306e97b3552c5a91a53e3744340b90af3fafdbbdf3fdfd085aa3332e97b3434544a348eea6a4cb543c37d35a94cda966d8f82700f868029b97c7cc088b0aa0d9a57ba3a0a39e6e84c8b6b5db267c350011e140e4eac57cd3cafa51b1297eb8e06a06039a090d787cde7e556745c8bfe8a17551a92309885521ed241e940f3f6c71f646aac2d55a2d1ef43e3e7b682e90f797edc6c8a04d141a7ef7410972d42e29793c3f0649ea48393fc04c1599345f722719716c9ef52c6f6e083136e91fb586269b58027fe050b2daaef75c228c2c8f51692b616357ed26977b5a5bbce80281cc3aecb8b319c4ba1ca21a6d9189cce09dde98c6552df1cced990a165a1c7cedf3986b5f64e8aa88c87087703bc054fa000b7cd22fe430f3ea4d28f322eb3da8440232a17639a6a620d2a3b746a7725d9531887289ef5d361b37969057f74703c0769a31e76e8b2911753c2461d4ad8fa0e574e6b7135c6c2292b31aecbfe2c24a970d4896e6eafd7a5275ad9713f1cf1322aba0015e2e6b33970eb861cb2054514355eaefd9edce125904b1f03f79af946ca627fd326399958fbc89b1c3ba5d10596f93677fc0956303b43753ac94a12b0be05dc891097be83742b20c48d609d6db67c0eb44ffa8ed3604229ec8d20bf3515d6b36107bdf1c13103d7b655eb93c2533144f9325957c8249d17ea39af45ecf13c1c1f574fc8fef0feefab0bf05a4368f0d759f5c59e152a0e74c5f5a1844ba9b998cab4e59e95f1e5e7031bc1d8e3d1d17fffbe115b780e5b066a3af5f8806345dd8cb3993f85c40de7f36eeec97e69ce7908fb3c59161efd93651ec6ef74a82cbd7919adca38b3e0d6602522cc433a4ecddf60a528ac83b36db5e5d5e0dbc78793b25928ad90593eb61af10131650059bef0a66fa7b567cbae98bee0e6bb99ccb787ff01b98a4073', X'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', X'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', 'NCBI', 1768159717, 1768159717, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136505, 33940, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'789c6d54416edb3010bcfb157be9cd09e2f6d0f658a09716452f0d7a097c58536b6b1b8a64b9a45df5357a8b5ed6a195c44560c012249a9c9d9d99d57d2f34442be4e230c4e047ca92622ed2117747c92624fbbdb8324f714f07cf45330f92899d142e426aa4e11736680c648a952c7c7e5bd3a957d7d3c041f762c588f1235f87445ca8a0b2d59dab8583c4fa1ae6963ea594e31f1d5005b436776f080c12084800d649bd7fe24a7b01d335b91e6bb6260e20ef7ab15bfa12d046a70b1d10195f00e6a9e7a310cf53c91cacad910e8374daba4a90e4c2e7b9a34660efabf51a0e6bb21eb58398b5e51df6947ea99dd82785383861cf2298f8fd4d168b1e454f5a0041efee68d0500b88ae1e36efb7abd5b786567a0eb4b9d26d87367d4ce435452e39a67e44413aaae9ce0bfe460b4fc2beb2a4ab4225928f8e3d0571399a9e6973072c785cd4accaed6af543b2363376b550e60c8bb47b8e80358c232f1b623e80a68d566440971a9caf1d7421c7b9d3786473d5335c39b081ab06b40949d9afa917781a535429ead6e4c721f57c7e1c6a3b15ed513cd285ad41f211d5165d6b8e070950d65fea9e4ddc89040a11a15db78cf5b8be42491c5ec0a31b010f8e7bf570bb4893ed123c17c31211248833ac86067f3100bb11db126640510cda264e153ac74cc9f36f482ab9a6760eba7d57173d57100b5d8e83b478d942ec79a0e669b1619e5c9f6300a12be3545a8e0654bb9da7d7989410a0a738947e9e122b522d792c4dd145a34e0d87623ea7ef7a1a807c8fc54bd788c2ebc6e709384005c9ffe3729ed94744f75c4a04e2bc44e761f3618bdb47c4f873ae879b76c3fc0173191e5badfe7f8336e50479e6e9a2c23c35dc882a993a1cb7c55e38bb28690511033f38b0e40dcf2083cf44575d21cf3bf18820b8bcbddbae7eb2731adaf7c8120a0a46be05ba433fc286a34b9ac716da4e0e59a47d839aac4f4377f602fb9ada57bc6a6536db7fc419f9ce', NULL, X'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', X'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', X'789c4d8e410ec2400845f79e82039846cfe0cabd3be3820e6831d3a101dad8db78164f26262e9ab080cf7f1f2e031b833834055c502af635e776571b31441b643d6ab686231b60e1c060d0858dd4d93b3837705e7e31034f181afa9222b1eeb79c0f3a57829e81c48bb69036337570520b29eac1a64210c61823b7d800e976a1cca7fceb7feaf3c64630b1b9249af62a29e7fe39dbdaedaec7c3ed0b3d1d528f', X'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', 'NCBI', 1768159717, 1768159717, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136506, 33940, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, NULL, X'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', X'789c5d8ed14d04310c445b9902d0d5410134e04d268ac1979cec64574bf5640f2410dff334efbd5582a5308d402fa8a7d8f4de344192661435a3439c70eef4d0cd884347fd45b3045f200d6c9fe79d18550636a77c04723f1ab6bef02643772e2c43dbfbf231ffb7ddf0faf7131a78880f4dd3c4edc40c9669382adb921099837ed7ebb9b78b7e9aafe527fb5b748d87acb577c47cd08b26155bc901ee9ad9d26ad94e6c36352ab246ead6fd797bfb0218c26c1f', X'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', 'NCBI', 1768159717, 1768159717, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136507, 33940, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, X'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', X'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', X'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', NULL, X'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', X'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', NULL, X'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', 'NCBI', 1768159717, 1768159717, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136508, 4177, 2.0, 2.0, 'mg/kg', 'PO', 1, 'Adult', X'789c0b4b2c4e2ecdc92cc92cb6523052c84dd7cf4e5708f0574849cccca904008ed0099b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136509, 4177, 15.0, 15.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c25c8c10d80201004c056b6028d120bf06903fe49d820a29c788096efc379ce309dbe8f1ecb8a3ce221a3e235281b13b2f9a3c3ecf6aa054e942802db2438281b6fe2608d723105fb01bbe01a4b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136510, 4177, 1.0, 1.0, 'g', 'IV', NULL, 'Adult', X'789cf3292d282d56c84b2dc828ca2cc92cb652304cd7cfd530d254f00c53c8cdcf2bc9c8a90400de090c0b', X'789ced575d53db4a12fd2b5dbc2c54c9b624638c9d270321815d088559eec3f52dd7586a5bb34833cacc08d0deca7fdf33233081e4562a79dadada078c349a8feed3e774f7fcb9939b66b354a2e29d29ed1cb759a9eb42dbba1095cc7927a29dc694fe53e15c6da783c183bce3aaafcdc63fc9c1f756d8cc889af3a5707e611aa707bd38e925f14d3c9e8e92691af727e970329e84b99c39a995c5cc3f7766792595b4ce083f16861c3f865d6eda9aa734534e2ad67529ac93d9405655a3982a9d372596a80d890d2bb75027dae2894eb5a9ec74a1ae75e3d8925ed3eb13a674761b9136a25ca8635d555ad18d1139d325f0b0d3605fb3fadac42f18726255b27ffbfd0fbc9552dd752ffedb0c96b8258e8731afecbf15366b4ae9a49d524ad56670b7a1ab4f940b59b60bf5e97aa19251377a764b9f537a60beb3f4382457b0a2cfc36ea00f07fed55847b9b64c4e93b8d73227cbf76c984a6eee74cd4a8a85fa4753379614d785e90e4d36836a37ddf3dbc34f57f8632fb931bab66d5648e18ccca8f4aba644717f3ca297059f934ad32325d4b230d1b349616c18c62c5c50992ef5069b3416d81102263351962d554d56502137059b60b7a55dee6ffab41f7b0f46316dfdd670a373469480a6b57bbf108279cd9914e5f24ad78115cfe47a8ec495e18d122a6be93a7066011a9c003091b9309b8cb4777ef04cad8572e1950a6169c5703b67a017f8c33988c5ca5b1ac20d9e7de41a5b64cf033f67fc5f5bf863159e78117793ed52aae576871d1cf8b2f16b1f7fbced76fed2cf5f66707aa38d84f15f02d4c720921152e588f4b740cfca92cda6f541ce20583bf0a966a1fe69a412a62568725dea07d22bc0d904887e4970608be5e5358bec5b13beb3e1ce9c8dd4cdeb7917a2941d60d3a022aea48868558a3c6710de8430d75cde4b1b8102a6f2ff85da48e41993e90a82bbc2b6993039a847bc5e37160746d48d64e444556b85d48244f33ca41f65265d1bd1f1c7d3859a9fcf0737ef2f17ea4c3978e4a05a7fa6e20684f3d680cd78f2c8ade5ca8061d6cf5d77ae0d2cd761e4a8b3793b6790851865ae311c5101f61a53082fd3ac0d87d868a166ffd648e0de2db1f31aef2eca3e33be09ad0e2a8bc8de4945b5dc54c8bb1db5b202c030f031c2161129643868b9423e46c211480e6270af2be9b90a2ca5803d2c3c9adaf063485ddb3486d5dc38f39cd366384487e96fadfc614ef87fcc7f10f3b72af91f08fa7fa90b3f99e0ae0a612a116a6bfbca978fa25cf74ab9465b34ec2569b150178c8d74296d35a5a752b450ef1f33c35db313aad52f9870c11e1b6cbbd4ebe52cfba6379b9577edd7fd1724001eda5ed8857cb15479e8be4e2e67c02ba7ebcb5944521572259da5da68c788866dd19630f8fb0b265ef31a1d90caf84d09aa7c053f8de884b33b288ce611dd0a45c7a2b4ce2fa0bf47c48e44d9a723c3e82aa15eec62c8b3e3b9884e910c20784431efca9cf705bb48af5a1586205b88ceb2b2e8ba2a660f469fde3786ce7198dfb14f699cc4eff60f7693c3bde930191df686c9c1619f7ebf6a56179ce3f364988ef7e33f401805395b70f2fc7d44b31a4968259a8a4eaf239a6785463bf5e1c9ec88160df6cd506b35a06768fc02cc44594523ab2c1ae5677aafb5a18b964b9db7f6a97fa679ab72a32ba6dfa42bd05ade7b4b733a91203bfacb0b6dd0d97be2a1f326101163676734774dde7a088e1adb94e89190cddedc02a210e61bed80cb114eec9d19f4d5b2b3c47f9a01b116a1f6db5c19bd513a18748aa4a50dd293772af7d821cc145acb8892c9e400bffbbbc9de344de3dec10b7687a3d1215678e88cca1d1d47f4513c40e290f30920dce279bd0df70cf7039c2fe8daf777ddc101a4639f304144dc6160b7ca1b0f499093c65fd17660dd4a95a129f2d7111ce17b0fa5ab36939d7b6ff1e8bf72c55321de7f97a6bb49bc374d0e27fbbd6412272fee24a3647f181fa62ffe402f73a71588793edbfa4627f3ad3bafecf9ca9c2e12d91b7b40d6aa1606473d7867ee7f6eb1289f780fc17fbb1e3041cf99f8abd51ee3a09c8a3d23b8171a6c14a8558e539f8beb14f958963924fa3790a4bb5bb4b431baa991513c014f2687f1f03bc04edea5e3dd2138324a0ed31e7ea0b15c4bdc80e27e82ef83f3e34f7d3faf9fa6fde1f86b092693f1381e8e870177adf47a4d1fc09823568a9da3df2efcb301f0e7f3adfe7ceb0d0a332ebd48674004c674d7825354105460dc2ec275803e34701fb6e202e431085745dbd1e5c9d588464093f33ec42651d4b9ac0b5f4dae661060159a0de42e8dbe1ae4f5ca29a021943365df79cfc768186882df641cf77f36897ef9f21f81218332', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136511, 4177, 0.75, 0.75, 'g', 'IV', NULL, 'Adult', X'789cf34b2d2dca2f28ae4ccec84c2c29ca4c56c8292d282db65230d033375548d7cfd530d254f00c532834cccd57a8503054a84c4d2cd25128c948cd532834068b1983c58a018d7017b1', X'789ced575d53db4a12fd2b5dbc2c54c9b624638c9d270321815d088559eec3f52dd7586a5bb34833cacc08d0deca7fdf33233081e4562a79dadada078c349a8feed3e774f7fcb9939b66b354a2e29d29ed1cb759a9eb42dbba1095cc7927a29dc694fe53e15c6da783c183bce3aaafcdc63fc9c1f756d8cc889af3a5707e611aa707bd38e925f14d3c9e8e92691af727e970329e84b99c39a995c5cc3f7766792595b4ce083f16861c3f865d6eda9aa734534e2ad67529ac93d9405655a3982a9d372596a80d890d2bb75027dae2894eb5a9ec74a1ae75e3d8925ed3eb13a674761b9136a25ca8635d555ad18d1139d325f0b0d3605fb3fadac42f18726255b27ffbfd0fbc9552dd752ffedb0c96b8258e8731afecbf15366b4ae9a49d524ad56670b7a1ab4f940b59b60bf5e97aa19251377a764b9f537a60beb3f4382457b0a2cfc36ea00f07fed55847b9b64c4e93b8d73227cbf76c984a6eee74cd4a8a85fa4753379614d785e90e4d36836a37ddf3dbc34f57f8632fb931bab66d5648e18ccca8f4aba644717f3ca297059f934ad32325d4b230d1b349616c18c62c5c50992ef5069b3416d81102263351962d554d56502137059b60b7a55dee6ffab41f7b0f46316dfdd670a373469480a6b57bbf108279cd9914e5f24ad78115cfe47a8ec495e18d122a6be93a7066011a9c003091b9309b8cb4777ef04cad8572e1950a6169c5703b67a017f8c33988c5ca5b1ac20d9e7de41a5b64cf033f67fc5f5bf863159e78117793ed52aae576871d1cf8b2f16b1f7fbced76fed2cf5f66707aa38d84f15f02d4c720921152e588f4b740cfca92cda6f541ce20583bf0a966a1fe69a412a62568725dea07d22bc0d904887e4970608be5e5358bec5b13beb3e1ce9c8dd4cdeb7917a2941d60d3a022aea48868558a3c6710de8430d75cde4b1b8102a6f2ff85da48e41993e90a82bbc2b6993039a847bc5e37160746d48d64e444556b85d48244f33ca41f65265d1bd1f1c7d3859a9fcf0737ef2f17ea4c3978e4a05a7fa6e20684f3d680cd78f2c8ade5ca8061d6cf5d77ae0d2cd761e4a8b3793b6790851865ae311c5101f61a53082fd3ac0d87d868a166ffd648e0de2db1f31aef2eca3e33be09ad0e2a8bc8de4945b5dc54c8bb1db5b202c030f031c2161129643868b9423e46c211480e6270af2be9b90a2ca5803d2c3c9adaf063485ddb3486d5dc38f39cd366384487e96fadfc614ef87fcc7f10f3b72af91f08fa7fa90b3f99e0ae0a612a116a6bfbca978fa25cf74ab9465b34ec2569b150178c8d74296d35a5a752b450ef1f33c35db313aad52f9870c11e1b6cbbd4ebe52cfba6379b9577edd7fd1724001eda5ed8857cb15479e8be4e2e67c02ba7ebcb5944521572259da5da68c788866dd19630f8fb0b265ef31a1d90caf84d09aa7c053f8de884b33b288ce611dd0a45c7a2b4ce2fa0bf47c48e44d9a723c3e82aa15eec62c8b3e3b9884e910c20784431efca9cf705bb48af5a1586205b88ceb2b2e8ba2a660f469fde3786ce7198dfb14f699cc4eff60f7693c3bde930191df686c9c1619f7ebf6a56179ce3f364988ef7e33f401805395b70f2fc7d44b31a4968259a8a4eaf239a6785463bf5e1c9ec88160df6cd506b35a06768fc02cc44594523ab2c1ae5677aafb5a18b964b9db7f6a97fa679ab72a32ba6dfa42bd05ade7b4b733a91203bfacb0b6dd0d97be2a1f326101163676734774dde7a088e1adb94e89190cddedc02a210e61bed80cb114eec9d19f4d5b2b3c47f9a01b116a1f6db5c19bd513a18748aa4a50dd293772af7d821cc145acb8892c9e400bffbbbc9de344de3dec10b7687a3d1215678e88cca1d1d47f4513c40e290f30920dce279bd0df70cf7039c2fe8daf777ddc101a4639f304144dc6160b7ca1b0f499093c65fd17660dd4a95a129f2d7111ce17b0fa5ab36939d7b6ff1e8bf72c55321de7f97a6bb49bc374d0e27fbbd6412272fee24a3647f181fa62ffe402f73a71588793edbfa4627f3ad3bafecf9ca9c2e12d91b7b40d6aa1606473d7867ee7f6eb1289f780fc17fbb1e3041cf99f8abd51ee3a09c8a3d23b8171a6c14a8558e539f8beb14f958963924fa3790a4bb5bb4b431baa991513c014f2687f1f03bc04edea5e3dd2138324a0ed31e7ea0b15c4bdc80e27e82ef83f3e34f7d3faf9fa6fde1f86b092693f1381e8e870177adf47a4d1fc09823568a9da3df2efcb301f0e7f3adfe7ceb0d0a332ebd48674004c674d7825354105460dc2ec275803e34701fb6e202e431085745dbd1e5c9d588464093f33ec42651d4b9ac0b5f4dae661060159a0de42e8dbe1ae4f5ca29a021943365df79cfc768186882df641cf77f36897ef9f21f81218332', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136512, 4177, 40.0, 50.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c0dca310e80201005d1abfc521ba4d0c61b58d9187b029b8508ae71d584db4b33cd9bf5f4928593c7aba433b67a25ef72ae28af8f888923dd08d2101d1936182d1ec16451783818cb0ef9daa2d4ea3282abdaff1ff11d4d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136513, 5905, 5.0, 10.0, 'mg', 'IM', NULL, 'Adult', X'789c33d53534c84d57f0f4d551282e4d2a4e2d2c4dcd2b5148c92f4e2d56484a2c4e4d51c8cf5328482cc9040917a51617e4e715a782e5531452cb528b2a150c1532f24b8b0085801990', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136514, 5905, 0.5, 10.0, 'mg', 'IV', NULL, 'Adult', X'789c458c410e82301045aff2979a882931ac3c8117703fd0a14cd2ce086d35dc9e868dcbfff2de77f7a1eb5d0a78bd6ff0fc61f5a201a66d848d19368382142a62fa44a21d5bb3a860b45833bc65c6e5276541e6b5b216a1d8681de3f93343544ef6f7af58fba17bb8249a515b1131514ca06911feb23f00d099340b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136515, 5905, 0.5, 2.0, 'mg', 'PO', 2, 'Adult', X'789c33d033d535ca4d5708f05748c92ccb4c494d5170f274d10df174d15128cec92fcfa95428c92c294a2c495528344f49ac2c5628c957484d4b4b4d2e5128cf2cc950f04dac50303430c84dd707ca0200d40619ac', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136516, 5905, 0.5, 2.0, 'mg', 'PO', 2, 'Adult', X'789c33d033d535ca4d5708f05748c92ccb4c494d5170f274d10df174d15128cec92fcfa95428c92c294a2c495528344f49ac2c5628c957484d4b4b4d2e5128cf2cc950f04dac50303430c84dd707ca0200d40619ac', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136517, 5905, 0.5, 10.0, 'mg', 'PO', NULL, 'Adult', X'789c33d033d53534c84d5708f0572834d435c9282ad651f04dac503034008aeaa7245602009a6d0989', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136518, 5905, 0.05, 0.15, 'mg/kg', 'PO', 2, 'Pediatric', X'789c55cc310e40301806d0ab7c07d06a4963178b41185ca0d1a2411afa47f5f6acf697573259240f06c18562824b752cf9b6e446270c3d8cbb9db10675dbb0b16d3284ddc73d811c5d9a2cceea8301e461e7d94e84e86845a71ffcaa171a702028', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136519, 5905, 12.0, 0.5, 'mg', 'PO', 2, 'Pediatric', X'789cb3333452d05530d033cd4dd735ca4d5708f05748c92ccb4c494d5170f274d10df174d15128cec92fcfa95428c92c294a2c495528344f49ac2c5628c957484d4b4b4d2e5128cf2cc950f04dac50303430c84dd707ca02006d0b1b8e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136520, 5905, 0.05, 0.075, 'mg/kg', 'PO', 2, 'Pediatric', X'789c33d63534aacc57d05530d03330d50512e6a6b9e9fad9e9fa2989950a01fe0a2999659929a9290a4e9e2eba219e2e3a0ac539f9e539950a259925458925a90a85e64085c50a25f90aa96969a9c9250ae59925190abe891540030d11460100302b205e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136521, 5905, 12.0, 0.5, 'mg', 'PO', 2, 'Pediatric', X'789cb3333452d05530d033cd4dd7056285007f8594ccb2cc94d41405274f17dd104f171d85e29cfcf29c4a8592cc92a2c492548542f394c4ca6285927c85d4b4b4d4e41285f2cc920c05dfc40a05430383dc747da02c006de91b91', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136522, 5905, 0.05, 0.075, 'mg/kg', 'PO', 2, 'Pediatric', X'789c33d63534aacc57d05530d03330d50512e6a6b9e9fad9e9fa2989950a01fe0a2999659929a9290a4e9e2eba219e2e3a0ac539f9e539950a259925458925a90a85e64085c50a25f90aa96969a9c9250ae59925190abe891540030d11460100302b205e', X'789ced586d6fdb3610fe2b077fd906c489e524cdea0d03dcb82f019ad66ddc62c35c083475963853a4425249b422ff7d47da92ad246dd2741d5aac1f0cc8e4dd73efc723df771253a6b162397606d079c6a42ed08844cbce16744a23fd6ae65c61073b3be76281f9b636a9ff123b57882d37acc02466cef3f47bfd07dd5ed48d7a93dec1607f6f10f5b7771f1e3cd88b022d7227b4b244f9bef314151a26c3b7c38bc03ea90a1c4cd5503951d88a67da093e555b3017c63a4803874798aa91b62c4578a24d6e07307eb90547c7f47b3b55873acfb582896109c20bb290f649e75add72b6a9c5252d393693e8fffdf98efe49a116e1cf5aab963ab73ba84d7ef9cecb1826a57431292d54dab278c84b8764712adcca32b27f9ffc97a7c1a2a0ef6989ca41a22d5a98318b09908105d1fb6583b6206b30ec278067682a8820d3a599aade768df5760b122c5025a481674f303588a0e7c06ad9bf40ce2ac22b9039986959da80093f9e0b97c14a0dc124ad96331970e62094086b6bfa9fe034daefeef672a12c94c42181339903e39920ed92a91a07ef586183b55ec73ea9387e098938130919f1e868d49d1c8dc87ca9cf65054e380a3cc2e941c22a0b4e03cee71446089a1db30b887a64e50eed4ed5842c4747d427954a8ccef10bc8d88857e362c23e8dba7b99b15b6df27be75d2de40e39d79012f21aa171f4ed086bd265c68e3111cc19c13f98b5d00825071fa9bfc83c6f11583647570153c9ca83e28c0ad75a50da015a4f246c46111094c4b5943a9d2dfc1af52bbd912304bedbf56bd085de766fbfdbdb8ef6c9b18be0dbcf8b680b6aaa7e8bfa4108ad7df18cbc6a53efe03f306aff5f34ea1166ec4c686ae13012569b04cd4db1fae6ecdaccea4d63226fccee97b7a5ee25d7c03fa3a7848a3e299053a78ec7ba28255b1fc44db330982aa67805af6957a5d49ce170aa9e33bef4071861177ef18d5a287d4eadef352a1ffdd01fc871fe8c2333945674a235fda3597986bec6f935fa7a5de4051326a726d0e6bebe7fdf867ad5c2dbbbe2c88f494b621b0b153708ed3edbf6d11d9a6d0d1353978c65cd1d87a94cb219fad375d5880fb5a26c127470f31b823694124d5af91ce39259bbe321c87fcc2ce8f8d5ea07ebab136968a0c988954147eabbaf2650182db54a9b03e613b36998d0a061317e8d8c5f57eb06c0ce090d8dbabc9a7341094af35793a99a96fde861dff74b63697aa37102a1d04239b4f5269c9449820a4634a364945355a11d2a1b4ee21758121c163e5972268577b103bbeab9537582e26f6ac49db6654b1ffb99b1a519b9ddd21cb73ae47f47a3add3b960d4f864690c697c269662df18a198f18393f3f3915f7a8ee5828664e5c9492b67ea3fc3d430554acd2bb79c7f4615c1d2d6cee30b8a725119968b64d9529741aba5bd0dd2aeea7ec7b45f3bf92eb9b9a28e89ba95e53784e576b89a294e30ae995aa81b21bcc3e56383b885f2f1d8df0ebcc11f37fc71c3df92b591471f07ad095bdc9b89753b448bba85732ded6e075bb1c46b96658bf99a2af36ad7f85e9adf4bf37f5c9adf54fadf6726fb0a7d3ece98c919a75a4bab96e79f3139ef4a31c701443f871716f2d331928d9aaeb4f9a01955bb004f65c9296f15f92c0c5dfe3a7cf8c77877b8d7cdc370eb1f421e5f7012eeef1ae095c140f50439931e97674c11ac7f6519f225d58c02b4b054e2d65101b0654da125f1f98c3e135d5094144d847ece8e02dca84f3ee1543e54ed7ef47319c2cc0f94e141c8d0c5dcbfe4ac3ea983f87d83d2c7d84bce7c59674c122e0f787ea1c82a4a02492e30949dc444e4e16189c650d660253e1882d365c3801f12cfc21c4d956f1de6f7b9c020c64369757b00de7c6d23f917820b77ff27970fa27dc29b5fdcf0513e5d5efe0307cd6d62', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136523, 5905, 12.0, 0.5, 'mg', 'PO', 2, 'Pediatric', X'789cb3333452d05530d033cd4dd7056285007f8594ccb2cc94d41405274f17dd104f171d85e29cfcf29c4a8592cc92a2c492548542f394c4ca6285927c85d4b4b4d4e41285f2cc920c05dfc40a05430383dc747da02c006de91b91', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136524, 5905, 0.01, 0.03, 'mg/kg', 'PO', 2, 'Pediatric', X'789c33d63534aacc57d05530d03330d40512c6b9e9fad9e9fa2989950a01fe0a2999659929a9290a4e9e2eba219e2e3a0ac539f9e539950a259925458925a90a85e64085c50a25f90aa96969a9c9250ae59925190abe891540f30c4de146010018082021', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136525, 5905, 12.0, 0.5, 'mg', 'PO', 2, 'Pediatric', X'789cb3333452d05530d033cd4dd73534c84d5708f05748c92ccb4c494d5170f274d10df174d151f04dac50303400caeaa7245602004e530df1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136526, 1538, 1.0, 2.0, 'g', 'PO', NULL, 'Adult', X'789c33d4354ad74f49ac5408f05748c92ccb4c494d51283434d23532c900007072080c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136527, 1538, 1.0, 1.0, 'g', 'PO', NULL, 'Adult', X'789c334c5708f05748c92ccb4c494d51283434d23532c950a85030344849ac2c06008a2a090a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136528, 1538, 30.0, 30.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3336c84dd7cf4ed74f49ac5408f05748c92ccb4c494d51283434d23532c950c84dac503002cb02000d9d0cd9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136529, 1538, 30.0, 30.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3336c84dd7cf4ed74f49ac5408f05748c92ccb4c494d51283434d23532c950a8503034004a15eb28e42602d96075009a0f0fce', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136530, 17042, 10.0, 10.0, 'mg/kg', NULL, 1, 'Adult', X'789c3334c84dd7cf4e57d0c84dac50303500f152122b3515521233732a1580424056653100deb10bd5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136531, 17042, 10.0, 10.0, 'mg/kg', NULL, 1, 'Adult', X'789c3334c84dd7cf4e57d0c84dac50303500f152122b3515521233732a1580424056653100deb10bd5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136532, 17042, 5.0, 5.0, 'mg/kg', NULL, NULL, 'Adult', X'789c15cb310e80201005d1abfc520ba321c1d2bba02c6074d90496446f2f7653bc390336ac60c99a2ae4f6d04419debd309385046821a74c595193b40e764221df0eea566039ce57c460ecd2ebffd83de307f8271cd4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136533, 17042, 4.0, 4.0, 'mg/kg', 'PO', 1, 'Adult', X'789c33c94dd7cf4e5708f05770f274514849cccca95448cb2f52303401722a8b153432d314ec148c1472f3f34a328a15f27352340190e40fb0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136534, 17042, 500.0, 500.0, 'mg', 'PO', 1, 'Adult', X'789c333530c84d5708f057c8cf4b4e554849cccca95448cb2f02b22a15940d154a3252f3148c4c71aa29565036d2350500f0dc157a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136535, 17042, 500.0, 500.0, 'mg', NULL, 2, 'Adult', X'789c333530c84d5770f27451a830574849ac2c0600287504f9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136536, 17042, 500.0, 500.0, 'mg', NULL, 4, 'Adult', X'789c333530c84d5708f47451a830574849ac2c0600291a0508', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136537, 839, 0.25, 0.25, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65230d03332cd4dd701d260ca1044188108631061929b6e0d12d3cff50100c5c10fb3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136538, 839, 1.0, 3.0, 'mg', 'PO', 1, 'Adult', X'789c33d43556c84dd74f49ac5408f05748c92ccb4c494d51284cd14fca4c0100792a08fe', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136539, 839, 16.0, 16.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb0523034cb4dd74f49ac04001bc40429', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136540, 839, 1.0, 4.0, 'mg', 'PO', 1, 'Adult', X'789c33d43551c84dd74f49ac5408f05748c92ccb4c494d51284cd14fca4c0100794408ff', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136541, 839, 1.0, 4.0, 'mg', 'PO', 1, 'Adult', X'789c33d43551c84dd74f49ac5408f05748c92ccb4c494d51284cd14fca4c0100794408ff', X'789ced5a7b6fda4810ff2aab48d5b53a488024b447ab9328b44ad4a645497ad2e9a8acc53bd82bec5ddfee3a8d53e5bbdfaccd6b0d2986bea41eff005ecfcccee3378fb5f97cc0541a7882c670d02107975c27a03893020e6ae42055915d0d8d4974e7e8e8139f407c2855607ff1a312b1f6154d8079d4589e56a3d5ae379af566e3baf1acd368768e4f0f9f9db49b7f3ccb69c1375c0a8d949f0fba2ce6826ba3a85dcb970cdce652aeb3043aa46bb284fb341a0a2a0c4f74e687d2707f28fa52d300c86ba962dd218dc3d6691cd4f03bff6ada8f96fd38b61f2771f0dcae1dc56f87e252a606349163e26ede21ef158d6ae4fc62287a328ea520d78a3220efd041b8456132a3516e443a5ab6e31e970c1d4560affef98857111793fc62619063c06617771df2fb8f768f2e4b23e3a1e95c048eb3d6e87470e587fc4e26a102c1a943fda27d4a32896ed28640c2b5643014cdfa314117319a91c17bc2f80d67c0c8bfec68c4d9505cd0db0e69b60b82a198498829170630367e2ee1e40b12daa7bf23cb262ab40d83f3e79c445105514662a980c0786cedbbc921b7e46eeb99973c9111551e436b140355f32c7ebc66cdebfa186f2fa602bdb8ec8466bdbdc9de19c19afdae65aac0a0e0ab4c3025f3145ac8b6707cc09df599f807a57f014cf9d6bf765ccb28fe1f05f6bb9b5af6ed4fb4f51b6f5dbd1ee7bb0f80716a14f7abd6d20543a2a40f2cc556e16960ab6dab71d8b09d6682aa21e4b19b90c7d3168670cfed3a898b7b4fd6a0cfc96daf5539d83b56445a52fdb4dede628773a5382ef1889b0ca5a6067b297a68b6a147b5963eba0dd8ca360f97a40752b2008b5e0f96a7db08ac8e8d6f1cea2ff6e77dac7f46acbf2604bb34aa7d0c76eb7a5bfaad1c9a5fd371dfcdaa7563c28f33ebeb77db7218b84a00dd14790399a4115d983ddb71a020b09370462ef1ae08867854ec0dc55bea9b9c9a28ae2776f15c8cf18c975f129f0a210d1901516984dae1a1138f9e3851479da1c88f71f8dd53bd88bc386e74c895a1cad8d32b1a465e9ef7890941102e7c05145bcb282b4eb6f9ad4f00930867f5b37e87bcc33d188cb9001c8ae69d0b452fdda8110d40a8dd93b07cdc3944664850797f59999047ac3e488390f422c40ee9ad518b0ab641abea4aec7a8e2ec763f351ba6f9f7314c4dae3c29b4b38c00d1782dd886e163ba7f72cbde763aa05527154be38adf7a4300a0f520c4782555875a30854901123896ffd7d649fc66018689a3f8d58f2e41165125de203822b311aefcc3d70ac18419218b4013514af224c7c1c3e72aa3ec4c8c1691d4f5ab60a90e26982e67a8a44c2e3847265a9e68070d606544db8d052fca6499f6b1b740c2aa40ad5492c714c236e35316496ab43116219920a917005fc0e877c325fe851c5b8bca1dac73c5398b853897d4e47609fc9c41061314b51bfab94fb98d5f340ec82932f2bba39bc4bfcde9c7f51941ce8ac9850019453166fce327bc673034a837709d45f45cdda41121497a94b779625120ff01a8986a23614a8b62f1374f6ab5bc46492291a738610d0599c18196bc49bb1e1b901c2328d5107cde9e660a3e410bbb5c272a562cb7066af8228f321bfc4fb6c35bab8da7fd39d23245f18284e13aee3fce2ca283929d6afcf91b09fe924a48195f816d2091a22a6d25141a45d5c770345451a493f3305d20b2451db242da0f3da6538f6ca35fdbb78ece766e9841a0430a735eb172385fd95ccf202f5ad61fe412c95b5a638231c0db10f181ea430b5ffeecebad3da4d46916d6e8cdc701b999a7daa79cbc1aa5623be14e3b408d825d5e1d4977808892c108475680dcb2c0f4243022c2bb5792566842609a055601f5d0a1c03925c9399ff950aa1708fa0a9b63f51c71b19f3a29d7d505c5095597158b170a7fca94f4f622bb07a7db83c47cf85121d6a0165b0df160aa311294208f3d8a46a649f156dd1ebd7427573d62c133b193805f86609575342877b15fb9b055d173cde128f23f347d69fe524ace4c405b523c749df8a82e6e48ea495b4dfa9223a35f64db7820c2472b8a635a6022ea6840ef7ac2a6d669f53babbe785acc2e6059dc38b95af0208cf4bf62eea63850166415b46eeaca85682e99cd891522ac515de789418dc48944af786682c533b72a6a579b388d753c212aaa7c5bc0a9a67a48e8469c1aff2fea72074b86d63a8f076ce52397ccb5d6133bf435dceeabc99544ae682d2e12ffa4f055015740eefac616de6fe6b4659f20136b42ac65bb26216db4f56bb4e56e519753f5aed47abfd68b51fadf6a3d57eb4da8f56fbd16a3f107c8b816097c7a2fb2cdd6769e52c1d8454c5d497910c32f71444a3713de263e8905623248f07ef9f3c27c7f536b16fe51e9f5f3c198a0b402cca08f3b643a66f176aa4f7f7a0d56fdbc312a653f1b74b9b12409e361ed5c86bf071ac699e3cdae135de05f821b555c29363afebaffc5be3839808f909f3f4f4ecbadec2040cf9881ba96c9ed30928d25f5adce5352280d78db4744bdaf29f38b12a39d7c4c85b3c42992dffc1f490f42dff525a4acb8735db42a637e743f8dcdfff0777102d07', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136542, 839, 4.0, 4.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e2d56b03351c84dd74f49ac54284a2c4acda954c8cd2f4a55484d4b4b4d2ec92c4b0500f0a10d45', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136543, 839, 1.0, 6.0, 'mg', 'PO', 1, 'Adult', X'789c33d43553c84dd74f49ac5408f05748c92ccb4c494d51284cd14fca4c010079780901', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136544, 839, 6.0, 6.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb0523053c84dd74f49ac04001b520418', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136545, 839, 0.25, 3.0, 'mg', 'PO', 1, 'Adult', X'789c33d03332d53556c84dd74f49ac5408f05748c92ccb4c494d51284cd14dca4c01008a730990', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136546, 839, 6.0, 6.0, 'mg', NULL, NULL, 'Adult', X'789cf34dac503053c84dd74f49ac040017e703de', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136547, 839, 0.01, 0.01, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c33d03330cc4dd7cf4ed74fc92f4e55f0f455d028a92cc84c4eccc9a95430d03332d535c985c869020022400d65', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136548, 839, 1.0, 6.0, 'mg', 'PO', 1, 'Pediatric', X'789c33d43553c84dd74f49ac5408f05748c92ccb4c494d51284cd14fca4c010079780901', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136549, 839, 0.5, 6.0, 'mg', 'PO', 1, 'Pediatric', X'789c33d033d535cb4dd74f49ac5408f05748c92ccb4c494d51284cd14fca4c010080a90943', X'789ced5a7b6fda4810ff2aab48d5b53a488024b447ab9328b44ad4a645497ad2e9a8acc53bd82bec5ddfee3a8d53e5bbdfaccd6b0d2986bea41eff005ecfcccee3378fb5f97cc0541a7882c670d02107975c27a03893020e6ae42055915d0d8d4974e7e8e8139f407c2855607ff1a312b1f6154d8079d4589e56a3d5ae379af566e3baf1acd368768e4f0f9f9db49b7f3ccb69c1375c0a8d949f0fba2ce6826ba3a85dcb970cdce652aeb3043aa46bb284fb341a0a2a0c4f74e687d2707f28fa52d300c86ba962dd218dc3d6691cd4f03bff6ada8f96fd38b61f2771f0dcae1dc56f87e252a606349163e26ede21ef158d6ae4fc62287a328ea520d78a3220efd041b8456132a3516e443a5ab6e31e970c1d4560affef98857111793fc62619063c06617771df2fb8f768f2e4b23e3a1e95c048eb3d6e87470e587fc4e26a102c1a943fda27d4a32896ed28640c2b5643014cdfa314117319a91c17bc2f80d67c0c8bfec68c4d9505cd0db0e69b60b82a198498829170630367e2ee1e40b12daa7bf23cb262ab40d83f3e79c445105514662a980c0786cedbbc921b7e46eeb99973c9111551e436b140355f32c7ebc66cdebfa186f2fa602bdb8ec8466bdbdc9de19c19afdae65aac0a0e0ab4c3025f3145ac8b6707cc09df599f807a57f014cf9d6bf765ccb28fe1f05f6bb9b5af6ed4fb4f51b6f5dbd1ee7bb0f80716a14f7abd6d20543a2a40f2cc556e16960ab6dab71d8b09d6682aa21e4b19b90c7d3168670cfed3a898b7b4fd6a0cfc96daf5539d83b56445a52fdb4dede628773a5382ef1889b0ca5a6067b297a68b6a147b5963eba0dd8ca360f97a40752b2008b5e0f96a7db08ac8e8d6f1cea2ff6e77dac7f46acbf2604bb34aa7d0c76eb7a5bfaad1c9a5fd371dfcdaa7563c28f33ebeb77db7218b84a00dd14790399a4115d983ddb71a020b09370462ef1ae08867854ec0dc55bea9b9c9a28ae2776f15c8cf18c975f129f0a210d1901516984dae1a1138f9e3851479da1c88f71f8dd53bd88bc386e74c895a1cad8d32b1a465e9ef7890941102e7c05145bcb282b4eb6f9ad4f00930867f5b37e87bcc33d188cb9001c8ae69d0b452fdda8110d40a8dd93b07cdc3944664850797f59999047ac3e488390f422c40ee9ad518b0ab641abea4aec7a8e2ec763f351ba6f9f7314c4dae3c29b4b38c00d1782dd886e163ba7f72cbde763aa05527154be38adf7a4300a0f520c4782555875a30854901123896ffd7d649fc66018689a3f8d58f2e41165125de203822b311aefcc3d70ac18419218b4013514af224c7c1c3e72aa3ec4c8c1691d4f5ab60a90e26982e67a8a44c2e3847265a9e68070d606544db8d052fca6499f6b1b740c2aa40ad5492c714c236e35316496ab43116219920a917005fc0e877c325fe851c5b8bca1dac73c5398b853897d4e47609fc9c41061314b51bfab94fb98d5f340ec82932f2bba39bc4bfcde9c7f51941ce8ac9850019453166fce327bc673034a837709d45f45cdda41121497a94b779625120ff01a8986a23614a8b62f1374f6ab5bc46492291a738610d0599c18196bc49bb1e1b901c2328d5107cde9e660a3e410bbb5c272a562cb7066af8228f321bfc4fb6c35bab8da7fd39d23245f18284e13aee3fce2ca283929d6afcf91b09fe924a48195f816d2091a22a6d25141a45d5c770345451a493f3305d20b2451db242da0f3da6538f6ca35fdbb78ece766e9841a0430a735eb172385fd95ccf202f5ad61fe412c95b5a638231c0db10f181ea430b5ffeecebad3da4d46916d6e8cdc701b999a7daa79cbc1aa5623be14e3b408d825d5e1d4977808892c108475680dcb2c0f4243022c2bb5792566842609a055601f5d0a1c03925c9399ff950aa1708fa0a9b63f51c71b19f3a29d7d505c5095597158b170a7fca94f4f622bb07a7db83c47cf85121d6a0165b0df160aa311294208f3d8a46a649f156dd1ebd7427573d62c133b193805f86609575342877b15fb9b055d173cde128f23f347d69fe524ace4c405b523c749df8a82e6e48ea495b4dfa9223a35f64db7820c2472b8a635a6022ea6840ef7ac2a6d669f53babbe785acc2e6059dc38b95af0208cf4bf62eea63850166415b46eeaca85682e99cd891522ac515de789418dc48944af786682c533b72a6a579b388d753c212aaa7c5bc0a9a67a48e8469c1aff2fea72074b86d63a8f076ce52397ccb5d6133bf435dceeabc99544ae682d2e12ffa4f055015740eefac616de6fe6b4659f20136b42ac65bb26216db4f56bb4e56e519753f5aed47abfd68b51fadf6a3d57eb4da8f56fbd16a3f107c8b816097c7a2fb2cdd6769e52c1d8454c5d497910c32f71444a3713de263e8905623248f07ef9f3c27c7f536b16fe51e9f5f3c198a0b402cca08f3b643a66f176aa4f7f7a0d56fdbc312a653f1b74b9b12409e361ed5c86bf071ac699e3cdae135de05f821b555c29363afebaffc5be3839808f909f3f4f4ecbadec2040cf9881ba96c9ed30928d25f5adce5352280d78db4744bdaf29f38b12a39d7c4c85b3c42992dffc1f490f42dff525a4acb8735db42a637e743f8dcdfff0777102d07', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136550, 839, 0.5, 3.0, 'mg', 'PO', 1, 'Pediatric', X'789c33d033d53556c84dd74f49ac5408f05748c92ccb4c494d51284cd14fca4c010084720960', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136551, 839, 0.75, 3.0, 'mg', 'PO', 1, 'Pediatric', X'789c33d03337d53556c84dd74f49ac5408f05748c92ccb4c494d51284cd14fca4c01008b0c0997', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136552, 839, 0.01, 0.01, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c33d03330cc4dd7cf4ed74fc92f4e55f0f455d028a92cc84c4eccc9a95430d03332d535c985c869020022400d65', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136553, 839, 1.0, 6.0, 'mg', 'PO', 1, 'Pediatric', X'789c33d43553c84dd74f49ac5408f05748c92ccb4c494d51284cd14fca4c010079780901', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136554, 839, 0.5, 6.0, 'mg', 'PO', 1, 'Pediatric', X'789c33d033d535cb4dd74f49ac5408f05748c92ccb4c494d51284cd14fca4c010080a90943', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136555, 839, 0.5, 3.0, 'mg', 'PO', 1, 'Pediatric', X'789c33d033d53556c84dd74f49ac5408f05748c92ccb4c494d51284cd14fca4c010084720960', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136556, 839, 0.75, 3.0, 'mg', 'PO', 1, 'Pediatric', X'789c33d03337d53556c84dd74f49ac5408f05748c92ccb4c494d51284cd14fca4c01008b0c0997', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136557, 914, 800.0, 1200.0, 'mg', 'PO', NULL, 'Adult', X'789cf34dcccc2b49cd4bcc4b4e5548c92f4eb5b23030d035343230c84dd74f49ac5408f057c8cc5348c92ccb4c494d01ab280600bb21111f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136558, 914, 4.0, 12.0, 'mg', NULL, NULL, 'Adult', X'789c0bc9482d4a2c482d2dc94c56284acc4b4fb55230d13534ca4dd7f751d03034d3b3d43535d0b350c8cd4c2ecacfcdcf492dd6f7d10400be031025', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136559, 914, 1600.0, 1600.0, 'mg', NULL, NULL, 'Adult', X'789cf34dac5048c92f4eb55230343330c84dd74f49ac54d0284a2c4acda95430d433d335d233010b6a020016a70c9e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136560, 914, 400.0, 800.0, 'mg', 'PO', NULL, 'Adult', X'789cf34dcccc2b49cd4bcc4b4e5548c92f4eb552303130d0b53030c84dd74f49ac5408f057c8cc5348c92ccb4c494d01ab280600b9081110', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136561, 914, 1200.0, 1200.0, 'mg', NULL, NULL, 'Adult', X'789cf34dac5048c92f4eb55230343230c84dd74f49ac0400424f0650', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136562, 914, 200.0, 200.0, 'mg', 'PO', NULL, 'Adult', X'789cf3cccb2cc94ccc51303230c84d5708f05728543034ca50c8cc4b2e4a4d2c4e5548aa8448e9a72456020036c50de4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136563, 914, 1600.0, 1600.0, 'mg', NULL, NULL, 'Adult', X'789cf34dac5048c92f4e5530343330c84dd74f49ac04003cc9061a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136564, 914, 100.0, 600.0, 'mg', 'PO', NULL, 'Adult', X'789c333430d0353330c84d5708f05728f40856282d5028c9573055284f4dcd2e060078c908b0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136565, 914, 200.0, 1300.0, 'mg', NULL, NULL, 'Adult', X'789c333230d035343630c84dd74f49ac5448cb2f5230d233d5b550284f4dcd2e060079260885', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136566, 914, 100.0, 200.0, 'mg', 'PO', NULL, 'Adult', X'789c333430d0353230c84d5708f057287449acd451c84dac54c8cc4b2e4a4d2c4e5528cec92fcfa95428c95730042bd34f49ac04009c461081', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136567, 914, 10.0, 20.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cf3cccb2cc94cccb15228494cca492dd1553034d03532c84dd7cf4ed74f5108f05728b4d03534cad051282e2d2e48cd2bcecccfd3c55062960100231f15dc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136568, 914, 35.0, 35.0, 'mg/kg', NULL, 1, 'Pediatric', X'789c0dc9c10d80201004c056b601c303fdd883455cb8955c94232a1ae95ebf338b9837ba78e28c221d6a8f29b19e3c6e7aeaf8bf220e239a155e50b1bdc36bc3cf7c13a98853c961cb41a57f93e71c5b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136569, 914, 50.0, 50.0, 'mg', 'PO', NULL, 'Pediatric', X'789cf3cccb2c49ccb152282e2d2e48cd2bcecccfd3553035c84d5708f0572834cbd05128494cca492dd155303480891a1a018573132b1532f3928b52138b53150a15ca5353b315922a21aaf453122b01012d1c63', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136570, 914, 400.0, 800.0, 'mg', 'PO', NULL, 'Pediatric', X'789cf34dcccc2b49cd4bcc4b4eb552303130d0b53030c84dd74f49ac5408f0572834d3b5c850d0c8cccd4d4dc94c2c4955284acd494d2c4ed5d45128343402cab806690200bd99145c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136571, 914, 200.0, 200.0, 'mg', 'PO', NULL, 'Pediatric', X'789c1d8dbb0a023110457fe5961b3090dd42c4ad2d0441b1b11e6534c13c7633b3857f6f48773887cb3de7a081e211b2c9c25942c916a34b170c9373e96370bb62ddfb194acfc86ad175b7e3e47748f443c8afca248cf5c1fced01c3e96ee6b6b487c6453d57bc4b4d5b246d1f62fe12de2670', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136572, 25269, 1.0, 1.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c55cc310ec2300c05d0abfc850d44ab8a850189910bb0073089451c07db2deaed59e100ef9defef998d1e108a42a2b9ea8d1b09a7234648debf322e57e84286c36e1a84db16925618754a016e180b3e1c057347e82fe2e7ff8a4a0b557870ad384dc3066af0557aa8383a99b3c7172f30321c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136573, 25269, 1.0, 2.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c73292a4dd7cdcc4b294d4e4d51c84d2dc948cdcd4fcfc94fcacc4bcdcd4cb45230d43552c84dd7cf4e57f00c5328cec92fcfa954c82f4b2d52284e059289390ab99979a525a9c500b7cd1a3d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136574, 1780, 1.5, 2.0, 'mg', NULL, NULL, 'Adult', X'789c33d433d53552c84d57f073755228543053c82802002bdb04be', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136575, 1780, 0.25, 0.5, 'mg', NULL, 1, 'Pediatric', X'789c33d03332d535d03355c84dd74f49ac54f073755248c92ccb4c494d510874d175f27401009c7f0986', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136576, 1780, 0.5, 0.5, 'mg', NULL, NULL, 'Pediatric', X'789c0b2e492c2ab15230d03355c84dd74f49ac04003075055d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136577, 1780, 0.5, 0.5, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb05230d03355c84dd74f49acd45308c92c294a2c495528c957c8c92f4f2d2e51484d4b4b4d2ec92c4b5548c92f4ed503009dfd112b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136578, 1780, 0.25, 1.0, 'mg', NULL, 1, 'Pediatric', X'789c33d03332d53554c84dd74f49ac54f073755248c92ccb4c494d510874d175f27401008fb50924', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136579, 1780, 0.5, 0.5, 'mg', NULL, NULL, 'Pediatric', X'789c0b2e492c2ab15230d033cd4dd74f49ac04002c99053d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136580, 1780, 1.0, 1.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb0523054c84dd74f49acd45308c92c294a2c495528c957c8c92f4f2d2e51484d4b4b4d2ec92c4b5548c92f4ed5030089f710c9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136581, 1780, 0.25, 1.0, 'mg', NULL, 1, 'Pediatric', X'789c33d03332d53554c84dd74f49ac54f073755248c92ccb4c494d510874d175f27401008fb50924', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136582, 1780, 1.0, 1.0, 'mg', NULL, NULL, 'Pediatric', X'789c0b2e492c2ab1523054c84dd74f49ac0400280504fb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136583, 1780, 1.0, 1.0, 'mg', NULL, NULL, 'Pediatric', X'789c0dcab10d80300c04c0557e82a0b4146c40c70216f9a0882023c710d81edad3cdf28c8838b621c91bb0143771c215553b9b833973f57213491bff21270d6a52d19ca62561334997d4fa42f24f98223ab9870fd287206d', X'789ced596d6fdb3610fe2b0703fbb4f8454ed26eee30202f5d5b2069b2242d30d481404b67890b456a2495582bf2df77a4e417ba69ed662f18b67c6a25dd1d9fbb7b9e3b45fed8497595c59215d81941e7b04ad128c953ecec40a7d2c2ddccad2dcda8dfbfe33758f494cedcff783fb435896625a631b3ce6538183eeb0ea26e34b81a3c1fed7d3f1a46bd287a4eb7bd2d26962b69c8f263e7202db8e4c66ae6eef95b16673eca555de2682cdfc89c094c2151daf244198b5af1742c8f956119c24f4a176604bb707c319617aab268404d218c3b8236ca581ea9a25012ae344b11de52e2e47c5e8982bbf81e5e355945784fb72c9b0874571faee94a7079e32f96501fc6b8b988ad5fbce6777fed4e3d482b61634a93cb2c284cd4dbef0ea1c8e0edcb43f80d9e41ae5d39402a0b059fc11db739289ba30689934af0df095a81294f7c310c309982e6d2201454b01cd8940e86cae0d7e5ef519e535c66354f1e427a606c5eb0b12c1897162593098e65d4fd0e6ad5a02c35571a265ac924572917ccd225134a92dda037dcef0e7afb94693f65b5cf36e5b7c4b8147e3eee1ebe391ecb4bcbb41dc1d26a2c4fd96cf5460faeb86301825520d41d1a0b389dba0c6f115265b0f71024de767441378f26da0e4b0025fa73409466e2112822782c08b8222587e742466aa99810754b951f23b843bc21c02f5dd3559973c113a08150e62ce3969bb1fc218a2895e668383f238030dbeb4643ef49cf4f89a91ed6b038f199f8a4f7210353d1341184c5819c92be9dbb1195d6359d7870eb104d954afb2991f80666bb03a2bd6ca1214b729f081533fad623187e01817bd6df5b45100dfe32088f1d278d6c368f8fd6ae19179725269c89f85c959560cb093b0f7aae31730aace1829eca6c4c53f1f005b805e00626e98f27e87225e2794b0b2519a2b4a6e5236a4313956e006b757dc212eb8fa271626e5cc493dd1770c9a6686ba8e48d547792a632295fb882d0a9233fa5529c72e9a6f16b7467240f3ddca1e124b99b07896b84a81f5bcdf5c437d7f5d82dc5c6d8c45cc68b081d3a701938cc7e73d8857decec639ac69829cd097cd3c12325499b5c2e0675384b85409dd58e908960c6f45de7888b6d2b768025b4fce886fba7ed10e08c25a8273edc581e3673d694cc144b7b4f6636d155697da353cdee98f8a7b8bb5ad0cf42df229c738d1bd738709d2fd35ba22fc61724ce4f6bfb40b29d4ba4f95badf540b232af059bb901b75a4d6272edf481d2d0f4bb25f6ebf6a01d5a2589e8816626a762cb8c2b4cd175ec20d55e18a62a4971c6f8161d552627da81a965aa55816de0e60581bb835e6975476a0cbc56a630053eca2b9d752f894b95312b915e095625ca1d7dc4684b103ecae28c14ad4aa52982e9840d6e38e95e9782227c7857ba054187975cbb855d538ad3a674d7d724774aa0590147aaca28e933eb2efd1b089dfd9ebbcdb2f0706088f1f4c838971dbf78082bb5522b9a35d4051febbd2a7833b68e39d33a4757c1494a775d0d4b920d95a1a4f9d43487b4f46b25dd5a6bdc2fa8fcebe96dc7e765cbb760e18a71c8ec45dfb709b2b00d62ac536373a4d6235e7804f15649b33956601de27a906e5ba05bf5fb0cc6396537475b5886d81c03b780e2cd02cf55d26e0ed058c78d758860c9ee2d70ac18877508e5b04539d61c8268732d6d0eb3b00cfce70adc6293ce2d433504badd421173fbd8db872c9e6b7e0b0a2f4cd738b23a2ab6214b601fc49a8f992f47f056ed5bdbff73cbac2fdba735f3b4669ed6ccd39a795a337fcf9af9afcdd7c7fc65fa24d22791feab457a9e335db0440995d581545f3331ed0a3ec5110c7bbbfe73ff2912df95a077b5119cf05bd42fe0e897f3bdfdc108760ff6c0e9c37fe72535cd128dcd8f20ef349708cf06dfec00c9161f7a13dbf4b9ff14939c493a3656d3f820f9e4479b3732e7136e492c95b0bc14e846846045d14c98a4b6ea864034bf41945aa515e1581a6782b66bfb6b88fb2a4546d46ca459b2bcd97caf363d7839a3974b52658b68fec1b1f7b569dddfff014b6163e9', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136584, 1780, 1.0, 1.0, 'mg', 'PO', 1, 'Pediatric', X'789cb3313454a8ccb7523054c84d5708f057087451a830d1353452284f4dcd2e0600766b0835', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136585, 1780, 1.0, 1.0, 'mg', 'PO', NULL, 'Pediatric', X'789cf3cdac503054c84dd737caf551f073755228cf2cc95030554857282e4d2e4accc92f4e5528c95748cb2fca5508f05728ce292d2aaad40300cf2811c1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136586, 1780, 2.0, 2.0, 'mg', 'PO', 1, 'Pediatric', X'789c3334d456a8ccb7523052c84d5708f057087451a830d1353452284f4dcd2e0600748f0825', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136587, 1780, 2.0, 2.0, 'mg', 'PO', NULL, 'Pediatric', X'789cf3cdac503052c84dd737c9f551f073755228cf2cc9503034504857282e4d2e4accc92f4e5528c95748cb2fca5508f05728ce292d2aaad40300dbe711f0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136588, 2064, 300.0, 300.0, 'mg', 'IV', NULL, 'Adult', X'789cf3c94f4cc9cc4b5748c92f4e55b055303630c84d57f00c5348cacf292d5648cbcfc9c92f4f4d5148aa543034054941c40382fc0021bb12c8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136589, 2064, 150.0, 150.0, 'mg', 'IN', NULL, 'Adult', X'789c33343550c84d57c8cc53303430c8f55170310d57c82f4b2d02727381821a86a640697d20535347212d3f2727bf3c354521a952c1102aac9052945900d161965154aca0616c0636b024bf24314713001b1d1ca6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136590, 2064, 0.5, 0.5, 'mg', NULL, NULL, 'Adult', X'789c0bc948cd5330d03355c84dd7cfcdcc534829ca2c50c82f4b2d52c84bad285130b450c8282a56d030353100aa5028c92f49ccd10400b596106c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136591, 2064, 400.0, 800.0, 'mg', 'IV', 1, 'Adult', X'789cf32f4acc5148c92f4e4c4f55484c2b492d52f00c53c8cc4b2b2dcecccf53c82c5630313050d0b50012b9e90a01fe0a298999399500e3061119', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136592, 149, 50.0, 100.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c3335d0353430c84dd7cf4ed74f49ac54f00c5348c92ccb4c494d512834cb0000858c094d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136593, 149, 4.0, 4.0, 'g', 'IV', NULL, 'Adult', X'789c335148d74f49ac54f00c5348c92ccb4c494d512834cb00004d050710', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136594, 149, 75.0, 100.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c73cc29b1523037d5353430c84dd7cf4ed74f49ac54f00c5348c92ccb4c494d51284ccf0000b80f0b00', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136595, 149, 75.0, 100.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c3337d5353430c84dd7cf4ed74f49ac54f00c5348c92ccb4c494d512834cbb056f04dac5030014b01000be50cfd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136596, 24893, 50.0, 50.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f55082e294acd4b2fc928b6523035c84dd72fcb4ccc010088d909a4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136597, 2021, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136598, 138, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136599, 209, 20.0, 160.0, 'mg', 'PO', NULL, 'Adult', X'789c3332d0353433c84d5708f05730d4355228c9cc4d2d5628482d524849ac04006ff20871', X'789ced564d6fdb300cfd2b82cf4df38122dd7ccb9a0e0db07645dbed32170623d3b616593224b9ab3be4bf8f72960f271d9206c34ebb5932f5483e3d92fa1924a6ca62050506210bbe82b4601ca8e0840595917e2f77aeb461b7fb43ccb038d526f35fa2db32b5dc4089490cce9f18f406c34eafdfe9f71e7aefc2de5978f6fe74787e3638ef37b6c89dd0ca92e5cf6094144209eb0cf8bd66cbe17383f2509718466aa432a11d2a2b149b4c98418ea5d386817290697fd6466aac2d64c83e6a53583a73a72b8796e994b5f143a60dc8485de8a2d08a3d184890dd50ee366463a19f7e27534d37639cd39683a944bffaf6482b29d4ac59ac833d20cafd946e80c49349bc04893741e68f3e9e5152491753d642652dd206bd4e7fd82b3276fb99f53b03e60425c74a342c81fa6dc9358e6e3111e08ce0af39bb87145dddc534151c78cd94760cad871336c7e40877f725720132bed56525612d93a5c75b83990245beeee8afca22bad271a43e01778d3533c2cefce644a5c45ab3641c948f6c8acc54121346e22089a002c99226a9902267907cafac2b50d1cf2b2c098ebffefb58896cc7be5f0f635f9a0b631b9326560801395c03b7b3df0fbbb28fbd7dccc161a68dc0a5b82eb4a27a112aa15bddbd82919468b29a39cdb8046bbbbe81f892525c1782fa01f10724809930a8225559645413a4a2297a4a3db144a23d96c515f401e5b4325d16cd131a8bf11d02dfcdeb9580827b3442575bf9fb22c5040ba0dec4a9cf50b17b29a5206465306827b1e0d3779b16c8555d2e0a5d134563f1f222145a7bc2728404788e91ba94f8441793b00f5f6eba17c6135c65f936fae1bda989f8c016b4b06d69ec0f99ee01f387e2e650bc3cb4b88a2389ddbe9fffccee30fb972979ebb8c8c114c0b5d459dd8e0164da9122c5900df3485d23a168aacf82a6f5e53337b818cfd7da3a59b31439c823dc5f23cf81e66411eb341ef19d27c5d6945ecfd5634615623c92566f538d66c5f5818f8263dae0a6a3fd726959b7d5f70fdf2df3f92f766991d6', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136600, 233, 0.25, 0.25, 'mg', NULL, NULL, 'Adult', X'789c33d03332cd4d57282e54283432d0353650c8cdccd351282d5028c957305148c92f4e2d560808f25348cecf2b294a4c2ec9cccf2b06008eb61092', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136601, 233, 0.25, 0.25, 'mg', NULL, NULL, 'Adult', X'789c33d03332cd4d57282e5428343250c8cdccd351282d5028c957305648c92f4e2d0600967d09ba', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136602, 233, 0.005, 0.01, 'mg/kg', 'IN', NULL, 'Pediatric', X'789c15cacb0d80201005c0565e01822b8a17ab30564022416216904fa2ddabe71992445a90a4815d7f3ad4083637484eecb0adb8062d14817de8d0d2cf23f6586c59bef720db644d850f5062c6115b2e2fb1321857', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136603, 44, 800.0, 800.0, 'mg', 'PO', NULL, 'Adult', X'789cb33030c84d5708f05708b4c8c82f2d2a060025a50506', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136604, 44, 400.0, 400.0, 'mg', NULL, NULL, 'Adult', X'789c333130c84d57c8482c56484a4dcd5328cec82fcf5328c907f2148062a96969a9c9259965404e89424162669e42516a4a2950243f0f246d06d69c9897a26001620100e0371984', X'789ced586d4fdb4810fe2ba37ca2528084228ad24f29b49453cb71c07daa91b5b137f65ed6b3d6ee1ae256fcf79b5927c10e70a148a77b11120af67a66f699679f99f5fa472fb55516a328646f04bdd349555a3395d8eb43afb29ac772ef4b37daddbd553359ec189bf195daed98bac48a52a6b1f0ecb137d83bd81e0cb78783abc1bbd1dbe168ffddcedbbde1e160186c65e2954147963f7a2712a5153a5c7b390fee57752947119e5d8e4f8f233c364e64123e195bb8115c8989969e2e8683411ff6f8679f7f0ef8e770308022db81cbca95121d4d32229322db2d349b41b88af0c8148541b8b2229570469953b8717aa3f47bf86abc554d46d5a40df48e863ccfcd77dfaee94e2b9c859b7be001f166e61ab3bb6b8e394e2bed63ca5161d6218172293238ff157e3bcc4d655d84fb6124170e265222b8dcdc227843774063723a65b83774e3a1140ac1cab40a09f0e383e02c30851038c26fc3eb9f4b33c03d97a9124451f218e421533d6b401f2c407f15f311511f1eeca6a27ec19c97a54c94d0f1b9292b2deea5b39cf6dcca0c0526355cd053a4dc4670045b43e7b7f7285f424b2beca57dd38763d87a6bdb43117e11890f41c12a378344789919aba4e3305ff6df83443224cead14ce43a1f4ac0fa94cf856ba700fae2a4b5d4778215168689889302ced08d08048ffa89c2f2852842b061f3cf92c4b02923cf4f734df54a14cd7bc57e32fd5eb3a739ba57bcccda23176b1c27815a14713de077e92d4cd33ac5c63768d5bae4dc11c19f496e49daae4112d8cb59636abb92c122d9cdbe5ee46152f6caacc8d700929c8b22a6b0255392a160485cd62a60d58330527ad32952393b61bf8dc9a6262788de40d2d99eb43519b6044cbae702a6c58807ea833e7ad99c93edce62ac9291472a14e8517a103b592a089a786a21388a00446503202fa11a1a24339d39fcf2561f3cc3e1b25c61a14b6066149a2354cea925286cc8aa987ada3f1879337244d9bd1b3084f040352246647fe8497938df0f4c9e4b37587ad93d33724d81baa06b92080b9d355ca78486a922ffa50e924005f124169507e8d1c287e48c29b42102b94f67202e91ea7eaa34ea5d535706d8429850d2d2e63baa46d60337f4bdc27a70b703b2fe835e326bdf8428ae4a1ba1e09d8bb6ca6edaa104599d75acc157511c2b3e486ebb764f9048a20558ea98f88a740363d6871d58f70626ea56e8f4578d568b04e6a4ffa4025a84fd08263a50d0f399ef1d23301dbbf981c1d717e59634a4e34cf992cc9dd9bb94a940fadb8c545535cbc33767239ae692f2d1d4f74c615c3134e52530449b030839a6905cb05c2cf52a4b4b634ddb1fafe9d1796205d089747f849578a84263d2d4fb0fd9824795d30ea7530cfea5f2d9e373796b671a759b51668739493d37865dc89f2d8ca6e0ed778c5c12b5e7a75e23ed0c0e6a01fd8256ebb7422aee9e519ccad3974a23d21b6cd51bb8ef1cab113fda16237bc5a75ed3bb1564a7ec636b732eda20905f00c148d5d97f54ed13c83f4a57d1cec3bb1da05b73952c7ba136759aa9b63ac2cbb8c2e0bfc198cae4c3b11b82f6c760e56cdf6ffdf6eb7eb9bc76bbf7dedb7affdf6b5dffe7bfbed3fdba15e72a87d95ddff4076e7b9b0744234da6475477c9f859e6e6b35952318ee1cc236ec41ce077a49ba305ab962049a8ecc34f4714e275b1fbe01c2ef9640b155920b24233e878e93e6a19cd3510f8ad5a30a67686ef13d9d4c73355174e24cea441b33af3389b45df49b0f6b7ce62dad715e649a4eb9743ae7b3eee213c15c201d726ba4b3ee4f2b79f19a23e3b176a693fbe28368f8077ff15af1377cabecafc3809fd823d83ebedf23e865e3ee4fc9e9c2db', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136605, 44, 10.0, 10.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3334c84dd7cf4e5708f0570834cbc82f2d2a0600329e05ce', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136606, 44, 40.0, 40.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf34dacb0523031c84dd7cf4ed74f49ac040029ab0527', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136607, 17035, 50.0, 100.0, 'mg/kg', NULL, NULL, 'Adult', X'789c33355028c95730343050c84dd7cf4ed74f49ac0400310e057c', X'789ced57db6ee33610fd958181055a208ee5749d6e85be184edb2c90a48693b75521d0d448264c0d5d5eb21116f9f70ee5ae2f8a0b2729b62d8a7d31ccd1dc78663887fcd42b6ca8721235f652e85d3685350f4db0287a27d00b5647e9c2fb954b07838f6a89f5a9b155fca7061d6527ad5861910b1f6dce92b3f37e32ec0f93bbe4fb74344a93d1e9bb61323affa1d545e99521c79a9f7ae3a256a49cb722ca5a91c787d6cb5db3c214c6e415a15969e1bc92195d18272a849f8dad5d9ad1cc048f0e4c09fb9e523056e88c26a6ae0dc19d1505c20defd4a56d0e61be9bc6238bbc986b8cab0fbff14a2b5aae17f1dbb808dae71c5a51b597e3a4f1c662115a57a028238d61699c174e391054c08277615ba1645d966634c8a895de2b2759e21b700d319c3566344ac01b182609d4d560590d0ad16474abe4522348d41a0ae55038d61c8efadf8d76b526d757199d80fb3d88da04b7565fa028da3c08e512a4208936da6eec3869e595d0ba79192e5b0c8eeef878375d6d5de4ec227fea8233d946fc0bf49ed3b5bb86f9c670cf3be378dc53547a6c7b638a8512de2a79a83f7e2d4bd0628e1a4a63c16deb78c235e6fa6dcaf08aa6bc5da1e4c2e553b30a5a6c8fd4e7d8075cf6a6162be22668f2195b7492bde8ed478c41ae84f4adefdc2ab7dc537f4fa5200f511e1b8b8c8739820d1a0b3e94077ccd9038dd0328cde20942288c4350254cec44c38fe7c9e9e64ca30551c65f865a37b1d1f8b45d5e0003e70e04bac415e77cb020ed49e6b9b1a95adab53f06fb7108bba07fc5b08be1df42a40befff03922fb78b2e5e5f741b2f76fec2a13731c40cafa850f2c0c81b6b8db66a22854abe30b841bce0bc8aefefd13acc6728e4f306eb2d5ac5a4bba777bb54044133e3b6a9323547c19a834fa01254592466f25ff89731833aac0f85838f036da8e29ad61022d74f85bd37f7ca32ab2b2ad7710f34e8fab2b397c37583dab8b0b2e85ccc2123c2e0ad59212991c5b55f3005ce5ba2fd2c8402a58db78c026ccc2ce8f89989cb047a32949e7547d8097a9c5b6f7694f798b99bea7157775d8b3567ff3bd5eaf6ccd7723db35cff1850afb9fefec7b09a2e84ad8534da54cd1e629742977dad4a7e539df5df9e8e606182e5d7c835f2168d56ae4ee1cfe90de7c99b8c7e7a9011a5f8966ac9e99bb7c99b6f5f314caf512e0413559d9b321fcb27efbcf7b45073e51d5cdc8ce35dde2f3092d8bc81387ca902c1ef0abe10cc0d05a9d178c54fb9f5a34b444e5c9b1bfbd2d41e1fff005b0a1d7d', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136608, 17035, 15.0, 35.0, 'mg/kg', NULL, NULL, 'Adult', X'789c3334d5353655c84dd7cf4ed74f49ac04001e06045e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136609, 17035, 15.0, 15.0, 'mg/kg', NULL, NULL, 'Adult', X'789c3334cd4dd7cf4ed74f49ac54c8cccb2cc94cccc9a904004cee0798', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136610, 17035, 10.0, 35.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf34f4b53c8494c4acd5148cb2f5228ce4ccece4955484ecdc9d1513034d03536cd4dd7cf4ed74f49ac040022750d82', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136611, 3730, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136612, 3343, 1000.0, 1000.0, 'mg', 'PO', NULL, 'Adult', X'789c33b4d4353550a84c4d2c2a56c8cf49b15230343030c84dd74f49ac5408f057d048c92ccb4c494d5128b4d03534ca28d20400559a0e38', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136613, 3343, 1200.0, 1200.0, 'mg', 'PO', NULL, 'Adult', X'789cb3333550a84c4d2c2a56c8cf49b15230343230c84dd74f49ac5408f057d048c92ccb4c494d5128b4d03534ca28d20400453b0de1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136614, 3343, 1000.0, 1000.0, 'mg', 'PO', NULL, 'Adult', X'789c0b284a4dcf4bcc2b51c82f52482a4a4d2c2e494b4d4dc9cc4b5728482cc94ccd2bb15230343030c84dd74f49ac5408f057d048c92ccb4c494d5128b4d03534ca28d2040019761661', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136615, 3343, 1.0, 3.0, 'g', 'PO', NULL, 'Adult', X'789c33d4355648d74f49ac5408f057c8cc5348c92ccb4c494d5148c92f4e2d06007f670973', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136616, 3343, 1.0, 2.0, 'g', 'IV', NULL, 'Adult', X'789c33d435524857f00c53c82f4b2d523052c8c82f2d2a06003cd80656', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136617, 3343, 0.5, 0.5, 'mg/kg', 'IV', NULL, 'Adult', X'789c2bcf2cc9c82f2d51284ecdac2a2d4a55c82f5228492d49ccabb45230d033cd4dd7cf4ed7cf2852f00cd351c84dac54484a55c8cc4b2e4a4d2c4e4d5128c9573082a90000aaf518f7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136618, 3343, 100.0, 300.0, 'mg', 'IV', NULL, 'Adult', X'789c333430d0353630c84d5748cd49cd4dcd2b49cc51484ecc49ce2ccd55d0a8334e8773d2734a93f3f3124b5235153cc314f2cb528b144c750d0d147233f300fb441646', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136619, 3343, 0.5, 0.5, 'mg/kg', 'IV', NULL, 'Adult', X'789c73cbcfc9c92f4f4d5148aa5448cecf2bc9cc2bcd2f2d56f00c53c8cc4b2b2dcecccf53482c5130d033cd4dd7cf4ed7cf280200c52e117f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136620, 3343, 3.0, 3.0, 'g', 'IV', NULL, 'Adult', X'789cb352304e57f00c53d03036d03533c8f551c84f533034505528cecfc9d30400654d074b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136621, 3343, 3.0, 3.0, 'g', 'IV', NULL, 'Adult', X'789cb352304e57f00c53d03036d03533c8f551c84f533034505528cecfc9d30400654d074b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136622, 3343, 200.0, 500.0, 'mg', 'IV', NULL, 'Pediatric', X'789c73cec8cc49294acdb3523032305028c957300552b9e90a9e610a1ac539f9e50a997959a9c92599f9799a0020fa0d9a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136623, 3343, 200.0, 200.0, 'mg', 'IV', NULL, 'Pediatric', X'789cf3cc4b4bcc2b29b652282d5028c95730323050c84d57f00c53d028cec92f57c8cccb4a4d2ec9cccf03000b2f0d6b', X'789ccd576d4f1b3910fe2ba34895404a200984b6e9e9240aedb512f410d0de87a65a39bbde5d17afbdb5bd405ab5bffd9ed9dd248497e34527dd7d20c2ebf1bcf99967c63f3a89abb2c8884276c6d4d9133a56551165ba8aad114176bad4a99ce6bd3c84d28f37372fd4992c36accbf83fb579eb111f3b51ca2412814f0efbc39d5e7fd01bf44ffbcfc7db2fc75b3b1b3b2f5f3c1f6ed7b2320eca1a0fc91f9d3fa4914ee8faff202febe3a7b3528ee98d869cb37a16e4c4ec5b2f32496fad2bfc9894f98a3d31d592bcd5156beb52bd0e5d8a45e92bbd3c73129c3421bffdd89806fd7e916d1607af5a05631af5bbf8c3cfce085bafe60a7903eb8939b655909e6c4abb49a18cf2c18946d7d19f5d7aff6962f66c515843a74e24923e20d57e5c075e4dafc6fe139f6a9bbcfafc052badcc59b3e0bddda4d2214214ca642bf9696f804eaab2d4b24074b5fd8919bcec8dfa3493c2c13d9dd4c171748998c1375a4bd4b94a6442df5ef406c3dcad4fccefd7e487f7c81f399919610259475327850fa994091ca4123ec09307d87c372b6d8c1064a1c4c41c2a9dd0da3c2460666348c89ede3c80e8a0b7450b55cad05c5962bdf4bc3da40c19277b2e1d0d29b795c3e71389a55c2afd8d064b95172a402c9097ea7b0529041264106636a6fec6088e9f659bb983d22e15b03b95b01b73a4301b2c0de7122b71c4731df0a9dfef6d710648b677a3296e1d59fbb5952d168bfa595f443042c5102035316fadd6f60226a733825450a6b295674165d2cae3b64984ab0e0374adde3817c6484d536de333280df652c52acc2600e8569dadb5ad7e6fa75f1c308407fd675c0c0699798d101e7f0a5990ee4ce8e636c7f4873a97d82f34cb89b9645d6c4d904d889e4f26cea6bab20ef913b14aae1a9d98cf832f13331c4111ebb8913528b9447ef83ae9394b5de0a3ab6d7181e3176a19a90245a2eacb2bf1416b687f6f70fd354662dcab67ce304d625bd7ffc92260b8dda6617ff41785dcd92acb49389857f565875cb22b75b4db0d281f57fecb52bf5a2bf753f38a34f4dfa48cbbc0f170da6f3544ad8668a161c5dead58badf081fbb47f355bc3d28234be96b7aee42df43b42ecf467cb6f3b366ec2350a108fcf116d65ea5bdbd1cbc87c63426502e130b9a0b154da179947edbac009675c66b0a24a3835155d62474972c735f436b49255932bf62747c07aca1a6bfb145c5019864c943a8d127f4ac9352c62882e8c8969516cb363f4f42db3fe2191d63d764cc187b137320e2a6879153fe8c3f7e4429d6b51d8baa89ec581a54579358d0c39edbd3043f3c2a10d53b1c710070ba4b53d4347708ee4a962bdd31f0dbb035ea5e837cde9c1cef63224859e2dd7ec3f546b6ad859c4caa36a1ef2477b6786e983e5812c9d7ca07e6f6a796f5f534dc0fb97d9eda1a611f29132d34aca27a3591f7ab5dc8472c1f81bb640654c3f906d17be83d4e2893803a6fde665d5d5e1aaf021a33f376fd6589f24fc811ca015070942a30b2d6eda8b2af32949b59141dad9d197b61b81dfbca0345412640fe075963d4e34662091bb8d258a6d0292eade1312ee14b5de0ff4953d639c7101d4b11df8cf016859d13f03c9af18adc6b8c7ab35838d47f97ce05fbd544daad4b30708e7871f89e9b0d8b81749c933e4ccca9f21ed56a64ec80318f91a9a95da87602ba44cb021f310ca3229480104f62d6072e5ff4ae58bace6a98cdddf114ba3a392286a0cad633314d2c2a46d4eda086569752b88d61172a19fa2211712eafebbe9704feaf09ba7e93ff5986fe55c38f04fc512e5c2162ab6d365bad66a1d39e56a904bb1ea2114f914d5f60b13bf5d6950dabc86f95c2add02715041ca4fd956d5cce725aaee99bbb23d813ad26512c8267565e61e212edd38907424cf198b845ca8b420aa6e75fdba367543ae00236a6b6327823944e15021432e3bb177a5a41036efdcd250c36efaf1424e14978aa8c60a7a6f0624efc5ee8406b2ffacfd6bb543905f2581b62f184041e4a9e81909ac8a6d16ec33b2b506766826ffcae45e04589b5097847da141403824348d27c9f15755f7173dee9129a190479864c21656485f89d30be00fe6b5414958f31dbc63529c72d52909a024f0ff22a63bcd427daeec58fb2fc42ccfcc6535ab994d1aef6f6d6a7679c6bb48944aebee69eda0eaf6b7dcc34da9eb83e233e796a46f1fefc1ba124e85d', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136624, 1420, 25.0, 100.0, 'g', 'PO', NULL, 'Adult', X'789c3332d535343048cf5508f007000ed602b9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136625, 1420, 50.0, 50.0, 'g', NULL, NULL, 'Adult', X'789c73cecfcdcdcf53282e49cc4b492c4a5148c92f4e55c82c56303548cf0500971e09fb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136626, 1420, 0.5, 1.0, 'g', 'PO', NULL, 'Pediatric', X'789c33d033d5355448cfd5cf4e5708f0070018c803a6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136627, 19365, 3.0, 3.0, 'g', 'PO', NULL, 'Adult', X'789c0bcd4bcecf2dc8c94c4e2c494d51080df1b452304e5708f057c8cf4b4e05009c4109d3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136628, 19365, 3.0, 3.0, 'g', 'PO', NULL, 'Pediatric', X'789cb3333452a8d4cfb7523056485708f057a8503004002dcf0495', X'789ced596b4f1b4916fd2b57482381c698403693c81f56328f24288158185056eb0895abafbb6be8aeeaad07c119e5bfefa96e1b1b70c6a158693ecc7e407277df3a751fe73eaaf86323b321bfd2a2e28d1e6dbc356e62aaa9547aa3431bc196f165e17ded7a3b3b5fd535575d63f3f84beddc9775d28a9ab32be1e392bd177bbf6dbfd8ddde7d71fee275efd5cbdecbd7dd57bbbfbd7ab3d7c8b2f4ca6807c93f36deb1662bcae6b7e7db66f9f9b4e6de48f7b5576365bc92237d689cc899de1a5bb91e7dc28a0e1d5f8ef481a92aa3e9dc8a8ce91466e0eb89d1c19a92360dc4b63a7460b4e7dad0e6f1e556b37f182fabf01dafbc18971c9ffefd054fa5d2d7cdc342a5852eeb3db324fbfd4b44ef67a1f4573041e9fc9ea1175a9aaa2e95149e33ba383feed1cb9c069fc868c9237d7c38ecd34459e7b7a11293658857ac3311951f69f8094bcb728a2f8eed0d3026c6d2d170ff231d75499a523dcdde46db01674a78abe42a8dffb9bb47d31d033da951f4967613b618d62c9528af06a60ea5589061becbc072ae8596533ac3579d8f748ff647faa390be91a633e5ae7b74ac27427bb2782029b4369ec6f05228e10813fc489fb11625b566f4e8bd282754aa0993d2d2b27010531abe8b42aaaa85b270aeef9036e4a28613254964bf07e7e3fb917ecf35b69794cd0021b7f89ccaac87b6aee7d7614cd956d85d297d758730a35be4bb154a6791578f7cdb2f4bb6f994bc21590ae7766205402289d078564da89899b970c9bdcf60215e91b863f936500ce219391c39e7951be95304c3178c80b865d986a08e6fd8c6284c66cea2cdf6d548d7532e8de6bab02d4c671473d971ed664f63700092951223bdd58db9ed54c6165b9028f14543f51b8e7a0a8a66445595235596c4da84bc88865bfe4f50d0406495720e1a7453a3775fdff5b11bdc97c71e0bac3b43d7c35cdc89de435838673dc4fe42765ea51002c757672ce463daac70d0c690ad32e101bd74ae0c675c213efd1a048b41efeb36607de78b4ad0d1ad906cc7b32a36cfaa5396b02a86f9dcdce2f98473013a4591832e656a82745425e397b0b6e0c6c4a5f8b4cc8fdde09e3e8733e991be14b9d22dabce8af92f2d828b1f21910959808199faf60dc5d6b9866bd720918206629c994ac542d13e675387c4302b15f929e21c2e59b126dde7926d98fe7aa73fa4c1dfc1eb7f9d8d295529d9cc41216cd510209fde3336f6ceedd83b7bf4aafb9a0a132ccc3861a8828aef2a8c6b47b768aa51cf1e5dd838aebc7cf34b87dea25b38da7df34b949685d0102633a1be6c45db3204926571a453ba40a3f08e24a3607fc56c436eaad1476655f18973c66212bb1a321a055a03fe787d65fbc0f7cd1f8eb40b4e720dbc9277dc0c8c6933b81027b02d4c6b23ad3068a261c6f9099f6e8455506e4acb4b6d34c5a32162c5d948df3dc66995e204c393a62b025bc29876be83ecf057a830c5ac9cab26bbbf2a5f2c7969d16111960b88de69181b2e264b8c94d06453a387bba9f3280d72d18081ff7917943584d1129cfdbc075eb64a604082cface9d038f846c110e7a6856e907ef927d20bc125cba24eefac0935f5c979cb35d520de14550ca943f8b8341a648163cbc63c3b110ca0985b9fff91b2e36c27cd01a9acd614106453a3618cfe3b2b2a1a98d6a171d9279b37446ea81151bb73733ab48f034787de6d34a57aceb9c8a68dcfbb6db7bec3fd01d460ae21af0019aec1b85416a904bf35d63e430b81686803ea529e04731473c148232520e6a14b30e8118e0ad50a98e3353027c3613f61f793b3a46507fdedc495432feaa24b47759c6a2b95adf4d95ae7a377ffcea8f4ab7db576f9c72e8180464ebdc9713e5fa5c2d9038826474e313dc41c710f014fbb949ba6a9195e49ebb52a01016d51352522d12927c68a5b544c81c3a28f6def078c5c0bf4be1b0b5419587f4b3366e970fe447a7c2879ec5434c2adcacab5c9d46ebcb380696e0b7e4d817a84f461709004d424787b74717587fa557d409af3ff15546d52ca0ec66c0b2eaf76f3fa1a3a5b4d95b0987f70604ed2419448c3e4600f0b95ff70f15a1306d67846c9ad94156395982973909b50e69886529c00881bd4422de14d577713131f0f0d4713110ee288d1f28a26960366f955d9fb249c4cc5f37648abef4b388926f591296097c0a490c48fbec48cefff5c89874de2516c1d876ca685601b9a89432400ed077b5d98122d132cc1ac2da45a05f313b30f8e5e706d5dccb4aa44e9f104fe27e1fd0b11c6342a8867534cbc1d9349506fad400eb886c53e94c2c6f549e4d9b7413e27193e72aeccb3d26920700209b681a8023c1c8f7f499d5870d58427c48302ce9fd3a4b4bc5463ab4cac523a5efafe5c4e9e28271fe565518a6a9a352a89c4c43a994a13ef70aac5512569c83853f29abd77ea398ab4e98d3192c4cd4f0e937d2d62137e3c04c623bf8eff325a3950aea76da38a412fc039c08a3cbd27f10dba52c33d2ef15ac72137312b0f4a838316265278e8eeb6ecb9409bf1187b87b695542d825b8a9d8eb77ca86936ed3830e0da9be63ce9e707b11f27fe97c7d730ffbf4df97bdca63ce576eefbf7ff02ae70264f', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136629, 30844, 5.0, 5.0, 'g', NULL, NULL, 'Adult', X'789c5dc8b10a80201006e057f9c70207a55c6a8da65e42e23221bdf00ea4b7afb9e9836f610991b072cd32c123a273a06030d88f7e86b3ff33a07ceb839d8b5251412aca885710414b7a62f4c81bf8400b4af5056ae91da1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136630, 30844, 10.0, 10.0, 'g', 'PO', 1, 'Adult', X'789c333450485708f1745108f05748cb2f52282d5028c95730b150c8c82f2d2ad65128c948cd53300429cacf4b4e554849cccca904008cbd0ff0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136631, 17041, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'789c4d8db10e832014457f853057458da661ebd8ddad36069528290281476a63f8f78a2e6ef7dc7772df8647eba74eb185638a70c38129eff00d616f656c6600e368967dc5872fa9b6534c22bb886eb0ccf0b16310fd82147542f224270db95352d282a46555d6557eb87c00a195dbcd0d3f15587d24e02b5cde2363b5997f92adc2b5ea3178e008ce53ab8e19df5f97c25e01eb258ff47aef2485fa9c1042f80350294942', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136632, 959, 200.0, 200.0, 'mg', 'PO', NULL, 'Adult', X'789c333230c84d5708f05730d4355128c9cc4d2d5628482d524849ac04005fe807df', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136633, 959, 2.5, 10.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cb35330adb45230d233d53534c84dd7cf4e5730d2355628c9cc4d2d5628482d524849ac0400a2670a18', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136634, 5578, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'789ced58db6edb3810fd15c24f299a38976dbb68de1c374d8336a911a74517eb22185363991b8a1448ca8db6c8bfefa11ce7b291ab947ddc7d30604a9cc33357cee87b2f73557e61a8e0debee88d78a6ed1549657a9ba257391d1fce4328fdfef6f63775c945dfba3cfe53db0ff77ae9a8e4ec824214d9dbd97bb5b5b3bbb5bb73bef3fbfecbd7fb7b2ffbaf77775fbdd86bf6b20cca1a8f9ddf7bc72638dbfc0b7cd5089fda20a82c9d5d7026941161cee2d378b23ca69ade97bec6a34053cd71f5e757acb43297cb457c77c4861de907f0e775c9fb13f3c67aca59bcb5aef0580e6d515823ce1d652c4e610ebf9f70deb864a9485f8c6c5969ba537275f6c8716ec8c85a9ce1adc92706477f20199abdf87fc686b400b7e6e520ab74989811678a82537262de7189ad72ed8e9fe3bc9e58b7fbdfc4b8596ef617ca5cdc22f4ae1b530c2d1c4bca644ab61862a035bbbc16c10aa9c9fbed188609061fcdc91524adb679fde08077a4675b5acda2ab4f1810562b5f607178251ddf58fb84e59c0c9e0b3b1383e6d414af0f4c505365e1978b311baf825ae0c70f356ec1edbde787a411e4bef2924be069def637602c362a5f91d6f5b389399e186502bba271395e2dc82990abc57d51c75ef9402640e26c626e9762c33a6190603c9b4526c09650063e5aa28f9f83428da4c9b11f71f64d85b990acb5f8861d826e35f513f3095b6f19ce80fbe9fc585803261b06a9e46b1fb8008632b3a5d2c0ffb23b31c68a8c0261b13731b424813487cd9cdd14d32a34042b8fecbfe386ddbffd60f7ddc67b9a454e47ce56a518081f1c97a244b8d42607652ff0f296991759c531180ffb62460c200505bfbc4839f1e624c3150a8aa2dec3e0b97e184c48c18661f4fe91a3428cecd2a051eca3cb9be86c4223a2f657ea6c8a834d31dc144771db5dccc568ea9df570c43dd83548a315414ec0f8ac9cca08666b946d01f8b2fb34160467188bc8157912cc614c052bad948058792e41a14738aa2a12604ec6e3418bd8b84becac55acebb4e1606b8de413cc4fe5bc2f0e4b95a194a8acd5685db4877df117e35668b75527870f7d8100b4b20e36c73dfd14b7352972ca39c514f1ff063ced8b1c80cecd2db786f571072300148cf21a0b449a494eaca32b944b12b8f5084cd6c46317cebb7e2c4eba62f377ab265df2a863b8145582e47bcd53afa20abe2d239f78f0f61d8c381c1f7c789e02f508e9fd68d806f4b4e49ea294b3f3e5a61814e55018ce5338b5419536c5c563760e719c66e695b028c849c6bd6fda28749701d248c164678fe72a4f161e391b18d5b6508ea62a2d4d56188b4ae768831221162882067dbbf0653f2de7b16802340d60183b8b654c8999e30a3d734ae6de87c9501f1daed55f8449d3678014415811da83a44b7d809992c38f3974828c3c57d90d0d624c17b1cfa014a483ca5dceadc645891041878d913709671c188da3b3e5fc8656413a6085d86fc3ebaa6a7fc0c1684149f04defa2212cdb90bafcf5d6616e53be89e080b9d545f1a47a72e02af98344e86e093857f657526944183a2ad72014188dad449f9a72ff12178d6baa381a6062acdb32b2539fcf6aea948de5c9a89992adf9f808e44479f92829e79a8a3a6b28517b5a7596a95ada12b5bab89b4d523a8b33252f3904afd6d0e8b449e4b14c6df48d82164fec1e0786e2cdfbb8eb8b73bbb1452d5b3bc8ee906da8585c0168fc1de56b6ea2ae6c1c395ee02e6ae28e351e9bd8d4b6e76327a7a1b618acd082c240999a2172946ef3d54f016dc4a9f516ed590adcdbcadf739d61d9143397d6fe8fb80cb6991fc36af05a5f35be3efeeaf2ffc793ffc6c7939ff918777dfd0ff10e749a', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136635, 1065, 2000.0, 2000.0, 'mg', 'PO', 1, 'Adult', X'789c33323030c84d5708f0574849cccca954a8503006b22a8b01540a0745', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136636, 1065, 2000.0, 2000.0, 'mg', 'PO', 1, 'Adult', X'789c33323030c84d5708f0574849cccca954a85030d63505b22b8b01616b07a7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136637, 1065, 2000.0, 2000.0, 'mg', 'PO', NULL, 'Adult', X'789c33323030c84d5708f057a8503004001678033f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136638, 1065, 2000.0, 2000.0, 'mg', 'PO', NULL, 'Adult', X'789c33323030c84d5708f057a8503004001678033f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136639, 1065, 2000.0, 2000.0, 'mg', 'PO', 1, 'Adult', X'789c33323030c84d5708f0574849cccca954a8503002b22a8b0154040744', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136640, 1065, 1000.0, 1000.0, 'mg', 'PO', 1, 'Adult', X'789c33343030c84d5708f0574849cccca954a8503005b22a8b0153fe0746', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136641, 1065, 2000.0, 2000.0, 'mg', 'PO', NULL, 'Adult', X'789c33323030c84d5708f057a8503004001678033f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136642, 1065, 50.0, 50.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c3335c84dd7cf4e5708f0574849cccca954a8503006b22a8b01630007e9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136643, 1065, 2000.0, 2000.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dac5030323030c84dd74fc92f4e0500232604b7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136644, 1065, 50.0, 50.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c3335c84dd7cf4e5708f0574849cccca954a85030d63505b22b8b0171a9084b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136645, 1065, 2000.0, 2000.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dac5030323030c84dd74fc92f4e0500232604b7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136646, 1065, 50.0, 50.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3335c84dd7cf4e5708f057a8503004001e6203e3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136647, 1065, 2000.0, 2000.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dac5030323030c84dd74fc92f4e0500232604b7', X'789ced59516fdb380cfe2b4480bd35ad932db75d061c90b6dbbac3d615693ae0701e0245666c5d65ca90e434ded0ff7e94d3b5739a2ecdbaddae581f5ad832457ee4475194f2a995d8321d93c8b1d587d648914ac447a3b1b505add2ea3098795fb8fecece993ac57cdbd8343ca99da6ac935614988c850f53ba51f7b776d46977a251f4ac1f3dee3fe96cffdeed3c8d9ed6b228bd32e458f253eb15125aa1eb678ff37afaa82ab01fd380bc2a84154e792563da374ea4082f8dcd5d1fbabd680b7a5114d3d0941e1d98290c929c41396f45d0df87a37731ed993c3704232b128443f693e732f444e4625e8329275fe239e7212f261ac3dbdf1ff84d2b3aad5faef03580ad8f5453fcfc43b031484aedc7ec92a2b4e1fb2b354338533e83a931c90a84add7c4ee7a45428f07394e14eb750d15dd288af294bd8744285dc11c1ef353e55a4ddf6a1841811c6b366ac762e224bab5badabd9bb4bd52c2265fc33387ce8a6923ab642698a53553631a59141e38969e9306bc0131332a018b6d9c17c6951657a8df15d2a3551cae99481599f5e1ead60ec6f46e1853e7dad7dec5d74343edc2624a823c9c991c090ce96a0582138b3eb3ccfe579dbb625e7ce4ffd6e49554046a0a643cf8e03a262b0418c34c99d25d37fd9564ae71dd299396d3f221957ee554ba23fbcbc9f440fffda2ffb67c2df3fc40d84f22ec7b077e99d887c8df14f99f10996572feafa1f92f71ddbeefafa11d219737cf8b6655cf3e280a6b666c746a2c8433ca1f8fa14261dd97603769e7c7dd86fe1ebbbf73baa20f8be9ade0fca8e3b39318b7aa06aeda996fa1bfddbbb585abe27fb3de9ab935aabea55dbd53a46ed3c2decf50fd004f6e6ed17eac2b77b1b3e1223f2e5086c27c648a528b2b573f5b3c5a945759c190bf521a531f602fa6375cd26b71b0ca9dd6a327e4c414631a22a72b2c6a464cf5a99fbf0e927f4ae721c004de844bf2cfa1173d82d2952cbd1876e0caa2d0c885dc87e2c6da0ff663ba2c4477537380052396d7901d1a4870aa888bd9627e6da29e3c293d4841fc57f287ec4281ca0ba16c10d886137751eb58248463bb01f7fbaafed6bb9b650ed75fdfec871bb285b01b2b1a5f6a68b1c12bc5cd2458aff6527e1ce4c79277add458c5e01737447b86bc158a122557a4e2406bb46915fa31a985733be11e8fc3fd19db16745cd80c55ce25136d4cbbbc2f3a3f45e68352288b30f3691732535a0762ea436f17b6ce106e4e072d4d6634043ad6c91e5ca38bad69deed20a9c2b5a05322a6bdc3634894333641fb0d2b7390702173381ea290d783b1aa3c1d738fc59b7d43ee18d547ee5743565a5564e1de11084b6bd881ace25637f40a13232b6f0aa400fba02a825d0a577733e52b6e7b1700c2ed64aa0c2698b3d8b1c7190bb5ff341939ce005751c2aad8d20b5bf98c6520e7f5a5b83f0883bbd690cc8c2b84cb576c128b2bcb06720a0b4380a0046626578be2332063711e60be452fb4660e3c73cc065e322169893b67284e894b3fc79fa7aa4519e5cf5cdc4a8d2459f464f43ac443cf7836f3c78ebd2ff5ccd4bd692822ca4993336e26f5fdc598498c0d36d9bccd788c019c0c5f6f5ad7ef1341cbc9f56b30747fbddcb4b9cf84cd8534daa455c3dd03a1a76dada6d8874eb7dd79b228810b3f27462b97f7e14de8b19ec3de5f474f7a11e7d35cf229a6fef9e1c4f266c72d49bbdb7bb40553e4268cd53c0ad3f9ec4d3cbbfed1422ea42fce855225423f0745999a28ef60ff7010b29573341c1437f72d90c825b9b9ce76b590a730317338139698c43eec09cb872493f2b292973bd886b68638451be86c5a7b5118de06b877df54e5f9f9bf2af9fb03', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136648, 52, 10.0, 10.0, 'mg', 'IM', NULL, 'Adult', X'789c658f4b0ec2300c05aff2965442e55b21b163c9824398daa59692b84a52a0b727152016ac3d9a79d6a059c9812dc9119b35fc0de70b16ad85a42c11ce1e1235dc900d0d2ce2503733c43248e0f96001add3a06dd174d4668ba95a82988bd9c2c70deb7e764fd355f04d08d738b9b9c3d8a2b7312650974b3bf7824e63ca6f0505c6fe0f485244fc26ca46b9931b290ba2a4a114040b4f4ff5a3fffcb89b57ac98a6aa7e01fdc6574b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136649, 52, 2.5, 2.5, 'mg', 'IM', NULL, 'Adult', X'789c3d8d410ec2300c04bfb20f403d2071e1071c38f10237318d45624789d52abc9e5224aebb3bb38fca4128a3497fa1920babf72b826997c80dd9366ea20ba275861bced30565c1ed0ed13f802d19a83122cf92c5c9399e8e30d1ca3fb93d914635e7dd6c0a6b475f68cc8c623b5b13b542c1e2502a1228e781fe5dbbacc7b565d23755519e3edc3d4362', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136650, 52, 5.0, 10.0, 'mg', NULL, 1, 'Adult', X'789c4dce410ec2300c04c0afec11a4043548bdf0039e611a03863a915217e8ef49c3a11cad59edfa9cc48446c43c317a1f3ae80d390d8c48322e0e9286c254d1327eda00970576675ca54c8637f3d381e263ae47957ecb9121f8d56b937179d5ad9dd24774d6367ac2716bdd3b28adb944ed85e6a1f37f91c317e7d53b5e', X'789ced596d6fdb3812fe2b83000512c04e6ca76e7afe50c04deeb601da6d906671bbb72e0c5aa225ae2552475249d445f7b7df3394fc22c7a9dbe00eb777bb5f5a8b1a0e679e997938a3fc7a10db32996a91cb83111dbccf84fe240aa5e541870e4a9bf162ea7de1462727776a21f3636313fea54edab22eb2a290f15478de32e80d5e747bfd6ebf77d33b1b0d5f8e4eff72dc7b39ecf54f83ac8cbc32da41f2d783719c2bad9cb782d7c29297f741cb4d55c8d1448fb55785aba2d478154d7487b0dfe89812a965bd6ba22f8c1389a4bf199bbb117931cba477903459c902f855ba426a1784af4de9a52333a7f6e1233256641d521a0b79e9a2321376a2df6391e09d8ab38a62053dd6291c4077622e2dc116a76269654c3365e43f4b2532a93d79d3d841735835d13ff73f4ef4b9c973a3e9c68a58d2f7401dd6fea32aacbc171dfc80f6005039dbc4e83396822a7efaf9239e32a517e1610d560ba5fdd16b8b7ffec8678ce332f35340a974d20ac43802602412e5034e74289c3391121e3edf299f928b52f5c914a9955a09a008240a03f0182e6301ced1883ea4c6faae805b3aa1cb7740f997da47841841f0808d62e3e488fa3dca83c8e1125bcacc9db4bc11a80ef980b3e3210bc512518df905cc8a008b8aa0668e538c75471d1271acf88c4637c77ca53d17d54c6e84ef98c6199f13d38052535a4762ee71b64f25cd9575be5621907acf1f083439192460a3bc1559097cc84a57e0044987b9b8577999373e9eb21527b1a88e8e27fa43212376df2ab7a00218237f90180fbd5faa1fd4de0714571be82e3524ac0428339571ac64dc098ba9b895b572f89f5685f175293090fcbe462237d85ba4c2e6223271054e603091f38ea5bdba0d479b55d9b3e19b711f1157ca445f6e049386dd1a6fa32318265456717d45568ada93fa6d7841b36a03eb3b29171cbf5f4a3ce0cd702d273cf5bbfc9e2b555a40bd8dee60ad1549900b96d32298d064587743e491088ce8b29596c3b61fff65e85f371576896a0ce599ab7ba42ed4e6025540b240e9c5f268199577461ba00b1eabb61d031afde1a3416a631fca7d05fbab415309bb401e6e62fca5081d075e9c295db34b63657d14c04c1576c12f1c58580368dbf6b752e830ac58a1936d038e70494810ad7381e96b50d62bb44d69db0c46878877b46166909a67a5b997a03406fa8be9b2ca6504726d2467054aa4a9e73a1bbfed0608cc7d2563986e55b48bbdb78a741c1be889f88a9a9483c18b61ff942a29acab41d97603a6751f7305a9b17a5de31f2e3d9b48bf45b73ba2c33bb7b2e0414e733687b4decee9dfb1135f9153975f9d55233a4f55162374e1de116bb76112d3e7d91eb71f721653acbc452ee86485819a93963266d272686a7cc53d4bedfdabfe60ed3ba0589350b0e8d5b0d77abd361dd4e7089c433309eb9d2f63853bf609c9dd70f3f4ca1468c8d69de332bfafac4c98772aba16dc5c4c50dee713fd164d408d29d32f2fae3b56528ee43d088e4303de323463b2f3c8b66c714caf1140df9d0311be7455ed86c50d9fe7e836b8d1ab38234bee334a2bed2eaf0eae4186d9ae7afc3e1000b7ab35fa3987930f9111f24658a4667d5e6e6eebb350dc59e5940be76c40c5e8bc917c09ed2cfc1f10be904f9168bae02f271bbfdfe0d576b01d783e8b8365404e7297d4aa9a07b67d55d7ba1dbbfd8deb05cf2bb5b09b2a3d5d6938c0816bc5ede8ef57bb929fb2fc3442d126c62a185ff7c6ffa9686e67cdff62387f7f79f88d0c736e78e2531824a21dfc82a940da245c0b51064a3fe191f909a78ce35b4c8e727a2d45f4f0945dc9f0015dbf29db72efad4f8de35c8d5afde4e1e933dc44cfd0e6fcf5de73ff841156c5dcd236c761905e0834534e8989be1276a1b433e8087437432990ab746c4d2eb97f6f3a3f272d3a2ff45c5998da1ebc197fb8e9d0f82dfef9eebb9b701b70f36bcb19cb8ea308b38bf6b000935e692b1c0af7791453be5a5d803b18ad9e915b4e5f587387b44241e17e559f3e353f2fe141aed99fbf4b95a49e12d13253140512cac3a71fa5056826675944db61f85d7e39a830d017ae562216b5e2f14c636687e950e837149668b148c031f42ab6540e9a6fb8b22dae1b95cf300ff0f9af45b4687e8e112d5ccc09abbf4e435abb2711e52341dd4f6ced8dd3d5c6165b6e42b25f654bbaa56789e07e1d2bc9d6fe1572fb15b0e83488d604fd07a9956d8af8b358fe2c966f2f963f42d63ce523eaff4168af9aaf489949aa5680df886c0efa9acb7a560c1ce4dadf6447142da7cd66bc7c598f97f4dbe9d9f2438fe0afc458e82d17fa9832bdcaa5a30421e40fa268ef6406c20a9fd6de49c06e32e5f211bd556881309dfd74d51f0f3afcffe0e245879ef79ead1ae45b259a2f80057a2dca57bb99ac79620b9f6f7eb0dc0b1efe760616efd09c7b6db03a1e9ed097bd93512a344e989af9741c3df833c415df1b1e7879911896e38e14ac6e3c9e340dbb6f6e267a309e684674c8bfcff9af1417a6008d68e46fbffb9c17709df8b0426fb0568b4fcadee9ac1f1ebb828147a789fcc7ac290bbf93f1f74ecb524ec79933ed1676f36bbfdbfa930a027daf225c34ff963f3d7c45ce6fc9b732ff71cbbe41e774b50f35f1f9f3bf00dda7629f', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136651, 52, 5.0, 5.0, 'mg', 'IN', 1, 'Adult', X'789c358d410ec2300c04bfb20f40dcb8f4079c79819b186291d85162b50aaf272de23abb3bfba81c84329af4372ab9b0fa82bb8a1f345ae7053794174c032392e401d17fb3634f066a33e155b23839c7cb09136dfcb3da13695473d62ea6b076e685c6ca2836b735512b142c0ea52281f2fce847db653adc6099f4435594af5f0d6d40f4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136652, 52, 10.0, 15.0, 'mg', NULL, 1, 'Adult', X'789c4d8cc10e823010057fe51d350103442e1cbc7bf02356d8d84dd8ad698bdabf071a13bdce64e6e6cd27c7819e79c0d52409cd987ce4016d53b73df4016f236322997305b1313045c63da3c8c2f196e4369738bcb6fed29de1fc126205a59d1a9545d9f675d7fcc283d24774d1affc53c7d30a5586346d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136653, 52, 10.0, 10.0, 'mg', NULL, 1, 'Adult', X'789c458a310a80301004bfb2a516820a36b6563ee32421394872219e4a7e6fb0b199626636890727529604f5b650ae78583d42035f11527053c84548ed8a3db1320518392da611d1c110878aee3385926bd732cc7fea5f1cd3229d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136654, 52, 5.0, 5.0, 'mg', 'IN', 1, 'Adult', X'789c1dcb410e82400c05d0abfca5264aa2091bd66e3c46a1056b86964c4bd0db1b67ffde43b62a11ea068af04929857168be30eae6852a58c32b4bc5490d93afa31ae53f343597dd3f926a721ef0344da502f690013dd6056e938049cbf702e2f71e89f40650c91681cfe8afb77bd77483dd0f229334c6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136655, 52, 2.5, 5.0, 'mg', NULL, 1, 'Pediatric', X'789c45cc310e02211085e1abbc5213ddb86bb6a1b3b4b2f004238c2c061903638137f0205ecc93981013daf7e5fd67bb84973c96cc2990c1c149e4623929beefcfb84765cac5e094291a1c53d040114e0a1b4cc3bc9d71f79064198e42ac1b90bb3d8be2523b37810a94b2676d6fc815e3aeebaa8d9992ff87a78eebe107954b36de', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136656, 52, 2.5, 5.0, 'mg', NULL, 1, 'Pediatric', X'789c45cc410ac2301085e1abbc650b5a6ca59bec74d795671893b18ca499924cc11ec18378314f2214a1dbf7f1feabcc1a296340457e3186664cf2e280899278f02c4503d70e97a0918be764f8be3fed192b532e0eb74cd16148624211410b3b744d7fec318dd0e4198124ae0750782ec5705f77de04a630ca23dbf6863ed09e76adb631531affe16ec7baf901c4693fa5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136657, 52, 2.5, 2.5, 'mg', 'IN', 1, 'Pediatric', X'789c558fb14ec3500c457fe58e0c55d554aa90327481a513dfe0c44e63f46a57cf0e10be9ed7302066fb1c1fbfcabd4a84ba81227c544a617c6ace18f4ee852a2e600daf2c154f6a18fd36a8513e906d6f2a8b7f49aa498f97590b57693263107b9118c512dd01e9e89eb10ad5e8f156a9f4b898a652017b34f6b83fe17685db2860d2b2a25dcb59201f626ad75d13be2f91d00926c2c23b044d922b26af9b04e7eef870fce23ea13d60df746f6d5bd1f974f837fe4bc74c01f3c420ad3e726115deff001c6f6495', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136658, 52, 2.5, 5.0, 'mg', 'IN', 1, 'Adult', X'789c25cbcb0980400c45d1565e01ea42b0140b88335103994430839fea555c5e0e77dc1987c48a4435c4ad81189297498cbefe71d6ea2787187f2e21a4c8feae3ec395eca6ed35ecab57cd300ff0999833fa6e680794059944afee01cf0c2793', X'789ced596d6fdb3812fe2b83000512c04e6ca76e7afe50c04deeb601da6d906671bbb72e0c5aa225ae2552475249d445f7b7df3394fc22c7a9dbe00eb777bb5f5a8b1a0e679e997938a3fc7a10db32996a91cb83111dbccf84fe240aa5e541870e4a9bf162ea7de1462727776a21f3636313fea54edab22eb2a290f15478de32e80d5e747bfd6ebf77d33b1b0d5f8e4eff72dc7b39ecf54f83ac8cbc32da41f2d783719c2bad9cb782d7c29297f741cb4d55c8d1448fb55785aba2d478154d7487b0dfe89812a965bd6ba22f8c1389a4bf199bbb117931cba477903459c902f855ba426a1784af4de9a52333a7f6e1233256641d521a0b79e9a2321376a2df6391e09d8ab38a62053dd6291c4077622e2dc116a76269654c3365e43f4b2532a93d79d3d841735835d13ff73f4ef4b9c973a3e9c68a58d2f7401dd6fea32aacbc171dfc80f6005039dbc4e83396822a7efaf9239e32a517e1610d560ba5fdd16b8b7ffec8678ce332f35340a974d20ac43802602412e5034e74289c3391121e3edf299f928b52f5c914a9955a09a008240a03f0182e6301ced1883ea4c6faae805b3aa1cb7740f997da47841841f0808d62e3e488fa3dca83c8e1125bcacc9db4bc11a80ef980b3e3210bc512518df905cc8a008b8aa0668e538c75471d1271acf88c4637c77ca53d17d54c6e84ef98c6199f13d38052535a4762ee71b64f25cd9575be5621907acf1f083439192460a3bc1559097cc84a57e0044987b9b8577999373e9eb21527b1a88e8e27fa43212376df2ab7a00218237f90180fbd5faa1fd4de0714571be82e3524ac0428339571ac64dc098ba9b895b572f89f5685f175293090fcbe462237d85ba4c2e6223271054e603091f38ea5bdba0d479b55d9b3e19b711f1157ca445f6e049386dd1a6fa32318265456717d45568ada93fa6d7841b36a03eb3b29171cbf5f4a3ce0cd702d273cf5bbfc9e2b555a40bd8dee60ad1549900b96d32298d064587743e491088ce8b29596c3b61fff65e85f371576896a0ce599ab7ba42ed4e6025540b240e9c5f268199577461ba00b1eabb61d031afde1a3416a631fca7d05fbab415309bb401e6e62fca5081d075e9c295db34b63657d14c04c1576c12f1c58580368dbf6b752e830ac58a1936d038e70494810ad7381e96b50d62bb44d69db0c46878877b46166909a67a5b997a03406fa8be9b2ca6504726d2467054aa4a9e73a1bbfed0608cc7d2563986e55b48bbdb78a741c1be889f88a9a9483c18b61ff942a29acab41d97603a6751f7305a9b17a5de31f2e3d9b48bf45b73ba2c33bb7b2e0414e733687b4decee9dfb1135f9153975f9d55233a4f55162374e1de116bb76112d3e7d91eb71f721653acbc452ee86485819a93963266d272686a7cc53d4bedfdabfe60ed3ba0589350b0e8d5b0d77abd361dd4e7089c433309eb9d2f63853bf609c9dd70f3f4ca1468c8d69de332bfafac4c98772aba16dc5c4c50dee713fd164d408d29d32f2fae3b56528ee43d088e4303de323463b2f3c8b66c714caf1140df9d0311be7455ed86c50d9fe7e836b8d1ab38234bee334a2bed2eaf0eae4186d9ae7afc3e1000b7ab35fa3987930f9111f24658a4667d5e6e6eebb350dc59e5940be76c40c5e8bc917c09ed2cfc1f10be904f9168bae02f271bbfdfe0d576b01d783e8b8365404e7297d4aa9a07b67d55d7ba1dbbfd8deb05cf2bb5b09b2a3d5d6938c0816bc5ede8ef57bb929fb2fc3442d126c62a185ff7c6ffa9686e67cdff62387f7f79f88d0c736e78e2531824a21dfc82a940da245c0b51064a3fe191f909a78ce35b4c8e727a2d45f4f0945dc9f0015dbf29db72efad4f8de35c8d5afde4e1e933dc44cfd0e6fcf5de73ff841156c5dcd236c761905e0834534e8989be1276a1b433e8087437432990ab746c4d2eb97f6f3a3f272d3a2ff45c5998da1ebc197fb8e9d0f82dfef9eebb9b701b70f36bcb19cb8ea308b38bf6b000935e692b1c0af7791453be5a5d803b18ad9e915b4e5f587387b44241e17e559f3e353f2fe141aed99fbf4b95a49e12d13253140512cac3a71fa5056826675944db61f85d7e39a830d017ae562216b5e2f14c636687e950e837149668b148c031f42ab6540e9a6fb8b22dae1b95cf300ff0f9af45b4687e8e112d5ccc09abbf4e435abb2711e52341dd4f6ced8dd3d5c6165b6e42b25f654bbaa56789e07e1d2bc9d6fe1572fb15b0e83488d604fd07a9956d8af8b358fe2c966f2f963f42d63ce523eaff4168af9aaf489949aa5680df886c0efa9acb7a560c1ce4dadf6447142da7cd66bc7c598f97f4dbe9d9f2438fe0afc458e82d17fa9832bdcaa5a30421e40fa268ef6406c20a9fd6de49c06e32e5f211bd556881309dfd74d51f0f3afcffe0e245879ef79ead1ae45b259a2f80057a2dca57bb99ac79620b9f6f7eb0dc0b1efe760616efd09c7b6db03a1e9ed097bd93512a344e989af9741c3df833c415df1b1e7879911896e38e14ac6e3c9e340dbb6f6e267a309e684674c8bfcff9af1417a6008d68e46fbffb9c17709df8b0426fb0568b4fcadee9ac1f1ebb828147a789fcc7ac290bbf93f1f74ecb524ec79933ed1676f36bbfdbfa930a027daf225c34ff963f3d7c45ce6fc9b732ff71cbbe41e774b50f35f1f9f3bf00dda7629f', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136659, 52, 2.5, 5.0, 'mg', 'IN', 1, 'Adult', X'789c25cbcb0980400c45d1565e01ea42b0140b88335103994430839fea555c5e0e77dc1987c48a4435c4ad81189297498cbefe71d6ea2787187f2e21a4c8feae3ec395eca6ed35ecab57cd300ff0999833fa6e680794059944afee01cf0c2793', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136660, 7108, 25.0, 25.0, 'mg', 'IV', NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db6523032cd4dd7cff551f00c5328cecf292dc9cccfb386089a2a0085f38b127390240c0d7480923a0a89792940b6416eba424962524e6a4931009cfe1b14', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136661, 7108, 10.0, 25.0, 'mg', NULL, NULL, 'Adult', X'789cf32f4accb15230345028c9573032cd4d57482d4b2daa543001f1cd1432f24b8b8a15128b15f25253535253f4147c132b1532f3928b52138b53751432d38012c9a9c5c58945957a006e82187f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136662, 7108, 25.0, 25.0, 'mg', 'IM', NULL, 'Adult', X'789c15cbc10d83301044d156a6008422029774c0214558f6c4b61476917703a2fb98e397de5fdf2f4ccb96a14278dd3862fd4014e5dad5295655a031fe9a0dc8f560d770c5f2e80f0fb60bcfbb6714ed06c12064621ae085023babc7720b6de18ba41632c73f0d8927be', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136663, 7108, 2.0, 2.0, 'mg', 'IV', NULL, 'Adult', X'789cf30cb35230ca4d57482c513052c8cdcc2b2d4955c8cc2b492d2a4bcc29d65370c957c8cb2f5148ad484e4d4d513032cd4d078a65e6805495e42b18e6a6ebe7fae80100feac163f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136664, 7108, 25.0, 50.0, 'mg', NULL, NULL, 'Adult', X'789cf32f4accb15230325528c9573035c84d573006b14c144a3273538b15121552122b01b5af0a77', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136665, 7108, 25.0, 50.0, 'mg', 'IM', NULL, 'Adult', X'789cf3f4b552f04c5328aecc2d28c9cf2d5628482d2ace2c2e5148cb2f52305228c95730564849ac2cd65148cf2c4b5530320509991ae4a62b78fa0200507312e6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136666, 7108, 25.0, 50.0, 'mg', 'IV', NULL, 'Adult', X'789cf30c53c8cc4b2b2dcecccfb35208cec82fcd495128aecc2d28c9cf2d5628482d2ace2c2ed151282d4e5528cec92f57f044566e64aa5092af606a909b0e1404d20620aea10190cef551c84f53284eccc9cc4bd50300c90e20d7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136667, 7108, 25.0, 50.0, 'mg', 'IM', NULL, 'Adult', X'789c35cd410ac2401044d1abd409060966e3da4d16aef4021dbb481a4c8f4ecf04727b4dc06df18a3fdc2e18dcaac90bd71c44d7a366f4a7654a78cc84eee3221b46a2f04da95498233b31e75612ee6d0c7e1abd1e38fedafc5928f1e3e28ac9563ab8b26ce8f6c4f9b80724e0a452d317e5322fc1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136668, 7108, 10.0, 25.0, 'mg', 'IN', 1, 'Adult', X'789c1d8d3b0ec2400c44af32278842204d6a1a2a1a2eb0642db0e45da3b583b4b78f936e349f37cf9664c1a3b27312dcd568c165842ba6b97ca0114bc715ce850c0939f5012ff528e7c411e59818ecab9b64bc095cd746c92887c27492e63148a75fa8ba81fed40ea636dc0ea061abce02ebe5e75ae2a61156adde5484f2b003c1a5388a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136669, 7108, 200.0, 200.0, 'mg', NULL, NULL, 'Adult', X'789c0b2d2e4dcc51f04dcccc2b49cd4bcc4b4e5570c92f4eb552303230c84dd74f49ac54c82f4accc9a9040023190e19', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136670, 7108, 0.5, 1.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf32f4accb15230d0335528c95730cc4dd7cf4ed74fc92f4e55482d4b2daa543001099b2964e49716152b24162be4a5a6a6a4a6e80100d0a5116f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136671, 7108, 0.5, 1.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789cf3f455c82f52f00cb35230d0335528c95730cc4dd7cf4ed74fc92f4e55482d4b2daa543003095b2864e49716150300490a0e94', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136672, 7108, 40.0, 40.0, 'mg', NULL, NULL, 'Pediatric', X'789ccb492d2e5628c948cc533055a84c4d2c2a56d0c8810b1919e9992b64a76b5a299818e4a6eba72456020076670ee9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136673, 7108, 75.0, 75.0, 'mg', NULL, NULL, 'Pediatric', X'789c335548cc4b51c8cf49492d52d03032d233d73531d53355c84ed7b4523037cd4dd74f49ac0400b61509eb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136674, 15472, 500.0, 500.0, 'mcg/kg', NULL, NULL, 'Adult', X'789cf3c94f4cc9cc4b5748c92f4e55b055303530c84d4ed7cf4e5748cacf292d56c82f4b2d5230cccdcc030012cb0d8a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136675, 15472, 50.0, 50.0, 'mcg/kg', NULL, NULL, 'Adult', X'789c73cbcfc9c92f5728c9c82c5628cf2cc950c8cc4b2b2dcecccf53482c513035c84d4ed7cf4ed7cfcdcc5348cb2f5230013200d2b011d7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136676, 15472, 500.0, 500.0, 'mcg/kg', NULL, NULL, 'Adult', X'789c333530c84d4ed7cf4e5748cacf292d060024740513', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136677, 15472, 50.0, 200.0, 'mcg/kg', NULL, NULL, 'Adult', X'789cf3cc4b2b2dcecccf53c84f533035d0353230c84d4ed7cf4ed7cfcdcc5328c92c294a2c494d5128c95748cf4fcc5108760a00009c4d107c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136678, 1778, 1.0, 2.0, 'g', 'IN', NULL, 'Adult', X'789cf3c94f4cc9cc4b5748c92f4e55b05530d4354acf55c8cc533034c8f501008545089c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136679, 1778, 1.0, 4.0, 'g', 'IN', NULL, 'Adult', X'789cf3c94f4cc9cc4b5748c92f4e55b05530d43549cf55c8cc533035d0353430000095ee08a7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136680, 1778, 4.0, 6.0, 'g', 'IV', NULL, 'Adult', X'789c4d8dc10ac2400c447f652e8282c25aab07cf5efa03bd079aae816c026eb6dfeff6a4a76198f798c92484f489f1f240c634a35036aed20a6ad39582717c89b69ef166dcd301d57b1537f88a31a592c1ca852d487ff619e1205c3bef1f0c7fda09640bb26c0cdf78df76f49650c4fa4dfd0213ac3078', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136681, 1778, 1.0, 2.0, 'g', 'IV', NULL, 'Adult', X'789cf34dcccc2b49cd4bcc4b4eb552305428c957305248d7cf2852f00c5328cd2bc9cc5128482ccaafa82cce2d56484e4d2c4e05009e091116', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136682, 1778, 10.0, 10.0, 'g', 'IV', NULL, 'Adult', X'789c05c1310a80300c05d0abfc455070d0c103082e055ddd6b4d63509321ade7f7bd90a186b0634e89dc7bb07c842db2924b7de1f5c9b110a6a181db538b98226c1807c66af114652ce6847662888262ba70d4522cdddd0fa9e31eee', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136683, 1778, 5.0, 5.0, 'g', 'IM', NULL, 'Adult', X'789cf34dcccc2b49cd4bcc4b4eb55248cbcfc9c92f4f4d5148aa5430554857f0f45528543051c8c82f2d2a060030f10ddd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136684, 1778, 25.0, 50.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cb35230325528c9573035c84dd7cf4e57284a2cc84c51c8cc4b2b2dcecccf53c82f4b2d52284e059289390ab99979a525a9c500aa3b11ed', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136685, 1778, 25.0, 50.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c3332d53535c84dd7cf4e57f00c53a85030040027a30477', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136686, 2994, 5.0, 5.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65230cd4d0700364905de', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136687, 2994, 5.0, 5.0, 'mg', NULL, 1, 'Adult', X'789c33cd4d5730d2355628c9cc4d2d564849cccca9d451c84dacc8cc2dcd5530054a9a204b01005b4d0f6d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136688, 2994, 5.0, 5.0, 'mg', NULL, 1, 'Pediatric', X'789c33cd4d572829cf4c4e554849cccca9d451c84dacc8cc2dcd5530054a182b9464e6a61643a40039ab0eb4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136689, 2994, 2.5, 2.5, 'mg', NULL, 1, 'Adult', X'789c33d233cd4d5730d2355628c9cc4d2d564849cccca9d451c8cc4b2e4a4d2c4e55484e2c2dc9cc2f2dcea904001b5e0e99', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136690, 25236, 0.25, 0.75, 'mcg/kg', NULL, NULL, 'Adult', X'789c33d0333255d05530d0333755c84d4ed7cf4ed7cfcdcc0300371105c8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136691, 25236, 0.25, 0.75, 'mcg/kg', NULL, NULL, 'Adult', X'789c33d0333255d05530d0333755c84d4ed7cf4ed7cfcdcc0300371105c8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136692, 11186, 15.0, 20.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c3334d53532c84dd7cf4e57f00c5328b4d03534ca0000365e054b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136693, 11186, 15.0, 15.0, 'mg/kg', NULL, NULL, 'Adult', X'789c3334cd4dd7cf4e57283434ca000017120398', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136694, 11186, 15.0, 15.0, 'mg/kg', NULL, NULL, 'Adult', X'789c3334cd4dd7cf4e57283434ca000017120398', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136695, 11186, 15.0, 20.0, 'mg/kg', NULL, NULL, 'Adult', X'789c3334d53532c84dd7cf4e5728b4d03534ca0000277c048c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136696, 11186, 15.0, 20.0, 'mg/kg', NULL, NULL, 'Adult', X'789c3334d53532c84dd7cf4e5728b4d03534ca0000277c048c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136697, 11186, 15.0, 20.0, 'mg/kg', NULL, NULL, 'Adult', X'789c3334d53532c84dd7cf4e5728b4d03534ca0000277c048c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136698, 11186, 15.0, 20.0, 'mg/kg', NULL, NULL, 'Adult', X'789c3334d53532c84dd7cf4e5728b4d03534ca0000277c048c', X'789ced5b6d6fdb3812fe2b443e25d8d871dcb79c7b38c075d36ed02435e2b4e8e1bc3068692c7123912a4925f52dfadfef21653b7e512a5bedde2d7af9e25816e7e170e6197266a4fcb117ea3c1a499ed25e87ed5d930854967029e4de21dbcb75e27e8dadcd4ce7e8e84edc50da543a72dfc4d1da6013689e5138e2d6c9b45bede78dd671e3b875dd3ae9b49e748e5bcd17ada72f4efee6c7526085920623ffd83b93562bffcdd2172f7ca92ce3b75c247c9c101392d998d887c1b098271f2f8b7fc54fd68d7357fffa0d57899037c585bb7741410c154d3a529351d7cbadccf58a0796b40844c893976c2c646898d09a6e491b314ea6cc2af6bac113def09f2ca02461771c1f99a64069a3f421548cc5585821a3a5fb662aa1b711a686d66f4992e6c98aa6d7d38c3a43f93699c2ec945911d250be568647c4de289d1adceca93455925d6b1e12bb84574d67b7d9efa75b9ea79a0c2ba3bffa3574c33cb1232808b3ac2ca444a3b91b7832ba20102a8231cd8ad0f1b346bb95464737113bfbc83e9f348edbf1deea3adca4f738a7325401d761095201f3b91ce10d8db548687449397899411bbe8bf8e046c8d1d1c8a8891d616693d348c8096d126f69410faea62f29873f3734a8961c5006e64191c22094d6c0e85d0e4667dbe93e941f3217296df743cc523e6563629a3ee74253e8eef02016082a06627eceb925d61bbc61b02e59cd3d7ec9eae1488bd5c38ca3fdacb8207836847ba76e75dc1815088085072beab55b8db6f3d2f921a60b8bf90b2137f124c945b83e5d5540d6e6e7c3447f24e82341ff0c826ecdab756a3e12eb91589bc4da9515ebac7aa4c54f498bef73eb3a491efdfa57f1eb0e9ed888f44757fcd810ab63cf75a73c1af47f48ae8d6dee2f648c3e01c06a11cc4af4517b65c65907622817e7fbf358bb7e0393ca32fa1210b478f10c46c3a2350b95f19d9a0c6b27690dbb1336c6509df2046693f89ce4d29b62282f4949e86d00de6a2cf04f1aeda731db0f09460c5d2b4549d6bfe81ed4689f0c320a5c2adc57599ef07bfbcf17d7d714492e8329bbe2ae6b33941dd61bca73c4991fcdae84b9e9b0be5663ee7a40864f6828df8fc9083bedb0d76eb1636e60018cb5ca627563154ed91d8928b62f3d5d665c61a9c2c7c45dc12ece4eae1d52c28d2b67a4b276c9b9e2618739863e5bd497d01f193ed66f989a6cd8f7820b69c92d903aec45f3d9dcc64721f482938e1b4fc09e5be188e41c67d87e617dcd9ca0bee58939b85f604ff7c003f7c9fef1acb582e8b33e3dbb09676edc76a0b3db7f3f5ebff9f4a4f102e26c5f69ac215cb16a82d8821643791d936b2ce656040c09681ec5c5bd8e9bafdd6269101da5e76cdf87f0fc6a02c48bab4197e1af71bd3c47ce59e09b83926dea5772cc0dcaec7fa90a76f3f0f7dcd8d479515200d3733ddd21e81e665f75776d21319a49141db647cafc5729b31eb17f3e67be979a3b6e9b3d25717809ecbe41c9a6d94d12d2916f8807090eaa23f7e8a0c62cddd0f5d66974453cd89ca53cb1d442e5abe3aee0f3944bd7650fb54ab13defc7c2589e0ae9cee984c00ad660265177b0d19d74cecc8ddbdb713cd3813b8416f52c64170d7f3a381c4a1b0372ac82a99d0fb8a40cbf59f545043802204026f367dc50ba2955e4fadf06e181430de0ef6dd958a62c98894f7fb37c232a3af8aba7559c907bba00e8b7672ccf0c59b6eff1faef3720b6da81d68d57bd0341620489d14202f32cf170a9375009b53c780565ddea5b3c825a9758d36ad967db28b6327e056bcdc9d560dd3581afb394fe2766f246e9f148e59f98ca75bcbbe349d18f39ea8740252a9aae4cf42b4f268d444c90ab3c6f9cb058e51a094969b571f012438e5b0c790c8670996bc141eb0bc2c42a1126edb04b14614379fa25d0e4243aec8346e8d5293b8846ddc4ac3eccee4a2bc642e10487593e22c1428127571fe3eef884b8147b0b372e0d5e21c45ca96a88c5c815f98da56cffa878b12f6e166c6bf56849c9b654b0e1bb4f865991240da57ff83c948b2277286769d48323eafa60f76cfeb57be5a2186c46428e16088bc85a4bc3d64cf1a312b1e5f05a9be23ec0564265394adc8dd9ab15aea0285eadd8f16d83221f5cf0723420890a1b658615549d16bea3d55d6130942637816316663b32333062fbb9c979924c11f76743e9eb95d4bb1db76e3936045fe32f896af7da86e5d242e26a281797beecf0fd8f89af0c801d6031f053813ef8052a4c25bc83f1e09adffbeedf08e1cb5bc1070c5d68e88a8f0fd767a862a0093632779e194b2930164508f03f1d0fa544cecf2d0ef24f6d9cd8851228d06033ad0ed938b75ec1dcd544f7ba61f4936f8cbe1fb8b432a7d35b544f19eb326335652c0361a6c5b36f5725dd97472cccc9d1f1b4c9269c00e48e804f4febcc389b69d185fe664e8030f41afa5d48f394f555615027f65e479e9d9e1a0eb5395fce217b75c87a87eced9edfb4e79c9bfa91c5deb6807d0069d126a71a181f85162187d9fc624b003e1d6fa7058733a4027359540be6d48582c2961e0062eeb91a0bdac011795a02735601733118746bcceeaaf61a62bd6ea3a6e4c0f22c6eb2d30c27984e45586ab3aac5f69aec77c2c1506eaa2a15ce9b0cf4f3e9624492b6719a0f904b8ab80b10b30e78d9641100b58e159592faaa422300a4f35763ca2d528570a134ff82cd92339c7b1c9a3cc0c64a5affda747b539293fc77e952aae3a2c9702c8a1a6b78870cd808b70853169155e2b3898fee61d8e9e0d5f92f75a03690def57bb5807c708ffd3328931db26e9af598a4e8474165aa0e595049bbe72ce566aede3f67d2281d754038f8652d1d788220acedec412ca2dac27d947784dd36159a8f45cd409983dce649843ca88e0d00e1bac212e93b3359b38e16887b5c788ad644e8b9e4a2a0957bd49223752e0bde9d7042e1fa28792dbb2ee3d45c5217810272712409b518de459946f6db4a54fad6501eceb4e08422c3251bbc06d0ab5cdfc42a09dd0b6ac887331e883a30034bc81db5cae2995228f72dae40ff3a70ff747d32a4708c66e94b02e1a00ca9d2da6f34ea37613c872d2a58ede46b51e795ce836f8442d59ace2912eabb62a9cf5178e4da43a42891957b35bed629cc29f5cec95d7d80b2715a2b263f8ab116ca6d51524c44b05d405e08136c04659cf0741a7a9578cda8ba98fa7f7940c99b7dab00a8c4b912c10d596bc4038a54a64ad0a3086da48f8cdf9627911b6a742577e7ef66f6e7aa77a9d269509a495693d6aba25c4307fb2f8fea9f47748b13c9538ffc7f96b8ecb6664cf61285fa0ab9282c148a09b823923ad5da32cebeab5d17600735d0dee466c9739202bf9de9edfcb7612fcaacf245a49d575fe5510fad7edbecbc3c3650fe3f1a28bb34e4be7efd0f6484c8d0', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136699, 11186, 2.0, 2.0, 'g', NULL, NULL, 'Adult', X'789c0b2d5028c957304a5728b4c850c84dac54484a55284a2d2ccd2c4a4d01c924266764a696a52a24a60005134b52159c83dd140a52f3524b8a124b32f3f300c2e416a9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136700, 11186, 20.0, 25.0, 'mg', NULL, NULL, 'Adult', X'789c3332d03532cd4dd7f7d151484c49494d5128c95748c94ccca92c4e2c495548cb29cd4c0100bbc50b9b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136701, 11186, 15.0, 15.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c3334cd4dd7cf4e572834cb280200179703dd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136702, 11186, 750.0, 750.0, 'mg', 'IN', NULL, 'Pediatric', X'789c0dcac10d80201004c056b6043fc6066c84c0aa97c81e81335abe7ce635bb431ee097c9826d5dea89c68ee28330a1a5302a065e8b6bd65ed38d4e4d8f4739ccf50317131831', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136703, 11186, 10.0, 15.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c3334d03534cd4dd7cf4e5728b4d03532c950d048492d48cd4bc9cc4b57c8cf5308f075d40400bced0aa8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136704, 11186, 15.0, 25.0, 'mg/kg', 'IV', NULL, 'Adult', X'789cf3c94f4cb1523034d53532cd4dd7cf4e57f00c53284a4d4f2c4ac9492d2e56c84f03f2f2127314d24af3924b32f3f30073eb1062', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136705, 11186, 7.5, 15.0, 'mg/kg', 'IN', NULL, 'Adult', X'789cf34dcccc2b49cd4bcc4b4eb55230d733d53534cd4dd7cf4ed74f49ac54c8cc5330d4355648c92ccb4c494d5148c92f4e2d56d028b4d03532c9285200692c2a4bcc29d654484a2c06cae7e729381739e7000069601b2b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136706, 11186, 7.5, 15.0, 'mg/kg', NULL, NULL, 'Adult', X'789c732e72ce51b03335b05230d733d53534cd4dd7cf4e57283434ca280200616d0752', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136707, 11186, 7.5, 15.0, 'mg/kg', NULL, NULL, 'Adult', X'789c732e72ce513034d03535b05230d733d53534cd4dd7cf4e57283432c92802006bf307a5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136708, 11186, 7.5, 15.0, 'mg/kg', NULL, NULL, 'Adult', X'789c732e72ce51b03134b05230d733d53534cd4dd7cf4e572834b1d03537ca2852d0c82f52284a4dc92f4e55484a2c4e4d51c8cf53c8492d4bcd29d60400dd4611a6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136709, 11186, 10.0, 20.0, 'mcg', NULL, NULL, 'Adult', X'789c0bc9482d4a2c482d2dc94c562829ca2f4dcf50c8492d4bcdb1523034d0353250c84d4ed7cff551d0303445e2a5e51729f806053b2a00e962a0eaa25485ccbcb4d4e492ccfcbc624d0080591b55', X'789ced5b6d6fdb3812fe2b443e25d8d871dcb79c7b38c075d36ed02435e2b4e8e1bc3068692c7123912a4925f52dfadfef21653b7e512a5bedde2d7af9e25816e7e170e6197266a4fcb117ea3c1a499ed25e87ed5d930854967029e4de21dbcb75e27e8dadcd4ce7e8e84edc50da543a72dfc4d1da6013689e5138e2d6c9b45bede78dd671e3b875dd3ae9b49e748e5bcd17ada72f4efee6c7526085920623ffd83b93562bffcdd2172f7ca92ce3b75c247c9c101392d998d887c1b098271f2f8b7fc54fd68d7357fffa0d57899037c585bb7741410c154d3a529351d7cbadccf58a0796b40844c893976c2c646898d09a6e491b314ea6cc2af6bac113def09f2ca02461771c1f99a64069a3f421548cc5585821a3a5fb662aa1b711a686d66f4992e6c98aa6d7d38c3a43f93699c2ec945911d250be568647c4de289d1adceca93455925d6b1e12bb84574d67b7d9efa75b9ea79a0c2ba3bffa3574c33cb1232808b3ac2ca444a3b91b7832ba20102a8231cd8ad0f1b346bb95464737113bfbc83e9f348edbf1deea3adca4f738a7325401d761095201f3b91ce10d8db548687449397899411bbe8bf8e046c8d1d1c8a8891d616693d348c8096d126f69410faea62f29873f3734a8961c5006e64191c22094d6c0e85d0e4667dbe93e941f3217296df743cc523e6563629a3ee74253e8eef02016082a06627eceb925d61bbc61b02e59cd3d7ec9eae1488bd5c38ca3fdacb8207836847ba76e75dc1815088085072beab55b8db6f3d2f921a60b8bf90b2137f124c945b83e5d5540d6e6e7c3447f24e82341ff0c826ecdab756a3e12eb91589bc4da9515ebac7aa4c54f498bef73eb3a491efdfa57f1eb0e9ed888f44757fcd810ab63cf75a73c1af47f48ae8d6dee2f648c3e01c06a11cc4af4517b65c65907622817e7fbf358bb7e0393ca32fa1210b478f10c46c3a2350b95f19d9a0c6b27690dbb1336c6509df2046693f89ce4d29b62282f4949e86d00de6a2cf04f1aeda731db0f09460c5d2b4549d6bfe81ed4689f0c320a5c2adc57599ef07bfbcf17d7d714492e8329bbe2ae6b33941dd61bca73c4991fcdae84b9e9b0be5663ee7a40864f6828df8fc9083bedb0d76eb1636e60018cb5ca627563154ed91d8928b62f3d5d665c61a9c2c7c45dc12ece4eae1d52c28d2b67a4b276c9b9e2618739863e5bd497d01f193ed66f989a6cd8f7820b69c92d903aec45f3d9dcc64721f482938e1b4fc09e5be188e41c67d87e617dcd9ca0bee58939b85f604ff7c003f7c9fef1acb582e8b33e3dbb09676edc76a0b3db7f3f5ebff9f4a4f102e26c5f69ac215cb16a82d8821643791d936b2ce656040c09681ec5c5bd8e9bafdd6269101da5e76cdf87f0fc6a02c48bab4197e1af71bd3c47ce59e09b83926dea5772cc0dcaec7fa90a76f3f0f7dcd8d479515200d3733ddd21e81e665f75776d21319a49141db647cafc5729b31eb17f3e67be979a3b6e9b3d25717809ecbe41c9a6d94d12d2916f8807090eaa23f7e8a0c62cddd0f5d66974453cd89ca53cb1d442e5abe3aee0f3944bd7650fb54ab13defc7c2589e0ae9cee984c00ad660265177b0d19d74cecc8ddbdb713cd3813b8416f52c64170d7f3a381c4a1b0372ac82a99d0fb8a40cbf59f545043802204026f367dc50ba2955e4fadf06e181430de0ef6dd958a62c98894f7fb37c232a3af8aba7559c907bba00e8b7672ccf0c59b6eff1faef3720b6da81d68d57bd0341620489d14202f32cf170a9375009b53c780565ddea5b3c825a9758d36ad967db28b6327e056bcdc9d560dd3581afb394fe2766f246e9f148e59f98ca75bcbbe349d18f39ea8740252a9aae4cf42b4f268d444c90ab3c6f9cb058e51a094969b571f012438e5b0c790c8670996bc141eb0bc2c42a1126edb04b14614379fa25d0e4243aec8346e8d5293b8846ddc4ac3eccee4a2bc642e10487593e22c1428127571fe3eef884b8147b0b372e0d5e21c45ca96a88c5c815f98da56cffa878b12f6e166c6bf56849c9b654b0e1bb4f865991240da57ff83c948b2277286769d48323eafa60f76cfeb57be5a2186c46428e16088bc85a4bc3d64cf1a312b1e5f05a9be23ec0564265394adc8dd9ab15aea0285eadd8f16d83221f5cf0723420890a1b658615549d16bea3d55d6130942637816316663b32333062fbb9c979924c11f76743e9eb95d4bb1db76e3936045fe32f896af7da86e5d242e26a281797beecf0fd8f89af0c801d6031f053813ef8052a4c25bc83f1e09adffbeedf08e1cb5bc1070c5d68e88a8f0fd767a862a0093632779e194b2930164508f03f1d0fa544cecf2d0ef24f6d9cd8851228d06033ad0ed938b75ec1dcd544f7ba61f4936f8cbe1fb8b432a7d35b544f19eb326335652c0361a6c5b36f5725dd97472cccc9d1f1b4c9269c00e48e804f4febcc389b69d185fe664e8030f41afa5d48f394f555615027f65e479e9d9e1a0eb5395fce217b75c87a87eced9edfb4e79c9bfa91c5deb6807d0069d126a71a181f85162187d9fc624b003e1d6fa7058733a4027359540be6d48582c2961e0062eeb91a0bdac011795a02735601733118746bcceeaaf61a62bd6ea3a6e4c0f22c6eb2d30c27984e45586ab3aac5f69aec77c2c1506eaa2a15ce9b0cf4f3e9624492b6719a0f904b8ab80b10b30e78d9641100b58e159592faaa422300a4f35763ca2d528570a134ff82cd92339c7b1c9a3cc0c64a5affda747b539293fc77e952aae3a2c9702c8a1a6b78870cd808b70853169155e2b3898fee61d8e9e0d5f92f75a03690def57bb5807c708ffd3328931db26e9af598a4e8474165aa0e595049bbe72ce566aede3f67d2281d754038f8652d1d788220acedec412ca2dac27d947784dd36159a8f45cd409983dce649843ca88e0d00e1bac212e93b3359b38e16887b5c788ad644e8b9e4a2a0957bd49223752e0bde9d7042e1fa28792dbb2ee3d45c5217810272712409b518de459946f6db4a54fad6501eceb4e08422c3251bbc06d0ab5cdfc42a09dd0b6ac887331e883a30034bc81db5cae2995228f72dae40ff3a70ff747d32a4708c66e94b02e1a00ca9d2da6f34ea37613c872d2a58ede46b51e795ce836f8442d59ace2912eabb62a9cf5178e4da43a42891957b35bed629cc29f5cec95d7d80b2715a2b263f8ab116ca6d51524c44b05d405e08136c04659cf0741a7a9578cda8ba98fa7f7940c99b7dab00a8c4b912c10d596bc4038a54a64ad0a3086da48f8cdf9627911b6a742577e7ef66f6e7aa77a9d269509a495693d6aba25c4307fb2f8fea9f47748b13c9538ffc7f96b8ecb6664cf61285fa0ab9282c148a09b823923ad5da32cebeab5d17600735d0dee466c9739202bf9de9edfcb7612fcaacf245a49d575fe5510fad7edbecbc3c3650fe3f1a28bb34e4be7efd0f6484c8d0', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136710, 23721, 150.0, 150.0, 'mg', 'PO', NULL, 'Adult', X'789c33343550c84d5708f0572854b050c8282a060025d404a0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136711, 23721, 225.0, 225.0, 'mg', 'PO', NULL, 'Adult', X'789c73c92f4e4c4f55c84dac54484a55c8cc4b2e4a4d2c4e4d51482c5130d635514849ac2c5628c95730323255c84d5708f0572854b050c8282a060012d311af', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136712, 23721, 300.0, 300.0, 'mg', 'PO', NULL, 'Adult', X'789cf34dac5048c92f4e4c4fb55230363050c84d5708f0572854b050c8282a060086ab08b0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136713, 23721, 450.0, 600.0, 'mg', 'PO', NULL, 'Adult', X'789c3331355028c95730333050c84d5708f057482c56485428cecc4bcf495548c92f4e0500965d09e8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136714, 23721, 300.0, 300.0, 'mg', NULL, NULL, 'Adult', X'789c33363050c84d572854b050c8282a5648cb2f523081303572132b142c51a435012c420cf8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136715, 23721, 8.0, 10.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cb35028c957303450c84dd7cf4ed74f49ac5408f057c8cc53305648c92ccb4c494d5148c92f4e2dd60300f1fb0c8d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136716, 23721, 2.0, 3.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf3cc4b2e4a4d2c4e5548aa54305228c9573056c84dd7cf4ed74f49ac54482d4b2d820b03058a0162da0ef4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136717, 23721, 15.0, 15.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cf34dac50303455c84dd7cf4ed74f49ac5408f057c8cc53305648c92ccb4c494d5148c92f4e2dd60300ef3a0c7d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136718, 14, 5.0, 5.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f55082e294acd4b2fc928b65228494cca492db15230cd4db75648cd4bcd4db4523034c84dd73736c8f5b156282e2d28c82fce2cc92faa84880300fe431675', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136719, 14, 5.0, 30.0, 'mg', 'PO', 1, 'Adult', X'789c33d53536c84d5708f0574849cccca904001fb9048c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136720, 14, 10.0, 10.0, 'mg', NULL, 1, 'Adult', X'789c3334c84d57282e2d28c82fce2cc92faa544849cccca904005be4086a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136721, 14, 5.0, 5.0, 'mg', NULL, 1, 'Pediatric', X'789c33d3353454a82c2ab65230cd4d57c82f52284a4d2e49ccc9a9544849cccca9040095890a5b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136722, 11683, 0.75, 0.75, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65208494cca492d5130d03337cd4dd75130d4035200c6d20aa3', X'789ced56df4f233710fe5746796aa58590dc0152fa94124e877a1c117055aba65a39de49e2e21d6f6d6f209cf8dfeff32e840ba0c2a13e9cd4be246b7bfc7966bef9f5b953f87a9e8b2ab933a0ce075e3a717ece217ab69d8c3ab5b7e96011631506ddeea5b9e0721b12e9cb741fcb07ed55c545ae62bad6dfe9ef6dedf4b67a3be73bfb83ddbd41ffedf65e6f676fff4d23cb3a1a2701929f3bc3a2346280a3d25eb315f9aa41395f553ca0032738d45c45b3e4898c5c5073a677ce976140e76a6a39d2cef6fe6e39cfa8b78dbf899cba3a722037a34df40139af6c46262142c41b61fae1e8d3e8c7891cb8b27442e75e154c1fe117a08fad92ad9f332a5d8834f54a8a0654bb726aa441a4938371c8e8d87816d5d8564fbf36ef065b31e998567ffc89953572d12ed2d9b0a86dcc619391f986ed8725c3bda257786d6dbf93096c688da5f109fdddebd315f52772723a91c6f6b4eb4473462a50705010ff950bc14007ba34716184f6fbb470b56f6ca9a5f22e42632e28f0d5b799f0acbacf47d2fa62be79f1a671cf980ba3a237fa29179d31939aba25bfc2ef67156ba36c3e76556dd57d34de618f3dcf45257b4e712af3e4f7df26f241e9d8f2ee4db8489b473253129b256925e210284cbeb6f027a210b188c0b0d4aa3f2071a48abfea104b161cbee70a709a8aa78e5fcbc543dd9f2761946a412b1c7223f91aa18307ef8137ad7f4195b893cf937cae55e4b9f306cab7ecb6996da430fa090a86d6223456141d69ab42e8a68a3591b56e1341e22286c5ae061319ea541ea862bb843f8dcc5aaf21e1e9ec7c04d9b2acc5217311eea5092824bf88bb6cce431daa3601a69e558819dd96862c9d6af64004856017dfe9251c93c56b9e0a20a9c049aedd8875e92073167dad638d627387454a5ca9ec0aaa695b17f034cdccd43b839212172a26a8e87c5ccb6bb53471f5aa92024502e7a7acf463af3e018844f2c6d50f12c0581be0d7d1afe713e98e0f3342117517f0c9f11176b9f28ca2e204fbb5d1a65016dab694e0d6a18eae020fd53d599f6eedaad8cf5c5b8e41e6d108005c05133a9b66b5f1914af2865a1f550d8fa3ba4d0bd09832ab4200a5445285d20ba85798eb6bbc1302989aa247c1e9b454f34616e89c5c9fdd324d91a5609fa4c1f55279a384f42a445cbe73c0500b82e51d149ed7bc3670dcc6597a3ca3656d97ae79c34483ab471e66a3ac78421a0706f66255397c3bef17acba6afdf9d0e817e5372879414a43a8cdb2ef86dd8761f73fbdff06bdff0d2f7e630d1c2f146cd2cebaf96ac335ef959d6d5933c35c7982ea3ca0defe567f7f7b7731916306a2b3269403baedcb1942dc94b018757b69141dfc3e7e337c8b04b8d29edb81b269ef19a1dd28fb0a458f592f1406d43277b37ca81f8dc063efd2908d1ff909ad6361a626a2e72d6f8796d47866eca3b1e6badd98ae48d92619e7684653f089162ba14aad05e31e3a9d2fd18b8a2e6e828ed78c4eccf9d006f7b27115a1f0fdcc945f0f33b78afd335212429adddc7c01a99d9868', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136723, 11683, 0.75, 0.75, 'mg', 'PO', NULL, 'Adult', X'789cb35230d03337cd4d5708f05728343452a8503002002d050496', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136724, 11683, 1.5, 1.5, 'mg', 'PO', NULL, 'Adult', X'789c33d433cd4d5708f057c8cf4b4ed551482c5628cecfcf03d105f9c5c5994939a90ae599251999790ae6460a19f9a545c50af9690aa5790545f925a9c925a9290ac5a9150021d51820', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136725, 21810, 0.3, 0.5, 'mg', 'IM', NULL, 'Adult', X'789c33d033d635d033cd4d57c84f5330b432d431303050f0f405003f820549', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136726, 21810, 1.0, 5.0, 'mg', 'IV', NULL, 'Adult', X'789c05c1c11180200c04c056ae011e3e2c8206fc07094c46bd6420fd8fbb4739bf897ac10642d29409279aa694f6fafde8da1076d0134b7738bb71221d1af603930315e4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136727, 21810, 0.1, 0.1, 'mg', 'IV', NULL, 'Adult', X'789c33d033cc4d57c84f5330b43234d03130305028cec92f57f00c5348292dcacc4b573055c8cdccd351484ecc53282e492c2a51c8cc4b2b2dcecccf036bd23551c84d4ed7072a01001e3016cf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136728, 21810, 1.0, 1.0, 'mg', NULL, NULL, 'Adult', X'789c33cc4d57c84f5330b43234d031303050f00c0b50d03034484e562f5628c92f49cc51c82f523054504acc2d50d204000ead0c1c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136729, 21810, 1.0, 1.0, 'mg', NULL, NULL, 'Adult', X'789c1d8d310ec2301004bfb22548109c960720d150001f389c733888ef22e752f07bec34ab2976679ff465fc6c2d8836f0315271f02ccaf3bbd4c44e1c83f102354726772e9084ab4316f4e7fe1042809586a1f11ea403443f1c1d7d1e2bba8130495bbe688425dc1e1d2ea234d5538dac5ec8c57453e6389ef2d4e1be2aa82a623c65d1cdead28a8c2ae494ea41f70781893f19', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136730, 21810, 0.1, 1.0, 'mcg/kg', NULL, NULL, 'Adult', X'789c33d033d43554c84d4ed7cf4ed7cfcdcc0300226b04b9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136731, 21810, 0.01, 0.01, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d0333054c84dd7cf4e57d030b43234d03130305028cecf292dc9cccfd354f00cd3f7f4572834d63555c8cdcc03000d8d0c5b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136732, 21810, 1.0, 1.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb05230cc4dd74fc92f4e05001d0e0460', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136733, 21810, 0.01, 0.01, 'mg/kg', 'SC', NULL, 'Pediatric', X'789c33d0333054c84dd7cf4e57d030b432d43130305028cecf292dc9cccfd3540876d6f7f455a850300400cb060a7f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136734, 21810, 0.3, 0.3, 'mg', 'IN', NULL, 'Pediatric', X'789cf34dacb05230d03356c84dd74fc92f4e55c8cc5328284ad52d284d4a2d2a49cc5128482cc94ccd2b29b606aa32455655929a9a97989e0a570000978e1986', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136735, 21810, 0.01, 0.01, 'mg/kg', 'SC', NULL, 'Pediatric', X'789c33d0333054c84dd7cf4e57d030b432d43130305028cecf292dc9cccfd3540876d6f7f455a850300400cb060a7f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136736, 21810, 0.3, 0.3, 'mg', 'IN', NULL, 'Pediatric', X'789cf34dacb05230d03356c84dd74fc92f4e55c8cc5328284ad52d284d4a2d2a49cc5128482cc94ccd2b29b606aa32455655929a9a97989e0a570000978e1986', X'789ced5a6d6fdb3812fe2b031ff62e01225bb29b6cebbbe0e073ba5b034d3717f7f261570b81a6688b1b8954492a89b1c87fbf19caef75e275d35eaf8b7c492c6938339c17ce3323fdde484d3549142b44a30b8dd7a554a2cc0cfe6d1c41a33239ddcd9c2b6db7d5ba95d7a2686a33a15fb2b5416cb961a54813e6684d3b6c9f04611444e1fbf0fbee71bbfbe2a41975c293ce4b4f2bb8935a59a4fcbd3150ce68ffcb893bbf782844acb8914e7296036746c0874af26b30622c8c501c1f8fb501d21d526d8585d1146e859c64ae192b2fa11aad0ab9c75b8e8d724157bffc8a57b954d7f5053dfb51286158bea6c5fb6929bab1ba6256974658ab8d8dd599b66c22e0076d0a8b0ffb1a9541fd19498a55afd09572a0c760755ed13d900a8ab750599182d3904abc2d203a0ac3b09810a1585a3156620251370ae9299ccea95af50de4720a6133c21bc55b925c14c8febd61a98077e83fdb855e8ac661b8337104e89d0ba1e060700eac725aaadfd01cda1cee679ca53556cdb03b36d6a8efbd897b6995bb04ed27d564cdce5b346af4142bb369ceeea45da30d9b9d206c1ed7a64353794b0dcebd23ac4c8589d524af389b9037a28008075720c750a28704b946c14838168c72cdaf85b1c0540a4a3b0c2d5b6a95a272e427f44a63dd2a7e0b33ad50519ed80c396c28172d14ab7d68737d4b0aa49521c6c75048758401adc03a661c06c7b8b21425b42878010547e74ab545749f9954329ef40c2aead6c46e0a1d5c5dc0411472fe378b5b719841982a11c40d569471e3700bf37f5372251831c99991e57a12b06b01535d19e03a150127ad5742160ea4c30cc404241b16cc3961c8dc03dc9b5d3888e4cfb43bf406afa3114873a9d0dc0c72492b47cc6fe5ddb0093f4845b9bf9a5f9ea53751de84cb4a0143169c93c53c5727895078ff8dc728a0b965af17755426e9e64ed17b41e43d70bdd5097f284be6c1b73b437e9c53deaf85d6570ef887f2f039e29f23fe0b45fcff22b436c3fa39b6fe8f63eb0b64ffa6ff9f5df4195cf4a736e266c47c312beec578cfaee642600e3983e7eb16d8fda4266bab89aadc0ad4c56e4bdab019e266682f98ab8b137dd6241d620eb7063fc1874ee04ff5589db3bb2e39ba45821f41e2089792f6638236e40cfb2d6c88ee209a894078053329d4a961cb1294d548183a456608cafe1da98e57a99cc02e0b9bc03901f19aa2d94ac19cb7147c380e22bf1314d5dea2fe50dca089939e7559c1be3df55763f623f37f064cf16854ee061afdd9f28496277e79b25c5ea38f2f1aac8f74b3cfd1fa2789d66ff218da0ccc67cf3ee4d96fcd328fe195cf6c9a3d59ef895986a5e012cfee0b5d56395b6e682e02a54f14537c0a97f8544d62d5857eacde621f59c33d23ed35dd1ca83153ce5f529348487324c054b94841572e5697342b851a19c5ca8f2763b5804cb17a23c8fefc418a4f9da46eee6077413ba3197d4d6c13a9920587060a5c325eb7c16eb60bfa84e8b15a3a31d1468af9c4b6af09434b956231fdd811bd3c17663225dccc73666d8b80e22738bc9762a659915c0ac63f96f29ef16cca8cc9a6988892512a4c35f7cd618ec89e6702efc66a804856301ab25b61aa0272bf3544b0c3324743650afdb8a43e93134909389b91d77d85d47b86eb52c92d2aedb6fe7251b258b4e6cec7b4dc112ff5caa45e992c57ceb04fc64cc1b8cef564ba66ec9f9415feed45ed090435419b0e99ca21f83f185c1d1ec1cb200a576e9d1f629eb07c1ce4722cbaf08f7a2ab3a08fd52fed5f6375042f8e37169d0bb4aacea52dba304bb458bdbe432fd6927d721219cf9842aa55ad4aed68b21957616714f91eceff6c034d97a475e03246e3a03a242cd466e694f565e5fc8252e0e195d12b1fb86196e3496368208a8bd90c62ee19c50b45133d4e7ab5b577bde4b830b260668a91cf45e9b4595b506f29565848ea8d2e7fe2dd6dd5f052d079792392d7be8db51becdad1ab68f5ef9b4b62b7797778b5fd2e12ffcb605b9de954d6c7321c2c9489d5b639189e9b2248b168a914dd95882d5a453e9aea391d040b97c19b4befa5e1150a69483cba8d2e31401aab43040ca2280cda5bd7a3befb57b5a73963d3b9cfde788a37bebaf536ddf96d99efeb6bbbe7f1f90e8ff46d4e9ed571d09c57c6227ca62495f914c6461750d34cf229d6b2291ede2dff7322547d09b7d265a89dbdc64e9f2a6951599ecfa68e4e5a5b09c8a6a5c66250bf3988d57f7007b40a6bc6e2f5fd1c85d70ffabd332c79fa96fa03043e52f94105e241965bc8d88df0dc5351e0cefd6031855b8df846d5b093eb42d84f30d0e0011486251e083f55b42bec10e4c71afb772b30d6150d3ba932a2356ebc62f85fa0d6585aebd730586125b61768396dc011f2aa4b27f18c3adfcd3e5758b24723617dc522dfc1223f145cab34a0af0fb010538126d38b92d879b1a84795a704c2f9ecdd25aac0c634c1ad55444223c686d1770a1e576a97d10bce9bb52f30daadf622da52505581dd944707358e04dc13e936c70079958a7a2fe9d42e60a48ff179709546a7d59300e0cd533f8e180aec3573bbfe19cc06001ccc615cacfabb06649fb28987c4ed8d37972bd7f0ec4ea59f3ed5bb9c5faf2709712486b7b74de6ec6fba32082ead679d6ad96223db8ab0758d4e5eb40ce745b31d4661781284afbe6ff707ff44b5120cadd39f3baf9a2f5fe2b11776fe6ac62691e929764b5d23d32e37da5a548658fa672973a7dc24d8ea7fd749f16f21d2bf60c4a61c7bff4094e978df23e0fefebf2f245820', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136737, 21810, 0.1, 1.0, 'mcg/kg', NULL, NULL, 'Pediatric', X'789c33d033d43554c84d4ed7cf4ed7cfcdcc0300226b04b9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136738, 2540, 100.0, 200.0, 'mcg', NULL, NULL, 'Adult', X'789c0b2e492c2a51303430d035323050c84d4ed7cfcdcc5328c94805128905a9450a29f9e57900d8a10c2c', X'789ced596d6fdb3812fe2b440e7b48013bb19c9736468b439aec6e0ae4d220e9f6c3ad0a8196289b0d456a49298e6ed1ffbecf90b26339eec5e915bbc05dbe049634339cd7676698dfb7325b4f12cd0bb135625b9753a11b25caa9955a6cf5d8566d15bd9f5655e946bbbb3379238a1d6327f44bee3e2077a9e5a5c8125e11d770303cec0fa27e34f83078393a381a1d1cec0ca2e855b4ef69455a49a31d287fdffa596861b9f2bf2b71e7d93f34a518c5fa2377a6b4c239635dac4f8de313c17e32b6702376628ac268d5b083012b26ac14961db0e29c6d47f4bc5b9cbf8875a0611f2ccf04bb80a1e0bb10c635ba553cd6efb513153339e35ea5113b1e9bba62112ba4ae2b109cd696d397659a68d01f0e5a0ae70daac7cb367dc1ab8a8f95a0a75f3fe149497de31fee6d5c36ee717f77a8bf7ca2138eb35a5509bc22f5a4e3bd351a6d9d35a5a9847678d1a1bdaeb885b903b20826a5f09cd4ac427459c5c9a99999e958ef0ffa87f79f67c6de38961bcb0ae3aa58c75bb1beacdd14c44e84c777fa338e273fce43f282495d193a8ade5d5cb3b77cc2de8467927b0e5f5b3ec3d9d20552ce5c83284d448fcd6435c5736a742a74751f1170cf998f33a8265d059d073b07fda13ff96061d70b266e856dd8b07fb01cb9a530914fcfcd2cf949e1cfa595bc94aee838eb542af0b17239f75984ec834f8e8251e4945c6aaefea3aec861e46d6bb8eac1d53782b466850a9494c1aa7b508f719db12ca84007823c4d71e6c2d963ee04b197027e082e1b1ef57fe64c0b9129c1b6794ede192b6332c65d295bdde06a289b4b5bb012d944ef503c9413ad8eadebf6fa0714fded82df9131ad5b6b5d49c5909a069a79532dc23e35b55df5ef4665b1c8a30d3008a40991262b95f19ceceb937d15149eb3fd7f21db9fa3f89da3b87937f7febf1499e49595e9ba5ebc0445bbd75393dec0f28fec2dcec52c82c2f5eebd99b0df3053445ed5d2ea1e8b5ce5d3823928a532a64dc5c45d0a9f500cc8bc1624c82e4f1882459ffc09ef745e3b3fac0c76a23ec214ce214443e8248558901333e1a485d4b797b1bee00e3970620042ce7b65fbfd87137875bffffab0b1d077083150757f6a494b9f37af5fb28c3798ce0efbafa3a1a7fa1acd37b8f6ba14a9e42ab93465adf83d702dcac78a89e63a6dd815be6a988ec130d6e718d47818d5a4ceb9ae9895ee86a55c931fc782d95ac1660c7ab1be1294f8217284ab98a980eff390c6fa4c9410957e95e25bc7bf55d51f0780531ad703b14ba44e16125a1c40e01056a93399ae71d5b152c24e1a5f388a3bb74bd37facafa94cd0c6a698b86d9ba818bc0904640a9f5bd4793a6d526e612f266a855c4321ea096a73a2789d9a825ef35046321f91c7a8cbe61c554f928d8db5673713d4784a194d55b01d44a61485121377c11b24636a0501824f6ea9c353c6ae3f5e210dafcb16a36c866f9f6bdb907066d0bf2d8302469b02f2b3c6e5b54e430293547107d3a400b2e1279f4c04e57eb6104fb814e0c5e32a74c65967de1dd3c61a9911a27e639097bdfa7880cf96a9217f6957581f8f0dd6867bc66499b1237d6d501f971dd812cf962cd83a923ba9b08103883c999377243dc8a00df4bb6749024b47e2c3747a5c64e04988276979baf63e4c9b4d427ecf30dfec509468f45782a70f2bf92db7c68a549495b1fdc2e310a26745aec41d1b63d76d83dc6325dc19828f3d995a0b700109d1f659a4bbb8c30c093c61f3625c2e1ed496f3e8c04e8e4fd15472940f00e6165d02f324ab5d982a2aa37831bf04581930af5178a65e51ff5e431aa41536748e462d324148f24f81a2320a51e6a9446393b4f88b3910580fd67059686eb1fe71a1515b612bfb5cb80158edc84b4877acefa4a81a8f5a190a445047189b1a634bba68843de6308efcdbe3ff0587e150b4c726dc516d3169adacd62ab011462cf9e3f17c5926ee64de8a233719275b86243074a43d8cc2e302173cc982674d6dfcf758d846ec711173c25544f261de088c0265873f84ff71ee962ed4f39f5f06ab85f85c07cf75f0d7d7c19f9f85df32b4fd1f07e872ca6dc153a3cca4e98689abbcaf642efc12e83765778f52ae18d16c404eb81561d490baa268114ecdb8523d5698cc0fdee1b302a125dc02a48545ed172ba90a49683ae51a3269a53d6e6fdc9d5014c65bc1e27ab0378eb0eac79a4f0cdd81617881098e01ff0cb2c4a7c1d770f0d2ca826afdaa9d9f3a462e44af1924ae04ed9fb722f931cf21d0ad300ea3a3085b4aacfdcfbdb32bb6fd70207bf1045c0ce1d858db553bff1275bfdba14fbc25b83095e81ef6cb7c874ce78be9eaf0eb1e4cff7d4beaa3bb8e973b3324e5b5f2d71815ba6f5540042526255b26c160d06afc76c166748f8c8d5440f4fca28d96dfcc947e40c692cd91c018bb53591246e12cbf93716ba74d352d2477742fb6a269f0d6f947361fcc7bacd6a62cfdceb6540db4ea2a4041b8d5998f0a27ef698e2f1a130c524c3a404541a69d99198df72c8537658a4f281cae1ccb8cbf6e7235cec0f686f51ade1421a4c1c8daf9fd79c1899ae665694d69691709f751167ba198ff0b0e049e873b6c998cab4a58ed5385945d7159b89147c5577e3331390add6bc67239b652857ba0587be7585eca8cdd2eadc7d8e14be40ddd1c3ae041588e3cad82bd964dfd4aeaafbfc2d5224ca8e4e2c2f3f6feff6c2f62fd6bf4695d75bd5bdcb174b2ee42d4b65d51dbabbe6b0140ca8076b08b4f287572bf5595d5f21afbe451699e511bdc19cd293bbd618d3f37e8529e29e93085aef19dddf1d43b42219263e54ce76cb2814c98cd7678e53ea35da1da9d37263372978fdd6e34d889a2c3fd5d9ba6c5ce70100d0687fdc1d1cbe1c9bb7fc011092ae3cdbff68e765ebda27faaecfddde63691d91b63e5c8ca6c945ae31ce08b44fa6f19afdea43629ebf10f7b19fe6231ff1b6a304bebb1e88b32cb9f6ada972f7f004e1edc34', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136739, 2540, 40.0, 60.0, 'mcg', NULL, NULL, 'Adult', X'789c3331d0353350c84d4ed7cfcdcc5328cf2fca2e5648cb2f52c8cd2f2e01007a110962', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136740, 2540, 10.0, 10.0, 'mg', NULL, NULL, 'Adult', X'789cf3cccb4a4d2e513054c8f551d0303450c84dd754c8cc2bc9573034300089f9052b3825a62bd842f8c9e9fab93e0071e80dea', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136741, 2540, 100.0, 100.0, 'mcg', NULL, NULL, 'Adult', X'789c73294a2c5728c9c82c56c8cc2bc957485428ae2ccacc4b4fd55128cf2cc900f293f3f39253f34a8a124b32f3f314f2d3140c0d0c7293d3f5737d007c4014c8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136742, 2540, 50.0, 200.0, 'mcg', NULL, NULL, 'Adult', X'789c734cc9cdcccb2c2e492d5230d033d53552c8f551d03035d035323050c84d4ed754482d4b2daa5430d23555002a2c2d492d060079110f0c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136743, 2540, 1.0, 1.0, 'mg', 'IN', NULL, 'Adult', X'789c05c1b10dc0200c04c0557e8340993e254a930910326009bf112245b6cfdda5e3dd82d985df90d9975210ad4189d312ee07d517aa320f146711ee95b73ae11531042bedb0f40394f318df', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136744, 2540, 500.0, 500.0, 'mcg', 'IN', NULL, 'Adult', X'789c73cb2f5230353050c84d4ed7cfcdd1512849cc4e5530d03355c8cd51c84f533034c805892b1464a4e655e6a416641465e6a5ea2824e6a528a464e69496a42a64e62958029527272bf8050300a3a51846', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136745, 2540, 29.0, 29.0, 'G', NULL, NULL, 'Adult', X'789c15c8310e80200c05d0abfc510717374f603c4681124bb025b489d737bef15dda38071239c32a06ab385e891bfbb19d04652e9db1500d9e48ddac807cc8a4105384219b56990f86b9fcb77ec6211dc9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136746, 2540, 100.0, 500.0, 'mcg', NULL, NULL, 'Adult', X'789c333430d035353050c84d4e57482d4b2daa5430d635cdcdcc53d0c84dac5030348048692a94e69564e62814a516e7e7949664e6e729e41729182a64e49716010086de14ce', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136747, 2540, 5.0, 20.0, 'mcg/kg', 'IV', NULL, 'Pediatric', X'789c25cbb10d80201445d155de0012c184c6d2ce05ec09201081af8291f18d5adf73e70513c5ab8c906ce049bb7e7338046742a690b19fb9832815868a45f17445834c15b6696b0d247f1fdca17a2824d57e482b04ffd203bc091eb8', X'789ced596d6fdb3812fe2b440e7b48013bb19c9736468b439aec6e0ae4d220e9f6c3ad0a8196289b0d456a49298e6ed1ffbecf90b26339eec5e915bbc05dbe049634339cd7676698dfb7325b4f12cd0bb135625b9753a11b25caa9955a6cf5d8566d15bd9f5655e946bbbb3379238a1d6327f44bee3e2077a9e5a5c8125e11d770303cec0fa27e34f83078393a381a1d1cec0ca2e855b4ef69455a49a31d287fdffa596861b9f2bf2b71e7d93f34a518c5fa2377a6b4c239635dac4f8de313c17e32b6702376628ac268d5b083012b26ac14961db0e29c6d47f4bc5b9cbf8875a0611f2ccf04bb80a1e0bb10c635ba553cd6efb513153339e35ea5113b1e9bba62112ba4ae2b109cd696d397659a68d01f0e5a0ae70daac7cb367dc1ab8a8f95a0a75f3fe149497de31fee6d5c36ee717f77a8bf7ca2138eb35a5509bc22f5a4e3bd351a6d9d35a5a9847678d1a1bdaeb885b903b20826a5f09cd4ac427459c5c9a99999e958ef0ffa87f79f67c6de38961bcb0ae3aa58c75bb1beacdd14c44e84c777fa338e273fce43f282495d193a8ade5d5cb3b77cc2de8467927b0e5f5b3ec3d9d20552ce5c83284d448fcd6435c5736a742a74751f1170cf998f33a8265d059d073b07fda13ff96061d70b266e856dd8b07fb01cb9a530914fcfcd2cf949e1cfa595bc94aee838eb542af0b17239f75984ec834f8e8251e4945c6aaefea3aec861e46d6bb8eac1d53782b466850a9494c1aa7b508f719db12ca84007823c4d71e6c2d963ee04b197027e082e1b1ef57fe64c0b9129c1b6794ede192b6332c65d295bdde06a289b4b5bb012d944ef503c9413ad8eadebf6fa0714fded82df9131ad5b6b5d49c5909a069a79532dc23e35b55df5ef4665b1c8a30d3008a40991262b95f19ceceb937d15149eb3fd7f21db9fa3f89da3b87937f7febf1499e49595e9ba5ebc0445bbd75393dec0f28fec2dcec52c82c2f5eebd99b0df3053445ed5d2ea1e8b5ce5d3823928a532a64dc5c45d0a9f500cc8bc1624c82e4f1882459ffc09ef745e3b3fac0c76a23ec214ce214443e8248558901333e1a485d4b797b1bee00e3970620042ce7b65fbfd87137875bffffab0b1d077083150757f6a494b9f37af5fb28c3798ce0efbafa3a1a7fa1acd37b8f6ba14a9e42ab93465adf83d702dcac78a89e63a6dd815be6a988ec130d6e718d47818d5a4ceb9ae9895ee86a55c931fc782d95ac1660c7ab1be1294f8217284ab98a980eff390c6fa4c9410957e95e25bc7bf55d51f0780531ad703b14ba44e16125a1c40e01056a93399ae71d5b152c24e1a5f388a3bb74bd37facafa94cd0c6a698b86d9ba818bc0904640a9f5bd4793a6d526e612f266a855c4321ea096a73a2789d9a825ef35046321f91c7a8cbe61c554f928d8db5673713d4784a194d55b01d44a61485121377c11b24636a0501824f6ea9c353c6ae3f5e210dafcb16a36c866f9f6bdb907066d0bf2d8302469b02f2b3c6e5b54e430293547107d3a400b2e1279f4c04e57eb6104fb814e0c5e32a74c65967de1dd3c61a9911a27e639097bdfa7880cf96a9217f6957581f8f0dd6867bc66499b1237d6d501f971dd812cf962cd83a923ba9b08103883c999377243dc8a00df4bb6749024b47e2c3747a5c64e04988276979baf63e4c9b4d427ecf30dfec509468f45782a70f2bf92db7c68a549495b1fdc2e310a26745aec41d1b63d76d83dc6325dc19828f3d995a0b700109d1f659a4bbb8c30c093c61f3625c2e1ed496f3e8c04e8e4fd15472940f00e6165d02f324ab5d982a2aa37831bf04581930af5178a65e51ff5e431aa41536748e462d324148f24f81a2320a51e6a9446393b4f88b3910580fd67059686eb1fe71a1515b612bfb5cb80158edc84b4877acefa4a81a8f5a190a445047189b1a634bba68843de6308efcdbe3ff0587e150b4c726dc516d3169adacd62ab011462cf9e3f17c5926ee64de8a233719275b86243074a43d8cc2e302173cc982674d6dfcf758d846ec711173c25544f261de088c0265873f84ff71ee962ed4f39f5f06ab85f85c07cf75f0d7d7c19f9f85df32b4fd1f07e872ca6dc153a3cca4e98689abbcaf642efc12e83765778f52ae18d16c404eb81561d490baa268114ecdb8523d5698cc0fdee1b302a125dc02a48545ed172ba90a49683ae51a3269a53d6e6fdc9d5014c65bc1e27ab0378eb0eac79a4f0cdd81617881098e01ff0cb2c4a7c1d770f0d2ca826afdaa9d9f3a462e44af1924ae04ed9fb722f931cf21d0ad300ea3a3085b4aacfdcfbdb32bb6fd70207bf1045c0ce1d858db553bff1275bfdba14fbc25b83095e81ef6cb7c874ce78be9eaf0eb1e4cff7d4beaa3bb8e973b3324e5b5f2d71815ba6f5540042526255b26c160d06afc76c166748f8c8d5440f4fca28d96dfcc947e40c692cd91c018bb53591246e12cbf93716ba74d352d2477742fb6a269f0d6f947361fcc7bacd6a62cfdceb6540db4ea2a4041b8d5998f0a27ef698e2f1a130c524c3a404541a69d99198df72c8537658a4f281cae1ccb8cbf6e7235cec0f686f51ade1421a4c1c8daf9fd79c1899ae665694d69691709f751167ba198ff0b0e049e873b6c998cab4a58ed5385945d7159b89147c5577e3331390add6bc67239b652857ba0587be7585eca8cdd2eadc7d8e14be40ddd1c3ae041588e3cad82bd964dfd4aeaafbfc2d5224ca8e4e2c2f3f6feff6c2f62fd6bf4695d75bd5bdcb174b2ee42d4b65d51dbabbe6b0140ca8076b08b4f287572bf5595d5f21afbe451699e511bdc19cd293bbd618d3f37e8529e29e93085aef19dddf1d43b42219263e54ce76cb2814c98cd7678e53ea35da1da9d37263372978fdd6e34d889a2c3fd5d9ba6c5ce70100d0687fdc1d1cbe1c9bb7fc011092ae3cdbff68e765ebda27faaecfddde63691d91b63e5c8ca6c945ae31ce08b44fa6f19afdea43629ebf10f7b19fe6231ff1b6a304bebb1e88b32cb9f6ada972f7f004e1edc34', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136748, 2540, 0.1, 0.5, 'mcg/kg', 'IV', NULL, 'Pediatric', X'789cf30c53f0cc4b2b2dcecccfb35230d033d435d033cd4d4ed7cf4ed7cfcdccd35128c92c294a2c495528c95748492dce2c4a4d51700a0000c76a115d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136749, 2540, 2.5, 2.5, 'mg', NULL, NULL, 'Pediatric', X'789c33d1b531ab2c2ab65230d233cd4d572834c928522828ca5348cb2f52b031574849ac2c0600b91a0acf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136750, 2540, 5.0, 5.0, 'mg', NULL, NULL, 'Pediatric', X'789c33d3b53134aa2c2ab65230cd4d572834c928522828ca5348cb2f52b031574849ac2c0600b0c90a9e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136751, 20440, 40.0, 40.0, 'mg/kg', NULL, NULL, 'Adult', X'789c3331c84dd7cf4ed74f49ac54c84dacc8cc2dcdd551305248cf058900008ee009a4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136752, 20440, 0.0, 0.0, 'units', NULL, NULL, 'Adult', X'789c333330d03130305028cdcb2c295648cb2f5228482d2acecf2b56a8cc2fcd4b4f2d5228c948cc533053a84c4d2c2a56c8cf4901009db01124', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136753, 20440, 0.0, 0.0, 'units', NULL, NULL, 'Adult', X'789c33d4313230d03130305028cdcb2c295648cb2f5228c9c82f4e553053a84c4d2c2a56c8cf495148cc4b01d1a945004d9a0f2b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136754, 20440, 40.0, 40.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c3331c84dd7cf4ed74f49ac5448cb2f5248cec8cc49294acd5348cc4b513054404824a694e694142b5428181a2800c58a012875130d', X'789ced5b6d4fdc4812fe2b2da468410232101222bef19217eec8062d2cf72113593d768fdd87ddedeb6e03ce2aff7d9f6a7bc6ee61c838b9ddd59e6ea448604fbd74553d5d2f93e2b78dc45469a47821368ed8c6992c33970923f9c636dba84c4e2f33e74a7bf4fcf9bdbc15c5ae3629fd269f87b43636bc1449c41db1ec8ff65fed8cf676f646d7a3c3a397fb47a383ddd1cbc397aff73dad889dd4ca82f2b78d131edfa646572af18f4e3c7809c78a5565290c33c296d270a74dcd9ce1b16332cf95b096c5bcb22261939a9de2432526f810c7a90a96cc8f26b61957f8278c9ec878acde195eb0525be9e49d602d071fabd34ce6891120358255b6e2795eb33b1ec752710725f7d2650c22d9d9e575fb5e8cd5a7bdcfde9e6ad237e92b5e393ec9053d7dfa8ca75caa5bffd0d9b7fc20abbd4e7cd18c2f9af37dfd4c5a4fa148c63c8fde0aee2a236ce0d2abba289d2eecdcbe8948a5622f770e59c26b4ba781731524f31c3fa78d49705ee2bda2a70efe5130b214b19cca98155ce65c5ae149a6dcc9b48253de8a3b844d4fd98bd7e36a349a8c4ed9e6de68b47bd03cbddd82b76bae6082851666895c206456700bf62b8d279719cd1df31c7bf86c0a7555ee6a66ef71727d2f553a56ef3537561014b659acab341bab0b9898f144285d7297d56335de38a9f29c2911df8e37485dce019554c0c20e2408e4fee7b13a13ca022fa911352bada8125d886262001e88c721a1d44380fc84276d18275738b2d5bfcf48f6432bed14982ec76a2747fc9ae32d810a620259858ca30f5cc9a9b08e779fcde2d65d34e6f4036c8801e95cf0048fed9b84173c15b38364821bc7368b5ac7dc2488a7ddda860bcc9dae2cb35ee3b68fd9ad4c94a8ed587de848c7ea631c57c6c7666f442af65f3e23c9f0a814ca81e0ba2e096540906e480f896cefa08111074e107ff8d27ba67f7f6d8b40c4ce1f71926bc4456d8f153726ab5d56486efd7363c21400038cf186c5d200018d9858e739478476c7ea6751199deb1468244fc4d2d57d03164f7e0133f3b152c4450891c2926ec1a69a60d5641364324557a04fb511dee9af83eeb887c0ea2bdd904162c7d98bc76afe3e7120a5e7e4d5523c71d41007527aa1592de5b8471c4809023af43433f226bbadefcaffce5df99192b806fd12d09fa1f6a13e2a2acad199e4a92f9c01e697d59593b631c8a379215f68069c11c0570c54227c4de94a1b4c6ffacfd8b5afc15b841b69adbf52a9561ab66ac181b3b35efddc3cdda57adaf65ce099eb67d7e8d932310b6a3f87e2f106687ff288e7ed6b5cc4028a5515e7828c87ba3727375072d962b5e9ced02c4a0719680f394af3c4c6d424661ced1567fba367c0782cd11ac4feee2f48fcf40225fba2e784e3b872829d18ade2ac79f34b2695be93a6c2ef6838b5e2edc331f51bedefef8529856d1f60405e09f5050e9af33d58f4bb52b01e3d874e059af748333b53addd0efd52e80a46cddba2f7e737b0bb39d52fc2195208ef5ed52a31e853b69638f767ade4dc850bc147d3a5ecce3f74a62c5abc9914b854a081421f4766e1585a24a2e04b647fa4508799570033d467315b72f8781e54788ecedb428c3aaf3636707895dccbf427e4c1d605971c534447f848d26510e3e336c69b97d7c780c39b52a6b976ae09d73ff93db7fc56762ebc44af8809c2511f27d5bf2b83f4778a19c22121e21d0a8ad771811a238c113f51feeffcd2571c8b3caff2468f6f3975c129dc80bcc2b19198b493d435e3454dd30774d902c99642867b55d9ccdbaadbb35ea2a3dc69c5c3545dd4a84b055d3554aab1ba017281f39e9f1a1cc0db24e20b1954e5b120db807690a4f26ed98d1b94869fcc0cab1358c01af55983b4b834a1ac963e678bfa6c81e4a7d2ceb70577c9b2c715c87d2a15ad96dd7146216720ffe23b9c7cf184571733d680ba451c518f2390d7e5bbd5927ab4818c5e9e1cd007f78843cbe60976804d1ded425b304fcc430a3111475616652e1ea225e2e6a97d10025ad205d704a560887b5a8665e7e9eac830eb5ada50c6d3f56780d0c7ccd18c39d4727e3340daf94db4131d9f9f5d459b1fb8545ba18ca7ead7900c157046b30c1fe1d491ef8a2351a24b3005b281cfaf79fde8b6ce8be46a7d73d2e8aeca536e1e5ddaa0c8ae8076471b5ed4e5e575c0ad0d19a31963989ac21a3d203f798667fb87365a86b26f97f8011e0df823cfdf75908b817ab25d1812ba1e73d432470d73a0a5df77ac161b500772163b96d5b2661ccb6fdae37e67488d8d6f2330558b207bd4280d48580d4bd4b184c07adc670d0057cbe4e13567fb46d0bb56ed7b23dee30ccfdd367c030e3ba30cf87b4de06a11441cb5c48bd7480f445c471a4af856d33940ea23f6a8c71e685aec5f570b6f399e4c22dfd1ff0e69817a82a24e50d413d40ce30d357d431d35d3f17a0e5fcfe1eb397c3d87afe7f0f51cbe9ec3d773f87a0e5fcfe1eb397c3d87afe7f0f51cbe9ec3ffb439fccd1dcf2bbffdb17200ff9736b7551990350335a385b2ca080cad39da6b1ae412c11231f51b7077b49136fbcff6e1ddbb3fdd1fa472f80a85d7fa812b04bc40b402cdc7d24cb4a165456975ce9bd1ea2ad8b96bc6f6feee49ac0b9caea0d5be82d7f8e83f9534541d5c356945f4166db802aafd6a8db44c69077a08c0491291d0624949c5adcef9033e9e54ceafe44c68cb52345b3946906bb49a4a53e0d57c4efc74f099a6df9970ef34128f310e9931975f44bbd1e3320880709e435452b3a97c68456350a984ddf66aa56b4574ecb3451902ee66a526b485bad50aa59d9f364ed4aa38322385932ced44ea6977cce3a440fcaccff0f8c866baca1332d0bb15b69e9f31bf32099dd6311c95f68e4ecf4ed99b429854a8b8661f4bd1b05b762a687c25b2cd5faf30f669258ed8e1e168e7e0f5eb9dc3bdd1686b19ccafc98914fc881c3691b84571f85dc3c7d253633c3735ad5716752c11c78351913ebf4d9f27887381101555b1cdf6595ad01b4cc446c7e8fb042b859231dc413cef58c2655e6fb3f30f6cf3c568b43d1a8dd8af5ec4541b98a7095442a61939766fc46e5386f7b9dfd424bfbe5ac553344ba05c35dc5b9ea65d9ada5df235884f826f1e4a6d71bda2cb0e70810bdee18e29c2459c933640ce61e2c499441b9f1ca91713a2c8342238fb38c0fa44fbe5cf1e385b5fb34d046ab654d66c48c190ada3b13aa199c365e4c4cbb913d9bbb19a79a1c2edb7de42a0c012066a003115a6f1c02b560b6e2cc399c66a6f7bff1157e3bb1e99f7317ed2399f8e36b1c6f3b56770ecb1ee039e205559f640fe27a7ffd03718b3dc3360369be526c44ec4bc6a801d76773d430674777deab0dc3e46f48022db32453da6f00b8fe5411ef09dc79c31ea18a3777f9cedfe7efcbfa587c5f4b8ce0f7fc7fcb0bed2ffc5955e43fa2f80f48fac31ffcd7173266df3e7430bc313b5b14d734bce0846834227d49e52bb3dfb739d659bea94c4efe15dc1f83d97bea96e071ecb92ca736748e073d9b6828c9834fa761be1edfdc11502ecbe770afafaf5779dd15ade', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136755, 20440, 40.0, 40.0, 'mg/kg', NULL, NULL, 'Adult', X'789c3331c84dd7cf4ed74f49ac54c84dacc8cc2dcdd551305248cf058900008ee009a4', X'789ced5b6d4fdc4812fe2b2da468410232101222bef19217eec8062d2cf72113593d768fdd87ddedeb6e03ce2aff7d9f6a7bc6ee61c838b9ddd59e6ea448604fbd74553d5d2f93e2b78dc45469a47821368ed8c6992c33970923f9c636dba84c4e2f33e74a7bf4fcf9bdbc15c5ae3629fd269f87b43636bc1449c41db1ec8ff65fed8cf676f646d7a3c3a397fb47a383ddd1cbc397aff73dad889dd4ca82f2b78d131edfa646572af18f4e3c7809c78a5565290c33c296d270a74dcd9ce1b16332cf95b096c5bcb22261939a9de2432526f810c7a90a96cc8f26b61957f8278c9ec878acde195eb0525be9e49d602d071fabd34ce6891120358255b6e2795eb33b1ec752710725f7d2650c22d9d9e575fb5e8cd5a7bdcfde9e6ad237e92b5e393ec9053d7dfa8ca75caa5bffd0d9b7fc20abbd4e7cd18c2f9af37dfd4c5a4fa148c63c8fde0aee2a236ce0d2abba289d2eecdcbe8948a5622f770e59c26b4ba781731524f31c3fa78d49705ee2bda2a70efe5130b214b19cca98155ce65c5ae149a6dcc9b48253de8a3b844d4fd98bd7e36a349a8c4ed9e6de68b47bd03cbddd82b76bae6082851666895c206456700bf62b8d279719cd1df31c7bf86c0a7555ee6a66ef71727d2f553a56ef3537561014b659acab341bab0b9898f144285d7297d56335de38a9f29c2911df8e37485dce019554c0c20e2408e4fee7b13a13ca022fa911352bada8125d886262001e88c721a1d44380fc84276d18275738b2d5bfcf48f6432bed14982ec76a2747fc9ae32d810a620259858ca30f5cc9a9b08e779fcde2d65d34e6f4036c8801e95cf0048fed9b84173c15b38364821bc7368b5ac7dc2488a7ddda860bcc9dae2cb35ee3b68fd9ad4c94a8ed587de848c7ea631c57c6c7666f442af65f3e23c9f0a814ca81e0ba2e096540906e480f896cefa08111074e107ff8d27ba67f7f6d8b40c4ce1f71926bc4456d8f153726ab5d56486efd7363c21400038cf186c5d200018d9858e739478476c7ea6751199deb1468244fc4d2d57d03164f7e0133f3b152c4450891c2926ec1a69a60d5641364324557a04fb511dee9af83eeb887c0ea2bdd904162c7d98bc76afe3e7120a5e7e4d5523c71d41007527aa1592de5b8471c4809023af43433f226bbadefcaffce5df99192b806fd12d09fa1f6a13e2a2acad199e4a92f9c01e697d59593b631c8a379215f68069c11c0570c54227c4de94a1b4c6ffacfd8b5afc15b841b69adbf52a9561ab66ac181b3b35efddc3cdda57adaf65ce099eb67d7e8d932310b6a3f87e2f106687ff288e7ed6b5cc4028a5515e7828c87ba3727375072d962b5e9ced02c4a0719680f394af3c4c6d424661ced1567fba367c0782cd11ac4feee2f48fcf40225fba2e784e3b872829d18ade2ac79f34b2695be93a6c2ef6838b5e2edc331f51bedefef8529856d1f60405e09f5050e9af33d58f4bb52b01e3d874e059af748333b53addd0efd52e80a46cddba2f7e737b0bb39d52fc2195208ef5ed52a31e853b69638f767ade4dc850bc147d3a5ecce3f74a62c5abc9914b854a081421f4766e1585a24a2e04b647fa4508799570033d467315b72f8781e54788ecedb428c3aaf3636707895dccbf427e4c1d605971c534447f848d26510e3e336c69b97d7c780c39b52a6b976ae09d73ff93db7fc56762ebc44af8809c2511f27d5bf2b83f4778a19c22121e21d0a8ad771811a238c113f51feeffcd2571c8b3caff2468f6f3975c129dc80bcc2b19198b493d435e3454dd30774d902c99642867b55d9ccdbaadbb35ea2a3dc69c5c3545dd4a84b055d3554aab1ba017281f39e9f1a1cc0db24e20b1954e5b120db807690a4f26ed98d1b94869fcc0cab1358c01af55983b4b834a1ac963e678bfa6c81e4a7d2ceb70577c9b2c715c87d2a15ad96dd7146216720ffe23b9c7cf184571733d680ba451c518f2390d7e5bbd5927ab4818c5e9e1cd007f78843cbe60976804d1ded425b304fcc430a3111475616652e1ea225e2e6a97d10025ad205d704a560887b5a8665e7e9eac830eb5ada50c6d3f56780d0c7ccd18c39d4727e3340daf94db4131d9f9f5d459b1fb8545ba18ca7ead7900c157046b30c1fe1d491ef8a2351a24b3005b281cfaf79fde8b6ce8be46a7d73d2e8aeca536e1e5ddaa0c8ae8076471b5ed4e5e575c0ad0d19a31963989ac21a3d203f798667fb87365a86b26f97f8011e0df823cfdf75908b817ab25d1812ba1e73d432470d73a0a5df77ac161b500772163b96d5b2661ccb6fdae37e67488d8d6f2330558b207bd4280d48580d4bd4b184c07adc670d0057cbe4e13567fb46d0bb56ed7b23dee30ccfdd367c030e3ba30cf87b4de06a11441cb5c48bd7480f445c471a4af856d33940ea23f6a8c71e685aec5f570b6f399e4c22dfd1ff0e69817a82a24e50d413d40ce30d357d431d35d3f17a0e5fcfe1eb397c3d87afe7f0f51cbe9ec3d773f87a0e5fcfe1eb397c3d87afe7f0f51cbe9ec3ffb439fccd1dcf2bbffdb17200ff9736b7551990350335a385b2ca080cad39da6b1ae412c11231f51b7077b49136fbcff6e1ddbb3fdd1fa472f80a85d7fa812b04bc40b402cdc7d24cb4a165456975ce9bd1ea2ad8b96bc6f6feee49ac0b9caea0d5be82d7f8e83f9534541d5c356945f4166db802aafd6a8db44c69077a08c0491291d0624949c5adcef9033e9e54ceafe44c68cb52345b3946906bb49a4a53e0d57c4efc74f099a6df9970ef34128f310e9931975f44bbd1e3320880709e435452b3a97c68456350a984ddf66aa56b4574ecb3451902ee66a526b485bad50aa59d9f364ed4aa38322385932ced44ea6977cce3a440fcaccff0f8c866baca1332d0bb15b69e9f31bf32099dd6311c95f68e4ecf4ed99b429854a8b8661f4bd1b05b762a687c25b2cd5faf30f669258ed8e1e168e7e0f5eb9dc3bdd1686b19ccafc98914fc881c3691b84571f85dc3c7d253633c3735ad5716752c11c78351913ebf4d9f27887381101555b1cdf6595ad01b4cc446c7e8fb042b859231dc413cef58c2655e6fb3f30f6cf3c568b43d1a8dd8af5ec4541b98a7095442a61939766fc46e5386f7b9dfd424bfbe5ac553344ba05c35dc5b9ea65d9ada5df235884f826f1e4a6d71bda2cb0e70810bdee18e29c2459c933640ce61e2c499441b9f1ca91713a2c8342238fb38c0fa44fbe5cf1e385b5fb34d046ab654d66c48c190ada3b13aa199c365e4c4cbb913d9bbb19a79a1c2edb7de42a0c012066a003115a6f1c02b560b6e2cc399c66a6f7bff1157e3bb1e99f7317ed2399f8e36b1c6f3b56770ecb1ee039e205559f640fe27a7ffd03718b3dc3360369be526c44ec4bc6a801d76773d430674777deab0dc3e46f48022db32453da6f00b8fe5411ef09dc79c31ea18a3777f9cedfe7efcbfa587c5f4b8ce0f7fc7fcb0bed2ffc5955e43fa2f80f48fac31ffcd7173266df3e7430bc313b5b14d734bce0846834227d49e52bb3dfb739d659bea94c4efe15dc1f83d97bea96e071ecb92ca736748e073d9b6828c9834fa761be1edfdc11502ecbe770afafaf5779dd15ade', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136756, 20440, 0.0, 0.0, 'units', NULL, NULL, 'Adult', X'789c333330d03130305028cdcb2c295648cb2f5228482d2acecf2b56a8cc2fcd4b4f2d5228c948cc533053a84c4d2c2a56c8cf4901009db01124', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136757, 20440, 0.0, 0.0, 'units', NULL, NULL, 'Adult', X'789c33d4313230d03130305028cdcb2c295648cb2f5228c9c82f4e553053a84c4d2c2a56c8cf495148cc4b01d1a945004d9a0f2b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136758, 20440, 40.0, 40.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c3331c84dd7cf4ed74f49ac5448cb2f5248cec8cc49294acd5348cc4b513054404824a694e694142b5428181a2800c58a012875130d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136759, 8160, 2.5, 10.0, 'mg', 'PO', NULL, 'Adult', X'789c33d233d53534c84d5708f05728b4c800001c4c03e8', X'789ced58db6edb3810fd15c24f2d60e7b69b6dd66f8edb450a341b2397be548530a64622618ad4925462a5c8bfef50b61b5331d64ef6027491a7c4c499c3b9cf88df7a99ad8b544389bd21eb9dcbcc64566aecf559afb62a9c09ef2b37dcdfbf93332cf78c2dc27f723f823a6ea1c22c051f248e0e8e7e191c1c0e0e0fae0fde0d8fdf0d8f8ef74e4e4e8e8f7e6db1c8bd34da11f25b6f9495524be72d84b3f6c8e3bc65b96e2a1c26fa3338535974ce5897e83e035509181c32284c104cf47be3a040f69bb1a523fca5a93d3a667216730fd9e422d163539646b36b0b19b2dfc96a47e7d68c4ac268ecb30b7b0b1e75ab673d5d57f5818e3c4c15865f5fbed22f25f5acfdf1a8f3bab2db5d18a11fbe861b4659ad7c4a26495d44de38da3b267f960559c1fe3811cf53b0a59e6026c15bc937d15f418ebed9c73c971c78c3b4f10c5da0934e60f682ebae2ae412543a3155ade031e2ab1b3750f626160b0d9a37e9658847ace298025318dbb0712fbe3adcf609b86f2f49ad74b348ee46cfb4b9d34ce60ce7dca2c78c49cda616c1f952aad906ba4bd4a4fa063fb5f119328ac6f750f4898d073264e098370a29e1162eebb09e61453a6ef4ff92f7864838d46d2d74e4b7867777df75ddfeeabcbfeb81ae477f4017fc432a773df1afeafc6cf267f6b0b1d1343da4cea8293eed60234576170dd9cfb802e7f6c3284df415dea2452610ac679974c14d745a57346098a0a16669c038624bf488d3ac6236787e85ecb39a862a50a98654d3bec54d041a2eac290d6fbc2921d1d7a2b1c69bb9e4643acdc5f1c2467627bd188631a7b929a5074d03728a1e065365f80cc308353621830a9225e637167385734a67c81a0e9646c4db489cd5e4411aa6c1360ab500ff18fbd3097b837bc55ea22b81ba515889b010d0944eb4c25be38392f3d549e5b0ce0c61305ba03a179d8f2e3ed2dc26ed2808786f94cc68b89fd3446ffd632cb9b40d37936505d296188cfb2c832b59650d85b1742f1ddc5d0f6f1fde4f24e89eb5e5258acf76b60e3ee28ae2b79dea3482474ccbb06fe778bf0446d251907772d01a3c628a92633bd3a7081eeb1427d50e5a750462bd5689b7834edfa1abc58daade617a89c0775b76aed04a53c7b8d3c7324cf407725368abece378b2611a2c56d9487c02b44d7a814e0215fa442a439da8bdb24f15428dc5d7aecf2c3841f588b6216809aca44e29735a9f439db25cd54e50374df459d4ab6eba6d2954646d0ba495833ad934a33a0e754aa5492c1aa86f409fcdd11a47e511ec190ba914e935d27349cb661822ce945a122cfca529a239f5bf3b8499a6a5b8ed0e79ed5aed33797f2f17a767081970814b0557063f63766cf4f70e85b5068ed2a61ba8bfa659a1d3808e7836446407baa550ba2614b1ae87713b5d848e79967edf8163855c94c6b313bd5b29af99fe9ae93f44a6bf26ea93447dc932f63fcd8e89005b0237ca144d942367a0f28192390ed94f839f45a2cf69859bd272e1ca21fba0ef9bb25d7b459359a31ada0fc307a86b9cc7928eb9b47cf9c242adb4fd446d9fbbdab5f9051f3de7c80568ba3b35793ae24fdee5ae5005b65b7c7c8acbe813863e854899e5abdc4bde8b10d3917226baabfb9ef6dfbfc93d3cfc0973494cf7', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136760, 8160, 2.5, 2.5, 'mg', 'PO', NULL, 'Adult', X'789c734c29cd29b15230d233cd4d5708f05728b4c8d051c8cc4b2e4a4d2c4e55482c5628c9cf492d4a2c494d01001cf40e1c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136761, 2058, 10.0, 10.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f55082e294acd4b2fc928b652484e2c282ecd49d55148ad2849cd4b494d51284acd494d2c4eb5523034c84dd7513002932660d202485a2b942426e5a496582918eb191a998284cdf420b4a1911e9806f100625a208e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136762, 2058, 3.125, 50.0, 'mg', NULL, 2, 'Adult', X'789c33d6333432d53535c84d5770f274010016ec034f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136763, 1777, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'789ced574b6f223910fe2b25a448890449372c7930273699dd592964a280348710b54c77d178e3b65bb63b0313b1bf7dcba62134242189f6b0875cc08f72bdfcd5d7e5c75aa28b34922cc35a076abf17397f6031e3126b75a8155ab8d589b5b9e91c1dfde4f7981d2a9dba113fda1036b166392611b3ee4c33681e3782b0110683e0a4f3db59a7191e1eb7c2b07dea6531b65c4943928fb53f51a266c28f2d4efdf1c12cc7ce505eaa980960128d9da0e5b119ca0b65588af087d299e900977f932a3612084689c2295d89f4ad4699da09890587cdf65e9dfe16bf27edbda1bc518545036a0c2cc9b8e4c66ae6ce77e02f39e6a29c0de5b9ca322561a05982704589227d3da67ddc75e8a3344a3f25a1185562ebb129cf8a2c2297d0446a1c7557b144dd14a53595b09d0a1f8d5bbebd7dac7919b773c913b5b2f283db0979ff35a7793ed16e9544da90a547f729ec676c0aad20c8d283a5f086e4c9ba647b2579512c627622ada0711600e5c56d5c29eb3daa857b2ecd1262252d3963200c9caa4c3437379ae5466d5e87b5307a4898e13b0229dd7bc1f9d3a7dd75872b7e6e58f548dd65b57958496078d27e3981ad75c966b3fd4c028f1ba730d115af1cfc36d2d45e64a9c76610b382a0c374c2590c4c6bc2091f9700c7840684c80766e242302d66170aa4b2302ac663d4f0935c841145a8474a328b1bf1dfa84aa53e1f7febd5acbf27ddd79a8b5d603dfecfac0d9012b3c35af8aab57079f35b4530d106f6c3c0fdf914137a0f5e8f7c57dcaf637b514ecf38125025c2fe99ff7bc993bbbbf9bcc21f7734135cdefbc913c96c91ea6eaaf747a2f523f33b67eb03f4b6c190558f3f19ef93f13e19ef93f1decc78eb0ce719a99f63cc89abae554eb0796ac4961474ad31954cc633b8a15d990ea9df3ba746935117b9eafe98b4a0b9b9076e1c21f08c09ea1751126d12d3f953dda4107628af91c06b358f87f21be6a4217e516227f9bd40d79b1eef66eb0bd7d22f844dc465b4d250b2f6b97295c56542e5b39da1ae10a8d3195805b160c61cb917c2507e1f198b2e0ec819a10fb5a3170123c2fdfdfb42f33e749307d406a31b64f1b60f17053afb5cc61a99212ec8e9d25d0a984c2029615287094f27c405feaad47828ad9af298db198d264c82b26e576cbf216ec3bbe79af53e6aae8aaa27579892b10704925256ab7c466667de1de37da8f2978389c93939a8f46cb5767ed58704739a2cceb8394ec9d3328e11e5806c939b194aba356eb9a98341feabd0587d13bcf11bbfccc4fb3fed9199d145673458e958a0e6ff9b9d7742ef7ac274c66225543aab44f38d897143f03176e09f96fb98a942135a7a48da94e026ebc02505ab87f2eb9480e9e9e203f67b18133a499d6f98e292f1d60a30e309362cbd80b7b0fb050c69e682ffa2972b2d81c4422be953938db4138461d10ccf9a8bc2345442942e9f485f3b54f7d264dc67da3d7de9e5ed6e2f23b2a40eee03c1f411a3ae30aa12c1a2c37cea05a15f620a0625a660ffb2db1f1c7c9413df65e02df85feb5b97aaa2a5aaa8544565309fff0b664bac48', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136764, 102, 15.0, 15.0, 'mg', 'IV', NULL, 'Adult', X'789cb33333cf4eb7523034cd4d57f00c53c82f4b2d5230d435cacdccb35628c948cd5330354092313640481883b48045f3522b4a14cc40520a1a997aa97a0a8606063039433dd38c224d00303b1edb', X'789ced596d6fdb3610fe2b848101099038b69338a83b0c70537733d0b45e12e4cb5c08b4444b5c245220a9a65a91ffbee728d99612b769826eebd07e8b78c7e3bd3cf7e67cec44a68803c533d119b1ce3875224fb9159d3dd6294c4a678973b91d1d1cdcc86b9175b589e92f79d062b5a1e1b98802eee8c6a03718eef7fafbfdde65ef647474321a0cbac3ded1e1c9d0f38ad049ad2c383f76c6512695b4ce703af3474e7cf0522ecb5c8ce6ea32313a5be8b474329cab97daf258b057da6476c4727d1309c396da30a9feace4b21d23428877d2154eb0850055b0c28addb93ad738b24c2f59fbdd119b5ecdd5a9ce32dcbf343c12ec0d3c8217dc6cec752e164db56f71e4f82215f4f5c73b7ca5525dfb8f86fe0dc51f76678bfbf61dbd308e8ad405b058aab8e5992d1a75c6214c0bcea62dc65f8627d7f188f58fb3181632fd1eceeaef0f60fa73e612a1d871af4139ec6d088774c59f2ac8624322b11dd9155dd6eff556b47ef73831f0ebbc180c86470f3dd6eb9e1cb32c3eb88ed94ec63ff8c7771bafb326eb8ad3d3eae7e9d22111763bed00786f7907481b2622936180d0ea6bd1f246affbac928927bdac676488d38ea7b0a1dffb898011692b98b48cd7001146448c5b86d014f63933c23a22c7f23dd4ac9523c509585bb43ae3d68235984d5aaa5c78365653d96c32aaddbaf2c6802566aede9ecf55af3b6c7862406f01aadc4492878c1b5268d48ea3e74152a4a9be81f28b724de64b474139f60c7289d88a4844db9c69c028791ab80a9656da96fefd2a3e892e0cc9471a291b72848ee44b85ef7d5e8bc0e7b2b0949885723265690961e4e94a7471cf6b9f49ae46a0bf27a46fcff51f50ff4ea0fe9f07fa2efe7e44faab47faffe2d27ba5e81bf6e9bfaddb970f895ebd9940689c415e6f19f1669339a6d27573a8949c5eedf959973364bacc8a8c341832a2d93da888048fa49f819d6689c8b991eaa9d32b80f8e0cc0a9e6a52bdc845488e9ee9bc48f9061d6b6146c48aabb064e7a0aa986c3b9dabd73c749e9b1969afe970aa965c39ffc942ae947618e0992952e013b33b2678a1108dc83b6cc4881e89a554229aabdf603086e76dc4273be18ede0fbbe4256d5315b30da40ad6123a787023b86df9c362d7fc01f10740a988b59150be0ac0a926b84a15c9708bfbc7692a4c5c122a426c6cf68076beb97a9122ada128231c2602889eab313c844203f40b439e5ed43c2825056a0862e31303eb9ea2b4405fd2c62458c9f6181ccc4149949651833057d3e60d25346d8dd91eab720b9548e9c202d129a09d79ed4153a230257101ee1aca19869dae02b745d271870b2574098dc00a4aa354051a24444bc18dfee72224f5777e3e6499de6d73e93adf6d2ec9685b985898f2de1d4bfa42d744f088ca4591f1fb3cbe47b31dca53c2236868b482dceca0ab0390897436a547671334e90b81628c0d558514445463b024d87de11e4525e709a5651c41a415c1b9e0e17d386cabe31795692dbee9f648b37d3802619d69ebf6b11fb3df3624d4a0d3abf15cfd3aad3c0f2e080e7d174a99585645748fe5ab532751b9c2ba4b399ee55a61fb8653bc1b012a21ff2a0cbd56a458ceb929195a51c6212205441a4237cd2e2aad494a976412e1192b9e27658a7a69c9e35cc5527b09f486ce69c16732cb7c2d1629623e0106449ea0740ad45f04151df16cae5ef14c3b19d1e951cf1f5ecdd54b9963864fcac8f08c28c76bca99707835c7a085814ba71ac4fee0784545ba5a49bf5c086ed29271696e80e68c2bf8302334cdcedf3ca2db350ad62763f205d5bcbe1b6cee5205a3bb7595ff81916f10234fea6bff244c6609471d0f61505cb6b0f25659e1a8425745698445787fb368a081a305eca77229466c30c4e483767534dc90e12e8e8d45da6cc45ea34961ee9d7c40fdf7b29e5024cf449800b7360bf4321887f77f7f94d61682f96e25958eb11b91e2efb90346762e67e3dd115ba0e55ab6940b40618f21cc68f5c252afa2024cfd1de63625c0a6fa133d0bad04fb98937e5ca8a5683f5a3ec19c0b2182716a75db86c6af8ab6f15b2a4daf50c1ef976c5aef97eca2ee5d882efad2e4c5efa3bb17361936c9aa58300a0b9a66598f0f247033355792298f2e2767d3aff14baa7ddc4fa9b63d773dc2018f7807c22805aa6d7d252ca8840595b096168ff7ecc3cadc95e987cf95cc60253368ca6ce9f489c87dc1ff01bcd5ab8bc1fa624bfa3afc9f9755b1a18cdcdefe0d38576138', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136765, 102, 15.0, 15.0, 'mg', 'IV', NULL, 'Adult', X'789c7bd4b9c4cc3c3bdd4ac1d034375dc1334c21bf2cb548c150d7283733cf5aa12423354fc140cfdc5421375d3f3b5d412337b142c1d420375d13aed4d8400159294c2558cecc002805d1640c92d00400762c2178', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136766, 102, 0.9, 0.9, 'mg/kg', 'IV', NULL, 'Adult', X'789c33d0b3cc4dd7cf4e57f00c53d0c84dac50b034c84d5728c92f49ccd1040075220884', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136767, 102, 100.0, 100.0, 'mg', 'IV', NULL, 'Adult', X'789c0b2e494cca4955f04d2c2ece2c4b550870b552303430c84d57f00c53c82f4b2d523052c8280200e78d0baf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136768, 102, 0.6, 0.6, 'mg/kg', NULL, NULL, 'Adult', X'789c33d033cb4dd7cf4e57c82f4b2d523052c8cdcc0300390605fc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136769, 102, 50.0, 50.0, 'mg', 'IV', NULL, 'Adult', X'789c734e2c4ac94c4c56482c2a4a2d2eb1523035c84d57f00c53c82f4b2d523052c8cdcc5348cbcfc9c92f4f4d5148aa844b27a69500e50d4dc10a32d314f2525353525300e463195c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136770, 102, 1.5, 1.5, 'mg', NULL, NULL, 'Adult', X'789c0dc74b0e80200c05c0abbc0ba871e1818a0169026dd2cf82dbcb6ee63e1fccefea9a86b21046e22f45af510d2cfb07d936d3d86de9ac8294e081b19c1dda10dd7496f41f23941c7c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136771, 102, 0.5, 0.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cb35230d03355c84dd7cf4ed7cfc82f2d52f00cd35148cb2f524854c84dacc8cc2dcd55c84f53305300c915eb2864e62924a6a4649664e6e72994e42b64a416241665e60100f13f16f6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136772, 1046, 5.0, 5.0, 'g', 'IV', NULL, 'Adult', X'789c334d57f00c53a830040009870225', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136773, 1046, 20.0, 20.0, 'g', NULL, NULL, 'Adult', X'789c0bc92f49cc5148c92f4e2d56282d5028c95730324857c8482c4b55484a4dcd53282d4e4d0100e8c20c83', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136774, 1046, 70.0, 70.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c333750c84dd7cf4e57f00c53a83004001c8b03e5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136775, 1046, 5.0, 5.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dacb052304dd72fcecc4bcf495548c92f4e55d0484c29cd2929d6040087c80997', X'789ced59db6edb3810fd95819f7681a476d2a45db84faed3450234592397beac0b614c8d25c21229905462a5c8bfef50f2254cbc6bc70d822ee09720a26686676e87d4f8472b36651229cca9d585d669151b3dd5428f30c35caad61eb44a93f957a97385edb6db777242f93b6d12ff9f6cafd2b0c260417184ce2b1e760e3fec770ef60f3ad79d8fdde3e36ee7e8ddf1c151e7e88f5a9684935a5996fcd1eac56c415a67d0afd54b8ea6b595ebaaa0ee50f59493b176345427da6242f0a736b9edc2d9b7a1bad4a5230b7a0ca19de66d5fe7b956706d3026b8607f59ab5fa1d213e96a20e5e83196075e7238cac83ffdfd9d9f32a926f5c312d41ccdfa302d241fbe7bcbbdb8cc5cc42e4895046eae40d2f228654c91d35329a4ab0285e384bd83e9c1509d6305860a42c78f20c7a088628a87ea5a3bcc20d696835316e0341c761248f1966044a4a0b414b742771ffec3fdda81b7c2b479566a58038a253a23c5b6b18d0e03958f1dc893f6e4913fd32e1c276d6f3ba31a3ffc863e99f6f79ff416a482c6d2cfe6e257f1e185b9bb2a4848cca2812eca0c97299afb3130942854a2824b7eab92213776ff137c264563e9b8ef4b77473249c1483bb110978685a0986b0dd55714aeb65b4b74e1ebfb4f7085637215946aa2f49d5a552197a418d48a72aa7bb80b17da41cc08940fd2a2fe82f5a709e5c7532a18caca32dddeee469cf5348cebb9ebc49f108b3846021d25da48dea521b3578ad0d3c0bf75885e372f2f2cfebe567c5a49154bb1a2f47b594626a97cd3890cad6dfb439b8f342ceb72e62e4df978349694954e72473a3de454f1e1b638974369ca3503cf2a2b5fd8a94b4ca1f9f555d40fe5e7e7e0ad871d5d128ae76eafaa8a2b325297a1dce963e7990099c01a7343757a7dc17f2847a7454af71257f4627333082c5e329779fee07bc61753398e17f2fd026dba072814c931df3a98120df29ea41c7c1e0065748bcda617c864887e5f8c91b765eaa172a20b529257cfd4b8b43e110c971e41fd4b30ed1990c64837337452d922c5c46bf546b1e6b8790a9656e89c11b8a1fac66b0d179e483426f5bb7a252aac571a70b08a940c6b31897b1ffa2959179838cb0b9486fdcdb9284ce52ddddfb3e7d6b2c72ccc91b2cd9337acfc0e03c3b171252fb587eac670bfa0f1db9d182ed1d46864b383543bfd28275b7115676f831b280bb1b5a55613fef58a33b940779eb20db69d4b06facb44afb7f04836b0b1c8fa06d4bc100d2ccccb62bd8185648860564c1b00984b3ef3a02ec1cd3c68449f209815e12610e6a2cf30a88d5c980906daf3125fafbe900cf4175db1dec052b4e1c4d760b867d7dc1dc5ed286e47713b8afb35286e47476f4447db5cec77dcb2e396ff31b70c5234390a9de9249c4a9e6236decfe498ba70f861fffd413a54e7c4dda03369f32edc342320a69fa930d4cc8d6f3c216df1357f4e2245c566233d8e7ae2d930dbef9b65ba30da9154dcc1e860c41fff164433cbf35ffa9ef14069558ff520fcdc6615e22f790b54836d266fe596683d1b33a586374e4f44460a6f3af69374399a4d0f14dc5cf192e10db2ca83042c5daa8dbc67d12fe7577b40399984fc84a9305420339d2faf3d60512d4459d454cb0499532c0543f6a343b3d5c49028ea655607c0fb8b0836d3503e14fc4f140c08aeca6cccaf6a4eceb96832b8232c783396c17bbe4173380b6d4bf3c228fefbe69b8d4582417ac8a74fa06ff87b0c6b44738dc0de53c737c037d388e61a21bee7615b03af5688160adcb30f0fff0034b92834', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136776, 1046, 20.0, 20.0, 'g', 'IN', NULL, 'Pediatric', X'789c0bc92f49cc5148c92f4e2d56282d5028c95730324857c8482c4b55484a4dcd53282d4e4d51c8cc53484c29cd2929060077dd1027', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136777, 5365, 1.0, 1.0, 'g', 'PO', 1, 'Adult', X'789c734c2ec92c4b5528cd494e2d5228294a4d2cc94dcd2bb152304c5708f057305128c9cc4d2d564849cccca954a85030d1b550284f4dcd2e060018e81296', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136778, 5365, 1.0, 1.0, 'g', NULL, 1, 'Adult', X'789cf34dcccc2b49cd4bcc4b4e5528c9482d4a2ca8b452304c572829cf048aa42466e6540200ead20ce2', X'789ced574b6f1b3710fe2b039da5686d3986b18702b2d33605ea54909d53552cc6e468971597dcf2616911f8bf67b8b25c4b91eb48487a287a13b9f3fc6686f3e9534fba5816066beae5d0bb89c2a19e63a05e1f7ad1e9745985d0f87c385caa05d56fac2bd32f35dc96f57c6848161892ca69767a3ec84e0627d96d769167a7f9dbd19bd1281b65179d2c89a0acf12cf9a93796b532ca0787e9aebb0ab4eaacdcb60de533f3ce7a2c097eb2aef639f8e81b329e65fb10f04e539899a98d813cd8396c5bcb61f2dbcc5cd9bab6066e1d4a820f9c295bb942874fa1c7bbe7113df05567389d7eff834f5a99c5fa90be8d65d4a1e0a09429b7c27d17ad24831aa216e46666cc36ef697d82e008434d26e47052725870064171282051e916567036b88025d1c2cfcc352a13d8921104a12206b6edb4c252f14da77058dc2fc5f87a9137f2c55afea14360425261704aec4361424d50e2316ba93ca1a71957e22c1b5c645097c3453994d8f2a77b2549c25fe750d9e87c1f6a5ca93ad670926519cb499b147ff4b6a9b05441313023e04286ca0fcea125745dc5b93572789b34be4075667e7814cc9f1b8539fb7b2e772c98fb527d1dd2b5d61ad062a3b506f6a621a118ec896da2c6bf6764e3704fa0bd89a332b54a5b4c5963a71897398c8560872915cedb41e4fc958166a3d5db4e3445f12b8ad0392f9cf28b2d7b1f595bb067ae9ce3dae193ed3d66a65ddfece990ce08c6e42185222a670dc3e8babe9c7341a223b00951d4ad575ca4c8736001efbc754da796eaae238f3ab78b471dfc1effefa9c1b0bf473fb031f967f4dd40eeaabe36ffdf00f0dd1afe8ff83f227e2c3cbb30ff57f1f9d7f3da05f67b257688dd03b7f8152f12c77b562ab1e7a11d6b4dae6c131642a3f7c3c4928ee20af7e43c155342f175cff90d3965e34e34069baad5bc1e79075e720d45657d83beee8346d79a92500f794b3efd8c9af7241f8124d5b8a713d79468cb0903e2836ad62cecc03a7da7a077b1f9c6517f85b903cb3de1746a1456dbb2dd0643040fda0ad4ccf578127ffe850921b704931ea6ab7577dd0ddd1dc99979cfb47aa0d53c91df6b6287562b5fe760ac498c68251c75ecf68808af4954c804b92eecbc188b2f28f7254f844f6dcfababe697b56e34ad60a942050d0f6122b41c2adb70253fb78db38194f129255a45c9849a795c52e57105847be505f70570d90371460be2a1adc8275a9c020f89e2f66159295125a66bc09326f1e825d9f16ca5f3b2e6d2c2762b9765316cee3d946c9ed92870aa9ddf92e7daf3f7353d43a1643f1df80de9031a09778a77f34b8fd9ebbd4ec5587bbb055bf302133c8655be64eb685639a5392f47467a7b403f36c1ca23fe023d3c7c06623fd193', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136779, 5365, 40.0, 80.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cb3523031d0b53050c84dd7cf4ed74f49ac5448c92ccb4c494d51283453c8c82f2d2ad651c84dacc8cc2dcd553034303000aa4bc92f4e0500d3e311a0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136780, 5365, 500.0, 500.0, 'mg', 'PO', 1, 'Pediatric', X'789c3356c8cdcf2bc928d63553a84c4d2c2a56c84f53484c4fb552303530c84d5708f057305128c9cc4d2d564849cccca9040068020f21', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136781, 5365, 1000.0, 1000.0, 'mg', NULL, 1, 'Pediatric', X'789cb33353a84c4d2c2ab65230343030c84dd74fc92f4e5548cb2f2d5228c9cc4d2d564849cccca90400e9660cd3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136782, 1510, 20.0, 20.0, 'mg/kg', 'PO', 3, 'Adult', X'789c0b4ecec82c2ec92fcecfcd4c2cce2cb6523032c84dd7cf4e5708f05728c94c51a830544849ac04000e670d1e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136783, 1510, 25.0, 25.0, 'mg/kg', 'PO', 3, 'Adult', X'789cf3c92c4b2d5248cb29cd4e2db6523032cd4dd7cf4e5708f05728c94c51a830544849ac0400d63f0b8a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136784, 1510, 50.0, 50.0, 'mg/kg', 'PO', NULL, 'Adult', X'789c73ae2c2ec94c4e2d4ace2fce2cb6523035c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5128b4c850a8303451000a170300c3881120', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136785, 1510, 5.0, 25.0, 'mg/kg', 'PO', NULL, 'Adult', X'789c0b492c482dcf2fca2db65230d53532cd4dd7cf4e5708f057a8300400781b0843', X'789ce5566d8fda3810fe2b233e2fcb4b17d4a2532596beec9daebb68a1279d9a2a72ec4962e1d8a9edb0848aff7ee3d017a0a85b504f77bafb163bf6cc33cf3ce3998f2d61ab2cd6acc0d6085a53cbd6f243c5b447d5ba80566555d8cebd2fdda8d379900b2c2e8dcdc297ec1c9e76dcb21245cc7cb8d4eff687ed6eafddebcebb4f47ddeea8ffe472f86c387cd66bce22f7d26847273fb6c6a2905a3a6f59d86bb63cae1a2bf3bac451a4c7dacb9259e6a4973cd217404e735474ad59bf308e6508af8c2ddc0886dd6ea4ef4de5d1814961dffa08ee2c53919e98a2301ae69609845b8a9f2e5e4be5ade4526003b14a76516e68cbb3446158bd7b4f2b25f5a2597c85bb87f37106f78f6fde071f6351291f534452677b54cc784e5118670a4917086ebf5b649d4506d33bf052c0aa0782d5919e6130e9118471c44052c3557b9847fab55c223c489f436a8c08a481361eb8ad5cdee1393e44fa773a622155d522d0d11f9c647f523b8a022d370dbac1165d87ee040b422e8957011f9ee664e92a987291be4b53502c410595c348cf493f0fdb240eda3bee57bd83a3a7e5a7e1758a42b290de63dc1eb1d7bad3aa8e536363e25d098bfa797c15d71df3c34949a468ef12f708bbedfe27527e1291f0c34ceed0b6798cc6ff0f2b27ea6b5622974cc55353568a7d95d1674ea61633cd34afe15eba05bc62dc1b0bd7c794778f9a0c1d91e9ad011bfe85d2a37f2030951ac5610e69794345ea8f6b7dc2aae00a98584a4794354fc22464b33dad32fa54cc39b806423739551de7203f8cfe1f82fe13dd9ea89c89d1d49ca416921fd1cd5829b4590dde000f7e3aa16347da70529905b75f695ff6f96eb550f1dcce80fc07e3917628d79545686edafa0cc4634135eb30be47c6bf457c2ca933b4d254fbe75ea346eac5724d94e6d4e7c9a20e9d70297d4d6ad99a8e746954edd09af08bd0336bf3dae721de4827d4be6bce2c3ded915ea20eef7b137f2a132bd5b60e697cf8031265f822228ec37d641761c388fa0b1b64ec376625f1d9be41bbca5116f42c7d4671a4c2b603c45e4005534c8687861c08462d35f85baf49e82e004f046529d44049c9ee6846ef0ca34146c092f67d10dd8992fd0f907aa8937f01ab7f138453c7959cd98271a34c56ef61b9612a6d2b99e20868b8be1ce436d26f904c19255d3182c99fd3ab010dc02f57dce276e27d6b09e91918de20cf198dce456cd278ccbf19ce7fd5e482852190a352506041d2d108a4ba0259221569ee9c4e8a188f95fbee4871ee807ec4ccf747f4c30b9b4f7d2e45ea671cf78bef9797a5e161367617f0b69c9b17f4f9fc5406369bbf00bbe5a722', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136786, 1510, 20.0, 20.0, 'mg/kg', 'PO', 2, 'Pediatric', X'789c0b4ecec82c2ec92fcecfcd4c2cce2cb6523032c84dd7cf4e5708f05748ca4cd12dc94c51a830544849ac0400468f0e7a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136787, 1510, 25.0, 25.0, 'mg/kg', 'PO', 3, 'Pediatric', X'789cf3c92c4b2d5248cb29cd4e2db6523032cd4dd7cf4e5708f05728c94c51a830d435524849ac2c0600f8fb0c5c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136788, 1510, 50.0, 50.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c73ae2c2ec94c4e2d4ace2fce2cb6523035c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5128b4c850a8303451000a170300c3881120', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136789, 1510, 5.0, 25.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c0b492c485528cf2fca2db65230d53532cd4dd7cf4e5708f057a83004007c860863', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136790, 3042, 7.5, 12.5, 'mg', 'PO', NULL, 'Adult', X'789c0bcac8cccb2cc92cb65230d733d53534d233cd4d5708f0572834d135cb0000866b0855', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136791, 3042, 25.0, 50.0, 'mg', 'PO', NULL, 'Adult', X'789cb3523032d53535c84d5708f0070010fc02e7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136792, 3042, 12.5, 12.5, 'mg', 'IN', NULL, 'Adult', X'789cb3523034d233cd4d572834d3b5c8282a56d0c84f2b49cd53282d4e4d51c8cc5348cecf4dcacc4b2cc9cccf5328cf2cc9000067041029', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136793, 3042, 1.9, 3.125, 'mg', NULL, NULL, 'Pediatric', X'789c33d235abccb75230d4b35428c95730d633343255c84d572834d135cb000064b70710', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136794, 3042, 3.75, 6.25, 'mg', NULL, NULL, 'Pediatric', X'789c33d3353452a8ccb75230d633375528c95730d3333255c84d572834d135cb00006e6a0768', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136795, 21647, 0.06, 0.1, 'mg/kg', 'IV', NULL, 'Adult', X'789cf3cc2b294d4a2cc9cccf5348c92f4eb55248cacf292d5630d03330d335d03354c84dd7cf4e57f00c03001cc50cbc', X'789ccd556d6fdb3610fe2b0703055a20b6652f4e3b6d18e03aeb52acf10cc7db3e4c85419367893075d4482a8e56e4bff728bb8d9d050b5274c33ed922efed79eeeee1878e7275be2451622785ce4c90ac9d255d979d13e8d4cec4d32284caa7fdfe566fb0ec5997c77fba7fcfd84b272a544b11a2cf30199e75934177902c9297e9e8db3479d93b7dc58767ad2dcaa02d79b6fcd0f909099d30edff8037adfba2a930cd688a9ca0acbdac8d70b032566ed065746ebdc811de58577ab69ad8b2b4040b2714c294a1f8b44d52af0ef3dcf251102b83f1eb8ff7fc65346dda8fbbbc0f267c9c8a23b7e527b7dbf731e758d5262cb9644df911c68930d13e20ac8447050c412b1406565635b0459d1721a3b714ea95882840598f29df9ada43d24b98dfde00cabcbfc9e1ed6f195d0a4d0189bbc2567c3f181d19c09fdf24ddb3a4d404bfcc415a0a9a6acba134ad6bcff1a3d3debc5f38f6781a892dd8192a2d82d3f221c053b4c4707d46efac506d8dc37fa8ff7ef9496fd43de5c266f369463f0c4a7b10e7f42b70c1cc7f4d2aae2a945a98e5cc56b1cb9fc7fd131b3387792cb08139df529e71d609431232b4d629fc4a1bb25bca68ce480cec18e57177130383a43b4aa07cd7670c298c15ff681fd0c1287906c48bc10e715ef6e6df0fee8ccf2d1b04a8e3e505569c4cee63734a8f20451df37fe90addc7f5f8f69c4709da19fba5a6e5e708fb0d9a707f1c375469f9008f6363d0e50d040bd208effb51d1c0f2f6f24af242f1b84d768840af592dde5863ec967381adb4d5ea0478f938ee35462741e84381911396180af05c28a5e36ddf37ac5339b3cc77b85e332ffe454633cb5eae6d50856e373e3190c76b74b8bf51daa3887c3334bc8921387d10b268a470bc313ccfc3d13358bcbe1ac3aa76c4355fb002bacbfc048aa6b23fef7e26029e6b920e5bbdf0483e56a643f3e20be673acb8408fcb390af977561f08d8b942a759308ed92751158d110c2aa3c51da29376fa187e143895d16b7e2864617d257cd982b32196bf1bb3833277fd8e7a7efc1e1c72d552b377cfe8c71b89dec7f67961f4753b2147a75bdcefd75cf822a3df0bc4bff6737998f8d17dfeb7d0dfa7f9ff09ffbfabeaa94f4e2158eda435366f8ecabb1066dd357acd2fc090535c2247b146fb3285cae952386d1a5642c2b630877bd1759a846ba2bd2c048b6a09760d63b9bb9d5aea2aac2c3ff33ad60b7e8386031b88afbfd9b5fc4650f80eb8df5c68540cc9a712abd0ca4b10b98d52fd54a4b7b71f01ab9d536b', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136796, 21647, 0.015, 0.1, 'mg/kg', 'IV', NULL, 'Adult', X'789cf34dcccc2b49cd4bcc4b4eb55230d0333034d535d03354c84dd7cf4e57f00c53283436d03533c8cdcc53f00f5248cecf2bc9cc2bcd2f2d56c8cc4b2b2dcecccf0369822ad7cf2802ea0000007d1956', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136797, 21647, 0.02, 0.02, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cf3c94f4cb15230d0333052c84dd7cf4e57f00c03003566054f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136798, 21647, 0.05, 0.1, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cf34dcccc2b49cd4bcc4b4eb55230d03330d535d03354c84dd7cf4e57f00c532834d033d535c928520808f20300205a0c60', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136799, 21647, 0.04, 0.1, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cf3c94f4cb15230d03330d135d03354c84dd7cf4e57f00c0300485b060d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136800, 21647, 0.015, 0.1, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cf34dcccc2b49cd4bcc4b4eb55230d0333034d535d03354c84dd7cf4e57f00c53283436d03533c8cdcc53f00f5248cecf2bc9cc2b4dcc51c8cc4b2b2dcecccf03e981aad6cf28026a0000e12018cc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136801, 1268, 900.0, 1000.0, 'units/kg', 'IM', NULL, 'Pediatric', X'789c1dca3b0ec2400c45d1adbc0da03150c10e28a85881135b6085f18cb08728bbe7d3dce2e8de92fb03dd75d4e6c6456bdfb432166fab231b26458c98b5a74d4ffd0bcf96af6ffc8c13d16e4f44186e1965b917e10d972bcc71f8cd4788bd4d54202d343ebadc2665', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136802, 1682, 300.0, 300.0, 'mg', 'PO', 1, 'Adult', X'789cb352082e492c2a51303630c84d5708f057a85030d45128c948cd533037858804ba0000c8780a67', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136803, 1682, 75.0, 75.0, 'mg', 'PO', NULL, 'Adult', X'789cb3523037cd4dd74f49ac5408f057d0c8cc5348cecf4dcacc4b2cc9cccf5328cf2cc90000b67f0b75', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136804, 1682, 162.0, 325.0, 'mg', NULL, NULL, 'Adult', X'789c333433d2353632cd4dd74f49ac0400157c03a2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136805, 1682, 75.0, 75.0, 'mg', 'PO', 1, 'Adult', X'789cb3523037cd4d5708f057087401001332030f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136806, 1682, 75.0, 75.0, 'mg', 'PO', 1, 'Adult', X'789c3337cd4d5708f057087401000f1802b5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136807, 17114, 25.0, 200.0, 'mg', 'PO', 1, 'Adult', X'789c1dc8510a80201045d1adbccf8202095a476dc174b0473a132644bb2ffabbe74ef338395712d605dd2d72e40756113df33320ca291aa909a6e057c1379af6c307042b1bf51fb8d97658dba5c26b6361a8b6d1e7eb051185220e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136808, 17114, 1.0, 3.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d435ce4dd7cf4e5708f0070012080326', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136809, 25404, 1.0, 1.0, 'mg', 'IV', NULL, 'Adult', X'789c3354c84d57f00c5348cb2f52482d4b2daa543034305028cdcb2c2956c84f53c8482d482ccacc53c8cc4b2b2d4e4d01d20a0589c5250ac6190018bd132f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136810, 25404, 50.0, 50.0, 'mg', NULL, NULL, 'Adult', X'789c73c957c8cb2f51c8cc4b2b2d4e55484b2c2e492d5228c948cc533035c84dd73734c8cdcc0300eb5e0c6c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136811, 25404, 0.5, 0.5, 'mg', NULL, NULL, 'Adult', X'789c0dcb410a80300c44d1abcc01440ae2d6bdc78821d529368aa90b6f6fb7fff1d70c361c12d8cc1ccb942a1d4157c329d1c96e797aa217d3c6cb07a471ae3baa7cfd41bc395369de7ec66e1a09', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136812, 25404, 50.0, 50.0, 'mg', 'IN', NULL, 'Adult', X'789c0dca410a80300c04c0afecd18bd0229e7c80ef10b348a04da4d66a7faf739e551b71257f52873716c471ca6a0bc4615ec177270573c807d4b059470cf8c75d8993455d307c3910172a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136813, 25404, 1.0, 1.0, 'mg', 'IV', NULL, 'Adult', X'789c3354c84d57f00c5348cb2f52482d4b2daa54300489a4e6e5572416241665e62924a6e466e6651697a416a5a62800f90589c5250a1619002b1013d9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136814, 25404, 1.0, 1.0, 'mg', 'IV', NULL, 'Adult', X'789c05c1d10980300c04d0556e01a11dc305c4df035309d46b8951707bdfabb84eac1bda08d86bf1a196022a7dd909575a88e943ec78e47963341cec6993e1fa0197f8161e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136815, 468, 400.0, 400.0, 'mg', 'PO', 2, 'Adult', X'789cf3cd4c2eca2f2ec82fca4cc9cc2fce2cb652303130c84d5728c85748ca4c0100b05f0ac3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136816, 468, 15.0, 15.0, 'mg/kg', 'PO', 2, 'Adult', X'789ccb4b2d2dca4fae2c2ec94c4e2dca2fce2cb652b051303350c84eb7523034cd4dd7cf4ed74f49ac5408f05770f27451a850b0d0353650008a14eb28e42602b90606b960157a0a76506d2620212c1a0016641f8d', X'789ccd55df4fdb400cfe574e79d90b2569a16c8aa6491d8cb109b68af66d4195737193532fbee8ee02b4a8fffb9c841f6b4162206de22d763edb9f3f3bce4d90d93a9f119418c42218e914298395d118ec88a0b6baf116de572e0ec32bb5c072d7d8bc7952e116d8490b156633f04dcc201a1cf4a27eaf1f4da3f7f1fefbb87fb03b1c0ef7077b2d16a557861c236f82af486841b7cf1eafdbf0e9b2c238a11179558105a7bc9209858d5da02e15b5f6917190a33836b674b118445199277468cad290985ac850fce0c65cdc325d415bb94eff2cbe669787546363fdba604b2b5ab4c603990d167fa1cb067c7dd1d41865b5f633e6ab28df68f44c496b5c65acca14bfe536f69b36446544aab284086b6be4d2712ab41de0a33888c4228f457f58e6e1220f33588af14ff1f9db91b8161f7a7b91608fdb1125b0d9646b10bbe2d36d5857e071c0cbe469db1a63a6c05b259f6aed6d539f542815e8d9d854b586876dbc633fb69813905c8a737e4bbc58f16142a7207d0b8e454d0b325794d0391268d109c02bdb4c3a1664bcc870ae087988f7326df94fb0e264f215b1af5de5edae9edfe6a3e63e7460375334bbcf70bbd98786bc054599924fa838d21a6dbe14de08a9c1b9b03937af98d628bb44eb70768e201f577922613041ab4cbd89d3582f4c85a4a0fdb0bcbd33aaa6217f6781ac3d0adb8e750e4ad716132ada5979e5129a7c9f049b7c3b219abbb3510f52e2d3c4594e8fa7ef3810d2ccf0ed6247c58a3107a81d4278c9ce6ec50a840c64c1e532b55af1a05d13a54dbbab09cd9155d82efdeca2ff7321b6a57fab4afc4f5e2f3da405300d69b4c9971b044f40cf7b5acd31e66bd71f88c2d436a133e464462b57c6422b2e99d0976b69b1bb4ca9d2d8606401c41061e66224bb578a0a952aef84af5366c0bf19bd2c794156edb7fb52e2ebf56fc0abd07c', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136817, 468, 15.0, 15.0, 'mg/kg', 'PO', 2, 'Pediatric', X'789ccb4b2d2dca4fae2c2ec94c4e2dca2fce2cb652b051303350c84eb7523034cd4dd7cf4ed74f49ac5408f05770f27451a850b0d0353650008a14eb28e42602b90606b960157a0a76506d2620212c1a0016641f8d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136818, 18466, 100.0, 150.0, 'mg', 'PO', 2, 'Adult', X'789c734d49cd4db452303430d035343550c84d5708f05770f27401005091062d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136819, 18466, 50.0, 100.0, 'mg', 'PO', 1, 'Adult', X'789cf3a82c482d2a49cd2bcecccfb3523035d035343050c84d5708f0574849cccca954c82f52c8cc53305248c92ccb4c494d5148c92f4e2d0600e99811ed', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136820, 18466, 0.5, 2.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c33d033d53552c84dd7cf4e5708f05770f274d151c84dac504849cccca95448c92f4e55303630c84d0700dfd20bad', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136821, 15449, 125.0, 125.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f55082e294acd4b2fc928b65228494cca492db1523033d233d55130343255c84db7868a2aa4e51729e41725e62814971617a4e61567e6e75929181be5a603006f63181f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136822, 15449, 62.5, 125.0, 'mg', 'PO', 2, 'Adult', X'789c3333d233d5353432cd4d5708f05770f274010022a00413', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136823, 1064, 50.0, 100.0, 'mg', 'PO', 1, 'Adult', X'789c3335d0353430c84d5708f0570874d151082e492c2a5130858b000087b70893', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136824, 1064, 100.0, 100.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb052303430c84dd74f49ac04001ecc0453', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136825, 1064, 50.0, 200.0, 'mg', 'PO', 1, 'Adult', X'789c3335d0353230c84d5708f0570874d151082e492c2a5130858b000087d40894', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136826, 1064, 200.0, 200.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb052303230c84dd74f49ac04001ed50454', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136827, 1064, 100.0, 100.0, 'mg', 'PO', 1, 'Adult', X'789c333430c84dd74f49ac5408f05748c92ccb4c494d510874d14dca4c01007413089c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136828, 1064, 1.0, 2.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c33d435ca4dd7cf4e5708f0570874d151082e492c2a5130d0b3d03544120700cdca0a91', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136829, 1064, 2.0, 2.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf34dacb05230ca4dd7cf4ed74f49ac0400260204f5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136830, 1064, 0.3, 2.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c33d033d635ca4dd7cf4e5708f057087401002284043a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136831, 1064, 2.0, 2.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf34dacb05230ca4dd7cf4ed74f49ac0400260204f5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136832, 281, 4.0, 4.0, 'mg', 'PO', 1, 'Adult', X'789c4b75770b5278d4b9d4cc4021d7473f37334fdf50cfdc5821d7c84ac14421375d21c05f213f2f395521253133a7120046f90e17', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136833, 281, 2.0, 2.0, 'mg', 'PO', 1, 'Adult', X'789c4b75770b5230365028c957b0313350c8f5d1cfcdccd337d4333756c835b2523052c84d5708f057c8cf4b4e554849cccca9040043840dc7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136834, 281, 1.0, 1.0, 'mg', 'PO', 1, 'Adult', X'789c4b75770b5230345528c957b0313650c8f5d1cfcdccd337d4333756c835b2523054c84d5708f057c8cf4b4e554849cccca9040043820dc6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136835, 9483, 15.0, 30.0, 'mg', 'PO', NULL, 'Adult', X'789c730df1f75028cf2cc948294a2c4fccb1523034d53536c84d5708f05730d6355128c9cc4d2d5628482d524849ac040044040e26', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136836, 9483, 15.0, 15.0, 'mg', 'PO', NULL, 'Adult', X'789cf3cc2bcecfcdcb4cb4523034cd4d5708f057482c51484a4d29c9cc4d050089100981', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136837, 9483, 15.0, 30.0, 'mg', 'PO', NULL, 'Pediatric', X'789cb33334aaccd751700df1f75028cf2cc948294a2c4fccb1523034d53536c84d5708f05730d6355128c9cc4d2d5628482d524849ac04009df70ffb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136838, 5758, 1.0, 2.0, 'g', 'IV', NULL, 'Adult', X'789c33d4354a57f00c532834d3b5c8000015c0034b', X'789ced597b4f1b4710ff2a234bad88eaf32b901237aa641c022840112651aa3a42ebbdf1dd86bdddcbee1ee41af1dd3bbbb6c194830bd7aa52d5fec163cf33bf9df7e3fcb5159b2239572cc3d6105a639ceb2fc209d56a43ab30d23f4b9dcbedb0dbbd12179875b449fc7fa27b87d472c3728ccf99f31c83dee045d4eb47fdde59efc7e1566fd81b7436377bfded978116b9135a59a2fcdada438586c9f0bfc32f81fdaccc7108031543123ef5d453c5314f99d436d746d0f1b5b62c4178a34d668790ebab180dccb501a13e2d2eb8a19938832a7129d1f593360ce8a7df4ba6ea54170e41cf6114674209eb16570de1e0fd548d759669056786c508c7641ee23e0a2a2f142e66eb7a5cd323c76612fde9b78f7492425d84c3ad5e7734f81603af935f7ff4778ce242ba73d24ba8e48ecdfad12021b9e1f38b683b7d9a8001f80463c19c11bc0afcd573205b900141cb780813364757c2f780f3b9e08c97a0b403b41e5fd814e3a9faf92ec7762feabfe84196742f926ecc4a2f692c2e458c317cde8c5ea4e627484592920be3e0330b36d5858c61865058a2f29ecdb441b07889f4878e168dd0852587cf578a3e5def498e5c30797ea2f342b2dbb85ca97e6230514cf1720863e630d1a6849da93a64dc2d83e58842276312f00b37e81f91403033c8ac834cc88b36489109473ac4cc31a0cfd9dc0b0c4e7bd199721489a8086161790a3d3396f0bc176d91c50ebb149a14b7d10012f8bc1df507a95952f47bd1f37b14fd4134d8bc21d98a5ede106cf5bc03a2bea71a6c4683ed1baa575b0f116d06a27dcc4957be946f18bc1de35c288c1b587c4c716198503185ce7d7b8fa4449394de385c326bbbbe3c4dd5316a45e66fe2e1514c0163f1fc1419bf7f5f05606b91fa77c85e0b664c8a6caa460a33c1dae052a3b399e6a5d339aaf0c43065052a07128b8bc5d3a9da9578c9bcf7c7a6bbf3ee78edc1e19bb3a0cf9af0d7b5e1ba88f97fb30affb0684fad83293319e35aeaa4bc23e33e93f3488a3975a6cdadc81733df858e90c03455bd6c4877af2ac010de299e3295901c540c0aaadf081bdb5bdf3df31cfe1362088d872f1b8e4ac54c380b338a51723115038e52c215a35fb6a4428a56340a7ee5085853f69e4f90ece7a8e83a81f501f416efaa3f992a5b58ea608427b16b9760a456610b92b224d50ea64a28123f0bbd843eba64a4ca4c96b0ce6abc2a8eca1e719c4ed5cd1136a8a6874612caa3c7e6a40c558905fae40712a1a47920217aaa4657c2a56b5662379adaa97a47a43712fad6f1eeec802a2f49b2a1a800dbd23a8a337edb3a08ff437faa940e459a0e83a9620b21c8816433a3db302b5c103034a45bd988faf923d4b7846b9a7999f68c2e721801cd1d9803f57a53aa8444b610a698555383b8405f0e773b306748408214fcb0d9e4c6e54d0a0bca40c11ecf5c1a5c8284defb7b866570a21706f56cbf98240471080d8fda59a9d3869d368cdbb0d70ae56a157365a06cd1156bb00f209dac04c40618ef851131958a85b2cd85a0ec154a53e0425285f2a15f03b3eb334173cd3941ac1c570174fa541c51644de4399a4c460dac71745ac95627f5781435e49c3896a71dd8cd69383499882b8d7650777d073e214dd3d5b6aa13e1b0e387d7d07cfc02f22d5e0b09728c09f30962ff0c78dc818400a9c769ac0cea3a7d0820a38617ca43338b1c69c3be50b164405397efb60f84635d3cec777c699205aadf1ba52755316aaea201e75b89331a004805db24ad9717776f616077b273f8439394bc87f4f664dc0828e4f6a2e7dbbc0da32c1f83c2e4ef82ca75938a4333a65f84abcdfcadcc9031c391babeaa12a1b65a4d98a4147cd0d9f5fcb44d36e73e31da2195db4c183613cd1265857159c884c6a086107e4556b4a082cd3b4daab7f68710a2cd00c67eb2584415cc0d16b4b555e56e6d3b5883a1bd9f42b46854d6d760aaf5a9431851925060311a0faa22a3969dd324ef1e17a1ce1627168b78290443da6efd98c11a00ed14e622d532f6fb020dc239e3a209ccc4210d8d46e7e952a88c49daba528afb2670bf927369fc6480cbc1451233af42aa33f61bdaf8b8b0217a5d2199f1ec8daac98e29f8234950cb7f8889d08fa551adcf192d1c8509085941e6e534a33691649f61167c53f8bd80d6cdb2492b7d2f6646685f9a94980b5e998bf744391296df4bc854b2ac8c8344ac3aa5ea07d392eb9c2a7576bb98540d16b538a7825fa07356fc154196fb779101bbfcc6417ba498efbcf7a73ebfdc2b9d95bc7282ac0fda208aa6064073bf6149e33e8497d48942e4a1a4c7ca0fb5d51959db0da4a6ad8a2650b24f2cfccb5f21ab7c55db0ed67036c2dbc415d8b30652bd29ec9adf14f250cb4ca5f76aad85b9d3617374ab9debc1c6f9f1feeb96ffdf9afc37de9a3cf54b06c4f391b4fa4e6cdcbe9ab3b071c4847ad6f47ba56aa4c7bf5c5ae3395ff25c7fbcbebefe0338213299', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136839, 5758, 80.0, 160.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c0d8c510a83400c05aff22e205a14292df4bf17f05f9bb809d50d26aed0db77bf8681615e3d76cba7046ca307ee5d731b3beca9fda696e61fde13482f25261c43338a3f219a841d6431270e8458d9080ba344ad56f37a7446f0c51555835dad0434affc39d572fc01f63c28cc', X'789ced597b4f1b4710ff2a234bad88eaf32b901237aa641c022840112651aa3a42ebbdf1dd86bdddcbee1ee41af1dd3bbbb6c194830bd7aa52d5fec163cf33bf9df7e3fcb5159b2239572cc3d6105a639ceb2fc209d56a43ab30d23f4b9dcbedb0dbbd12179875b449fc7fa27b87d472c3728ccf99f31c83dee045d4eb47fdde59efc7e1566fd81b7436377bfded978116b9135a59a2fcdada438586c9f0bfc32f81fdaccc7108031543123ef5d453c5314f99d436d746d0f1b5b62c4178a34d668790ebab180dccb501a13e2d2eb8a19938832a7129d1f593360ce8a7df4ba6ea54170e41cf6114674209eb16570de1e0fd548d759669056786c508c7641ee23e0a2a2f142e66eb7a5cd323c76612fde9b78f7492425d84c3ad5e7734f81603af935f7ff4778ce242ba73d24ba8e48ecdfad12021b9e1f38b683b7d9a8001f80463c19c11bc0afcd573205b900141cb780813364757c2f780f3b9e08c97a0b403b41e5fd814e3a9faf92ec7762feabfe84196742f926ecc4a2f692c2e458c317cde8c5ea4e627484592920be3e0330b36d5858c61865058a2f29ecdb441b07889f4878e168dd0852587cf578a3e5def498e5c30797ea2f342b2dbb85ca97e6230514cf1720863e630d1a6849da93a64dc2d83e58842276312f00b37e81f91403033c8ac834cc88b36489109473ac4cc31a0cfd9dc0b0c4e7bd199721489a8086161790a3d3396f0bc176d91c50ebb149a14b7d10012f8bc1df507a95952f47bd1f37b14fd4134d8bc21d98a5ede106cf5bc03a2bea71a6c4683ed1baa575b0f116d06a27dcc4957be946f18bc1de35c288c1b587c4c716198503185ce7d7b8fa4449394de385c326bbbbe3c4dd5316a45e66fe2e1514c0163f1fc1419bf7f5f05606b91fa77c85e0b664c8a6caa460a33c1dae052a3b399e6a5d339aaf0c43065052a07128b8bc5d3a9da9578c9bcf7c7a6bbf3ee78edc1e19bb3a0cf9af0d7b5e1ba88f97fb30affb0684fad83293319e35aeaa4bc23e33e93f3488a3975a6cdadc81733df858e90c03455bd6c4877af2ac010de299e3295901c540c0aaadf081bdb5bdf3df31cfe1362088d872f1b8e4ac54c380b338a51723115038e52c215a35fb6a4428a56340a7ee5085853f69e4f90ece7a8e83a81f501f416efaa3f992a5b58ea608427b16b9760a456610b92b224d50ea64a28123f0bbd843eba64a4ca4c96b0ce6abc2a8eca1e719c4ed5cd1136a8a6874612caa3c7e6a40c558905fae40712a1a47920217aaa4657c2a56b5662379adaa97a47a43712fad6f1eeec802a2f49b2a1a800dbd23a8a337edb3a08ff437faa940e459a0e83a9620b21c8816433a3db302b5c103034a45bd988faf923d4b7846b9a7999f68c2e721801cd1d9803f57a53aa8444b610a698555383b8405f0e773b306748408214fcb0d9e4c6e54d0a0bca40c11ecf5c1a5c8284defb7b866570a21706f56cbf98240471080d8fda59a9d3869d368cdbb0d70ae56a157365a06cd1156bb00f209dac04c40618ef851131958a85b2cd85a0ec154a53e0425285f2a15f03b3eb334173cd3941ac1c570174fa541c51644de4399a4c460dac71745ac95627f5781435e49c3896a71dd8cd69383499882b8d7650777d073e214dd3d5b6aa13e1b0e387d7d07cfc02f22d5e0b09728c09f30962ff0c78dc818400a9c769ac0cea3a7d0820a38617ca43338b1c69c3be50b164405397efb60f84635d3cec777c699205aadf1ba52755316aaea201e75b89331a004805db24ad9717776f616077b273f8439394bc87f4f664dc0828e4f6a2e7dbbc0da32c1f83c2e4ef82ca75938a4333a65f84abcdfcadcc9031c391babeaa12a1b65a4d98a4147cd0d9f5fcb44d36e73e31da2195db4c183613cd1265857159c884c6a086107e4556b4a082cd3b4daab7f68710a2cd00c67eb2584415cc0d16b4b555e56e6d3b5883a1bd9f42b46854d6d760aaf5a9431851925060311a0faa22a3969dd324ef1e17a1ce1627168b78290443da6efd98c11a00ed14e622d532f6fb020dc239e3a209ccc4210d8d46e7e952a88c49daba528afb2670bf927369fc6480cbc1451233af42aa33f61bdaf8b8b0217a5d2199f1ec8daac98e29f8234950cb7f8889d08fa551adcf192d1c8509085941e6e534a33691649f61167c53f8bd80d6cdb2492b7d2f6646685f9a94980b5e998bf744391296df4bc854b2ac8c8344ac3aa5ea07d392eb9c2a7576bb98540d16b538a7825fa07356fc154196fb779101bbfcc6417ba498efbcf7a73ebfdc2b9d95bc7282ac0fda208aa6064073bf6149e33e8497d48942e4a1a4c7ca0fb5d51959db0da4a6ad8a2650b24f2cfccb5f21ab7c55db0ed67036c2dbc415d8b30652bd29ec9adf14f250cb4ca5f76aad85b9d3617374ab9debc1c6f9f1feeb96ffdf9afc37de9a3cf54b06c4f391b4fa4e6cdcbe9ab3b071c4847ad6f47ba56aa4c7bf5c5ae3395ff25c7fbcbebefe0338213299', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136840, 58, 125.0, 125.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db652704e2cb052303432cd4dd75130b430c84db75670ce482db75200b1752032d60ac1a5c540652640218582d42205033db35c1f0012c11504', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136841, 58, 40.0, 360.0, 'mg', 'PO', 4, 'Adult', X'789c3331d035363350c84d5708f05708f474512828ca5348cb492c29cd49cd4b4e050083bb098f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136842, 58, 500.0, 500.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb052303530c84dd74f49ac04001ef00457', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136843, 58, 20.0, 20.0, 'mg', 'PO', 4, 'Pediatric', X'789c3332c84d5708f05708f474512828ca030020a40464', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136844, 58, 240.0, 240.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb052303231c84dd74f49ac04001ef50458', X'789ce5566d6bdb3010fe2b4760b041d33869d675ee1884747d8136cd921606f33017f9e288c89291e4b6a1e4bf4fb6b3ae4ecd9ae6c3c6b66f967477cff3dc9d75ba6f443a8b438909357c688c794276c69992d4d88146a645be3bb336357eab75cbe794ec2a1de75fbcb5666c98c694a2106deed3f13afb4dafdd6c7b57de81ef75fcf6deaee7bdebbcf70a5b62962b699ce57da317255c726335e67bc596a5bb22ca913218131c2b9d181ffa98fad0eebc4de21d681f78497c08fd19ddfa907fef94278730ce8c33ebba2d484983b7bb9f9c0772a4324b06d414aa703e5c6a1481ecab245112ae34460403970e877782a6f9a5a09b4d1e335eba2d8b1341f9eaeb37b7125ccecb457ed68b326143c79dcbb822a7eb35f7f63d70cc8697f0f9ec08522d612ad0668224a3405ee09d0f6f3dc7bd15e1620be821451cade6ac0efe43071684da65414481ec78151e2bf04e7705ee0c9aed8a43b7d6a17b900b2a3d3e561dae0d01e6b980a824f3723de3941847110e559a09fcd9333f24d5846c0c35c512255b8423e7b196830b5c40e678459976474ec7cab6512592639f23b30564a8b99957a20c14ccb20425446811f006b9c87d6b828c483afa35c5289ac48741ab17c887aa15eb9a28a7943a26b545dd3cceb3bdb36dded60bf0bf256e3bbdeb59fb8b046f49755df16fe1ba35c80b6faabe926ea470197156734ff584201d2fc02a60028d69e563379067d20d25f7afa1c867d554953329902767703971232a2bf0b71a4137a40d852342b6d9ad3926cd5566d6ba5712684a95b614d5345b3934ab139ba3d633c2400ed0dd17f882723d0df2fc1be4c1d2c57dc4fb01fad7de2bbb65396a3649c07ad6fea90c6c2866f356fcc37a8633d409322554bca8a83a45316d0a3e251faee55caadbfc31434e8412dc24ee0670650fe4a73ba6a97c231e13738fc7d76dcf7b059964339431456fb6f82f2f28777620a19a863df6e4c1db13d6fdb710a38149367171c0647a8a8cc092345bdc05cbe577a6b6dc8a', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136845, 58, 40.0, 40.0, 'mg', 'PO', 4, 'Pediatric', X'789c3331c84d5708f05708f474512828ca030020c20466', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136846, 58, 480.0, 480.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb05230b13050c84dd74f49ac04002224047e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136847, 4207, 1.0, 2.0, 'g', 'IM', NULL, 'Adult', X'789c33d4355248d74f49ac54f0f45548c92ccb4c494d512834d33534ca00006ba507f3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136848, 4207, 2.0, 2.0, 'g', NULL, NULL, 'Adult', X'789cf34dacb052305248d74f49acb456f0cc4bcbb752484cc92a2d2e5148c92f4e55484a2c4e4d51c8cf53284e2d2acd55c8492d4bcd290600d2bc1251', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136849, 4207, 15.0, 15.0, 'mg/kg', 'IM', NULL, 'Adult', X'789c3334cd4dd7cf4e57f0f455283432c95030d535afd02fcf06004d7c0693', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136850, 4207, 25.0, 30.0, 'mg/kg', 'IM', NULL, 'Adult', X'789c73cc29492dca4b2cc92c4bb5523032d53536c84dd7cf4e57f0f45530d235aed02fcf0600c4dc0a97', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136851, 4207, 1.0, 1.0, 'g', 'IM', NULL, 'Adult', X'789c334c57f0f455283434ca50a83034504849ac2c060032350575', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136852, 4207, 2.0, 2.0, 'g', NULL, NULL, 'Adult', X'789cf34dacc8cc2dcd5548c92f4eb552305248d74f49ac54d0484cc92a2d2e018b2a242516a7a628e4e72914a7160155e6a496a5e6146b02003cac1404', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136853, 4207, 1.0, 1.0, 'g', 'IM', NULL, 'Adult', X'789c334c57f0f455283434ca50a83034504849ac2c060032350575', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136854, 4207, 2.0, 2.0, 'g', NULL, NULL, 'Adult', X'789cf34dacc8cc2dcd5548c92f4eb552305248d74f49ac54d0484cc92a2d2e018b2a242516a7a628e4e72914a7160155e6a496a5e6146b02003cac1404', X'789ced596d6fdb3610fe2b843f0c1d60c7b21337adbb2f6efa1660c982241d30cc85414b2789357554492a895ae4bfef2839b6a5d8b593a16e801afe6289cf1d8fcfbdf0487d6b043a8b46c81368f459e3c26a48ad4a725f60a3c91a9996ee756c6d6afaedf6b59840b2a774e4fe89761d6d7ccd530846dc3aa1aed77ddef23aad8e77e9bde87bddfe416fefa0f772ffd02bb0e05ba1d010f25be33d20682e8bff166e0af1cb3c85fe1007894015c9dc57460430c437caf008d83ba51343c3c72785b26cbca8ef965e593e96e09efefd444f52e0a47898ebaf2a5ebfd81afef6939b651064d28ec8268151c5fa2556358e319c3e3647afb96f418bda9a3bad2e8bda01cfd9f1090bc4154d14b02fcf5b9d6e3cc4137ed367d3f1578c94a93ee3c1e7cc581628036ccc0da11532033a4b98842b906688e7805c3a049938c4230ddc0a1408ec4802d71c7d603daff5c2ebb3485c01fbd23d8857c03a5eabb7006b1d765721ffe8cc7087ddd6cbe771a3ea91823aa2e20a46361b83f63349f6992a17bd246a4f22c784b389f55a8737edeb09458424e6903b69e2a3d7daf766c06e6bdf6196cc76267994417582523771cb6e3a1e23564d41b248883dc7e88c6df66c2dcfbf2f99f332935c4322f816a7fd4ee81736fde231584fc95d10fe8c20fcc1acd79dbca37d8be15727ff2912b12d9b366f4b4aff4020b8d5c2ff5f0dc5a85b91eb7aad03af924ef534aa00ba65a25597dd71cb764b1561a1a1c994669dbddec2eba9dce685fe706f9ae41b56fc7bf875a5bf26f0903ee42752b872d7a8d9b45822b750c5b63ffba31a995decaf89fd0dfa9f5df03ffde07f7a6e5bde73edfcb6ac03db8e5d2b1bb1a747cb964d7b605b769182eff6963395929d7342efac3cd31021d5de9c9dbb724cb5bfcfde0cf14fda940a749f9d6935a6097276c14320e3150aab3441594a553b014a4b7797f5fae369db9fd7746e8b359031d064360664296d722a103e9732df1be245b130777f373b687f24ad9cb6a19c2a02257c160845ea75ce424add584431d3c24c685a2b00ad79ecdd597dc9eb6fcf6612a3a944797f76a4d06a2ed02daa3061d41e1df1ec3ec91520048eada3f74cbaed4db8912b308e17da1445a042752534f1535e4f7e55bec021faa55a57b5e29c98348046502d143667563193c950583015a048522e348511a9b762ecc2948519166c2d0772a29c7c9b2f87f90afd4c6ba29e294bbf1be1331e394fac8221647a35b0184d32e3179605c200054c05a18ba6a4342f21f9ca6000711e68fe3d3311d2b86200cb6a3380a4e8d14ae69642768c4a275c12af35265342288c88a1aa3cd20c8af624306e731118f2ea1a91f407a029771e17b3d35bda2be7efd13970ff7e682d2b96172ed3b22aeeafa9c728609a733fffb6101b433c9db98b50d3c7997fc652f913ee2eb14fe7ac16b801baead76431248e48e10ff1cc258b5529a0e043bc247832560b6f06c8d3389754075da26324140490d0c0877a70ebe9aa87f8f6265452140d00f99e1c650943e21799ab2c770df5922df54825090d2cb271cac9919c71a4e45089280bdfdfa0ad8894b35e132b312525ad2ae4ae7e5283cc0d7521efa8546957a968995c974b995bffd6b5cf2a8d8574236f808708c6ac36bd4ac357651d91547c219bace6aeca6d49fe102bf43ba74960d7c027a50183840ab84a1df0183f974c31e21866fc3e60d75bf8ca51336e7d25bd2741f32c7cd598f3b1c1278d057045cb12e7aed7560a8d48683413aa689d46c77a4d77c08ab48b9ef5a205aa2257c4db7ac11256919c85e87ae939b4e68dbbc8dec41933ec0ff06819e49b282870e5eefcab57c1faaeb02b83bb32b82b83bf5c19dca5fd8669ff98a3e42ec77639e66ec6624e61edd32131ca2b99f681cbb02545087dd663b1cab4bbfd010a2b4a0893f4d9479ca0bac657ece89fb3839ee772c5d750debbb8db1077df027ecc91d04c856ce09763d36f06be08e87cfc6c2c3030ee1a60dfbb605a8c9551748c6514d0190adba473682cc6459cb993ac053a979a1c8b147fdc9d12c068208daa2c7580d4410945ee35ecd90917f840cdeb34ad73c74c663495295d730e2168401faa8de0db54f9da1ddc1fbafcdbdbff00efd612db', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136855, 4207, 20.0, 40.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3332d03531c84dd7cf4e57f0f455283432c900002c0804de', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136856, 4207, 20.0, 40.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c73cc29492dca4b2cc92c4bb5523032d03531c84dd7cf4e57f0f45530aad02fcf0600b1290a33', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136857, 4207, 1.0, 1.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dacc8cc2dcd5548c92f4eb552305448d707b11432d3140a8d4c327414f28b140cf54c91848d2af4cbb301df7e10f0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136858, 4207, 7.5, 7.5, 'mg/kg', NULL, NULL, 'Pediatric', X'789c732e4a4d2cc9cccbcc4b5570ce494d2c4acc4b4e553035d0b530b05230d733cd4dd7cf4e5748cf2c4b55283432c900006a6e0eae', X'789ced596d6fdb3610fe2b843f0c1d60c7b21337adbb2f6efa1660c982241d30cc85414b2789357554492a895ae4bfef2839b6a5d8b593a16e801afe6289cf1d8fcfbdf0487d6b043a8b46c81368f459e3c26a48ad4a725f60a3c91a9996ee756c6d6afaedf6b59840b2a774e4fe89761d6d7ccd530846dc3aa1aed77ddef23aad8e77e9bde87bddfe416fefa0f772ffd02bb0e05ba1d010f25be33d20682e8bff166e0af1cb3c85fe1007894015c9dc57460430c437caf008d83ba51343c3c72785b26cbca8ef965e593e96e09efefd444f52e0a47898ebaf2a5ebfd81afef6939b651064d28ec8268151c5fa2556358e319c3e3647afb96f418bda9a3bad2e8bda01cfd9f1090bc4154d14b02fcf5b9d6e3cc4137ed367d3f1578c94a93ee3c1e7cc581628036ccc0da11532033a4b98842b906688e7805c3a049938c4230ddc0a1408ec4802d71c7d603daff5c2ebb3485c01fbd23d8857c03a5eabb7006b1d765721ffe8cc7087ddd6cbe771a3ea91823aa2e20a46361b83f63349f6992a17bd246a4f22c784b389f55a8737edeb09458424e6903b69e2a3d7daf766c06e6bdf6196cc76267994417582523771cb6e3a1e23564d41b248883dc7e88c6df66c2dcfbf2f99f332935c4322f816a7fd4ee81736fde231584fc95d10fe8c20fcc1acd79dbca37d8be15727ff2912b12d9b366f4b4aff4020b8d5c2ff5f0dc5a85b91eb7aad03af924ef534aa00ba65a25597dd71cb764b1561a1a1c994669dbddec2eba9dce685fe706f9ae41b56fc7bf875a5bf26f0903ee42752b872d7a8d9b45822b750c5b63ffba31a995decaf89fd0dfa9f5df03ffde07f7a6e5bde73edfcb6ac03db8e5d2b1bb1a747cb964d7b605b769182eff6963395929d7342efac3cd31021d5de9c9dbb724cb5bfcfde0cf14fda940a749f9d6935a6097276c14320e3150aab3441594a553b014a4b7797f5fae369db9fd7746e8b359031d064360664296d722a103e9732df1be245b130777f373b687f24ad9cb6a19c2a02257c160845ea75ce424add584431d3c24c685a2b00ad79ecdd597dc9eb6fcf6612a3a944797f76a4d06a2ed02daa3061d41e1df1ec3ec91520048eada3f74cbaed4db8912b308e17da1445a042752534f1535e4f7e55bec021faa55a57b5e29c98348046502d143667563193c950583015a048522e348511a9b762ecc2948519166c2d0772a29c7c9b2f87f90afd4c6ba29e294bbf1be1331e394fac8221647a35b0184d32e3179605c200054c05a18ba6a4342f21f9ca6000711e68fe3d3311d2b86200cb6a3380a4e8d14ae69642768c4a275c12af35265342288c88a1aa3cd20c8af624306e731118f2ea1a91f407a029771e17b3d35bda2be7efd13970ff7e682d2b96172ed3b22aeeafa9c728609a733fffb6101b433c9db98b50d3c7997fc652f913ee2eb14fe7ac16b801baead76431248e48e10ff1cc258b5529a0e043bc247832560b6f06c8d3389754075da26324140490d0c0877a70ebe9aa87f8f6265452140d00f99e1c650943e21799ab2c770df5922df54825090d2cb271cac9919c71a4e45089280bdfdfa0ad8894b35e132b312525ad2ae4ae7e5283cc0d7521efa8546957a968995c974b995bffd6b5cf2a8d8574236f808708c6ac36bd4ac357651d91547c219bace6aeca6d49fe102bf43ba74960d7c027a50183840ab84a1df0183f974c31e21866fc3e60d75bf8ca51336e7d25bd2741f32c7cd598f3b1c1278d057045cb12e7aed7560a8d48683413aa689d46c77a4d77c08ab48b9ef5a205aa2257c4db7ac11256919c85e87ae939b4e68dbbc8dec41933ec0ff06819e49b282870e5eefcab57c1faaeb02b83bb32b82b83bf5c19dca5fd8669ff98a3e42ec77639e66ec6624e61edd32131ca2b99f681cbb02545087dd663b1cab4bbfd010a2b4a0893f4d9479ca0bac657ece89fb3839ee772c5d750debbb8db1077df027ecc91d04c856ce09763d36f06be08e87cfc6c2c3030ee1a60dfbb605a8c9551748c6514d0190adba473682cc6459cb993ac053a979a1c8b147fdc9d12c068208daa2c7580d4410945ee35ecd90917f840cdeb34ad73c74c663495295d730e2168401faa8de0db54f9da1ddc1fbafcdbdbff00efd612db', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136859, 4207, 7.5, 7.5, 'mg/kg', NULL, NULL, 'Pediatric', X'789c732e4a4d2cc9cccbcc4b5570ce494d2c4acc4b4e553034d03535b05230d733cd4dd7cf4e5748cf2c4b55283432d13537ca000096420f3d', X'789ced596d6fdb3610fe2b843f0c1d60c7b21337adbb2f6efa1660c982241d30cc85414b2789357554492a895ae4bfef2839b6a5d8b593a16e801afe6289cf1d8fcfbdf0487d6b043a8b46c81368f459e3c26a48ad4a725f60a3c91a9996ee756c6d6afaedf6b59840b2a774e4fe89761d6d7ccd530846dc3aa1aed77ddef23aad8e77e9bde87bddfe416fefa0f772ffd02bb0e05ba1d010f25be33d20682e8bff166e0af1cb3c85fe1007894015c9dc57460430c437caf008d83ba51343c3c72785b26cbca8ef965e593e96e09efefd444f52e0a47898ebaf2a5ebfd81afef6939b651064d28ec8268151c5fa2556358e319c3e3647afb96f418bda9a3bad2e8bda01cfd9f1090bc4154d14b02fcf5b9d6e3cc4137ed367d3f1578c94a93ee3c1e7cc581628036ccc0da11532033a4b98842b906688e7805c3a049938c4230ddc0a1408ec4802d71c7d603daff5c2ebb3485c01fbd23d8857c03a5eabb7006b1d765721ffe8cc7087ddd6cbe771a3ea91823aa2e20a46361b83f63349f6992a17bd246a4f22c784b389f55a8737edeb09458424e6903b69e2a3d7daf766c06e6bdf6196cc76267994417582523771cb6e3a1e23564d41b248883dc7e88c6df66c2dcfbf2f99f332935c4322f816a7fd4ee81736fde231584fc95d10fe8c20fcc1acd79dbca37d8be15727ff2912b12d9b366f4b4aff4020b8d5c2ff5f0dc5a85b91eb7aad03af924ef534aa00ba65a25597dd71cb764b1561a1a1c994669dbddec2eba9dce685fe706f9ae41b56fc7bf875a5bf26f0903ee42752b872d7a8d9b45822b750c5b63ffba31a995decaf89fd0dfa9f5df03ffde07f7a6e5bde73edfcb6ac03db8e5d2b1bb1a747cb964d7b605b769182eff6963395929d7342efac3cd31021d5de9c9dbb724cb5bfcfde0cf14fda940a749f9d6935a6097276c14320e3150aab3441594a553b014a4b7797f5fae369db9fd7746e8b359031d064360664296d722a103e9732df1be245b130777f373b687f24ad9cb6a19c2a02257c160845ea75ce424add584431d3c24c685a2b00ad79ecdd597dc9eb6fcf6612a3a944797f76a4d06a2ed02daa3061d41e1df1ec3ec91520048eada3f74cbaed4db8912b308e17da1445a042752534f1535e4f7e55bec021faa55a57b5e29c98348046502d143667563193c950583015a048522e348511a9b762ecc2948519166c2d0772a29c7c9b2f87f90afd4c6ba29e294bbf1be1331e394fac8221647a35b0184d32e3179605c200054c05a18ba6a4342f21f9ca6000711e68fe3d3311d2b86200cb6a3380a4e8d14ae69642768c4a275c12af35265342288c88a1aa3cd20c8af624306e731118f2ea1a91f407a029771e17b3d35bda2be7efd13970ff7e682d2b96172ed3b22aeeafa9c728609a733fffb6101b433c9db98b50d3c7997fc652f913ee2eb14fe7ac16b801baead76431248e48e10ff1cc258b5529a0e043bc247832560b6f06c8d3389754075da26324140490d0c0877a70ebe9aa87f8f6265452140d00f99e1c650943e21799ab2c770df5922df54825090d2cb271cac9919c71a4e45089280bdfdfa0ad8894b35e132b312525ad2ae4ae7e5283cc0d7521efa8546957a968995c974b995bffd6b5cf2a8d8574236f808708c6ac36bd4ac357651d91547c219bace6aeca6d49fe102bf43ba74960d7c027a50183840ab84a1df0183f974c31e21866fc3e60d75bf8ca51336e7d25bd2741f32c7cd598f3b1c1278d057045cb12e7aed7560a8d48683413aa689d46c77a4d77c08ab48b9ef5a205aa2257c4db7ac11256919c85e87ae939b4e68dbbc8dec41933ec0ff06819e49b282870e5eefcab57c1faaeb02b83bb32b82b83bf5c19dca5fd8669ff98a3e42ec77639e66ec6624e61edd32131ca2b99f681cbb02545087dd663b1cab4bbfd010a2b4a0893f4d9479ca0bac657ece89fb3839ee772c5d750debbb8db1077df027ecc91d04c856ce09763d36f06be08e87cfc6c2c3030ee1a60dfbb605a8c9551748c6514d0190adba473682cc6459cb993ac053a979a1c8b147fdc9d12c068208daa2c7580d4410945ee35ecd90917f840cdeb34ad73c74c663495295d730e2168401faa8de0db54f9da1ddc1fbafcdbdbff00efd612db', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136860, 4207, 7.5, 7.5, 'mg/kg', NULL, NULL, 'Pediatric', X'789c732e4a4d2cc9cccbcc4b5570ce494d2c4acc4b4e55b03134b05230d733cd4dd7cf4e5748cf2c4b55283437d2b534cb00007d980ef0', X'789ced596d6fdb3610fe2b843f0c1d60c7b21337adbb2f6efa1660c982241d30cc85414b2789357554492a895ae4bfef2839b6a5d8b593a16e801afe6289cf1d8fcfbdf0487d6b043a8b46c81368f459e3c26a48ad4a725f60a3c91a9996ee756c6d6afaedf6b59840b2a774e4fe89761d6d7ccd530846dc3aa1aed77ddef23aad8e77e9bde87bddfe416fefa0f772ffd02bb0e05ba1d010f25be33d20682e8bff166e0af1cb3c85fe1007894015c9dc57460430c437caf008d83ba51343c3c72785b26cbca8ef965e593e96e09efefd444f52e0a47898ebaf2a5ebfd81afef6939b651064d28ec8268151c5fa2556358e319c3e3647afb96f418bda9a3bad2e8bda01cfd9f1090bc4154d14b02fcf5b9d6e3cc4137ed367d3f1578c94a93ee3c1e7cc581628036ccc0da11532033a4b98842b906688e7805c3a049938c4230ddc0a1408ec4802d71c7d603daff5c2ebb3485c01fbd23d8857c03a5eabb7006b1d765721ffe8cc7087ddd6cbe771a3ea91823aa2e20a46361b83f63349f6992a17bd246a4f22c784b389f55a8737edeb09458424e6903b69e2a3d7daf766c06e6bdf6196cc76267994417582523771cb6e3a1e23564d41b248883dc7e88c6df66c2dcfbf2f99f332935c4322f816a7fd4ee81736fde231584fc95d10fe8c20fcc1acd79dbca37d8be15727ff2912b12d9b366f4b4aff4020b8d5c2ff5f0dc5a85b91eb7aad03af924ef534aa00ba65a25597dd71cb764b1561a1a1c994669dbddec2eba9dce685fe706f9ae41b56fc7bf875a5bf26f0903ee42752b872d7a8d9b45822b750c5b63ffba31a995decaf89fd0dfa9f5df03ffde07f7a6e5bde73edfcb6ac03db8e5d2b1bb1a747cb964d7b605b769182eff6963395929d7342efac3cd31021d5de9c9dbb724cb5bfcfde0cf14fda940a749f9d6935a6097276c14320e3150aab3441594a553b014a4b7797f5fae369db9fd7746e8b359031d064360664296d722a103e9732df1be245b130777f373b687f24ad9cb6a19c2a02257c160845ea75ce424add584431d3c24c685a2b00ad79ecdd597dc9eb6fcf6612a3a944797f76a4d06a2ed02daa3061d41e1df1ec3ec91520048eada3f74cbaed4db8912b308e17da1445a042752534f1535e4f7e55bec021faa55a57b5e29c98348046502d143667563193c950583015a048522e348511a9b762ecc2948519166c2d0772a29c7c9b2f87f90afd4c6ba29e294bbf1be1331e394fac8221647a35b0184d32e3179605c200054c05a18ba6a4342f21f9ca6000711e68fe3d3311d2b86200cb6a3380a4e8d14ae69642768c4a275c12af35265342288c88a1aa3cd20c8af624306e731118f2ea1a91f407a029771e17b3d35bda2be7efd13970ff7e682d2b96172ed3b22aeeafa9c728609a733fffb6101b433c9db98b50d3c7997fc652f913ee2eb14fe7ac16b801baead76431248e48e10ff1cc258b5529a0e043bc247832560b6f06c8d3389754075da26324140490d0c0877a70ebe9aa87f8f6265452140d00f99e1c650943e21799ab2c770df5922df54825090d2cb271cac9919c71a4e45089280bdfdfa0ad8894b35e132b312525ad2ae4ae7e5283cc0d7521efa8546957a968995c974b995bffd6b5cf2a8d8574236f808708c6ac36bd4ac357651d91547c219bace6aeca6d49fe102bf43ba74960d7c027a50183840ab84a1df0183f974c31e21866fc3e60d75bf8ca51336e7d25bd2741f32c7cd598f3b1c1278d057045cb12e7aed7560a8d48683413aa689d46c77a4d77c08ab48b9ef5a205aa2257c4db7ac11256919c85e87ae939b4e68dbbc8dec41933ec0ff06819e49b282870e5eefcab57c1faaeb02b83bb32b82b83bf5c19dca5fd8669ff98a3e42ec77639e66ec6624e61edd32131ca2b99f681cbb02545087dd663b1cab4bbfd010a2b4a0893f4d9479ca0bac657ece89fb3839ee772c5d750debbb8db1077df027ecc91d04c856ce09763d36f06be08e87cfc6c2c3030ee1a60dfbb605a8c9551748c6514d0190adba473682cc6459cb993ac053a979a1c8b147fdc9d12c068208daa2c7580d4410945ee35ecd90917f840cdeb34ad73c74c663495295d730e2168401faa8de0db54f9da1ddc1fbafcdbdbff00efd612db', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136861, 4207, 20.0, 40.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3332d03531c84dd7cf4e57f0f455283432c900002c0804de', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136862, 4207, 20.0, 40.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c73cc29492dca4b2cc92c4bb5523032d03531c84dd7cf4e57f0f45530aad02fcf0600b1290a33', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136863, 4207, 1.0, 1.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dacc8cc2dcd5548c92f4eb552305448d707b11432d3140a8d4c327414f28b140cf54c91848d2af4cbb301df7e10f0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136864, 4207, 15.0, 15.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3334cd4dd7cf4e57f0f455283434ca50a83034504849ac2c060055600718', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136865, 4207, 2.0, 2.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dacc8cc2dcd5548c92f4eb552305248d74f49ac54d0484cc92a2d2e018b2a242516a7a628e4e72914a7160155e6a496a5e6146b02003cac1404', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136866, 4207, 15.0, 15.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3334cd4dd7cf4e57f0f455283434ca50a83034504849ac2c060055600718', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136867, 4207, 2.0, 2.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dacc8cc2dcd5548c92f4eb552305248d74f49ac54d0484cc92a2d2e018b2a242516a7a628e4e72914a7160155e6a496a5e6146b02003cac1404', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136868, 3454, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136869, 26, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136870, 13865, 160.0, 160.0, 'mcg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db652b030d05130343350c84d4ed72f2e284aac54f075f10400c6640acf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136871, 13865, 80.0, 80.0, 'mcg', NULL, 2, 'Adult', X'789c335428284d4b53d0b03050c84d4e5728482d52282e284aacd45470f2740100825408d8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136872, 13865, 320.0, 320.0, 'mcg', NULL, NULL, 'Adult', X'789cf34dacb05230363250c84d4ed74f49ac040026d904da', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136873, 13865, 80.0, 80.0, 'mcg', NULL, 2, 'Adult', X'789c33d4355228284d4b2b56d0b03050c84d4e5728482d52282e284aacd45470f27401009ad209aa', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136874, 13865, 640.0, 640.0, 'mcg', NULL, NULL, 'Adult', X'789cf34dacb05230333150c84d4ed74f49ac0400270e04df', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136875, 13865, 160.0, 160.0, 'mcg', NULL, 2, 'Adult', X'789c335228284d4b2b56d030343350c84d4e5728482d52282e284aacd45470f27401009608097b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136876, 13865, 640.0, 640.0, 'mcg', NULL, NULL, 'Adult', X'789cf34dacb05230333150c84d4ed74f49ac0400270e04df', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136877, 13865, 80.0, 80.0, 'mcg', NULL, 2, 'Pediatric', X'789c335428284d4b53d0b03050c84d4e5728482d52282e284aacd45470f2740100825408d8', X'789ced5aff6fea3812ff5746482b155da084962f4d4f2751fafae56d6951e9d369ef51219398e025b123db69cb5bbdfffdc64e0884760ffab4a7dd95fa539b643c9ef9ccc733639bdf2a814cc3092731ad7850e9333fa24a7016d08a03955446e6ed5ceb44798787cf6c41e3ba90a1f98f1d6e092b5f92840613a2cd9866a3d9ae35dc9adb786874bc56c33b72eb9de3e3a6dbb1b2d4d74c708592bf557a41cc38535a12f3cebed2f4c56a795826d41bf36b3e27110dc01752335f284da560c1989f0b45420a1742c6ca836ec301b7dd80d80f0f5522c91206e7d7637e2f524d1588199427f2c0aab5ff8f795fc4b1e0f0204940e116e14085bde8892a5f5883d3e9a6cddff1952653741f9fbe3ee253c4f8c23eac8d7fdbeaddb8e6e3265be3be3f9a597b411ae9093ace7858826a289990309582fb731130f40b1f4924381d73179274368383ae0507122ac1025485b3ebf3311f6922b507b914cbcdb69f06e4c583a366066a409663fe40cc702d2012cf5469a0b39901e689422014ce95d9b1525284caad35ad7af5c356b48fdf6d8590245a9b50189093e49505ef9da60ed9f7cd69148448a19444d112c80cdfc1bf5c78a674f13e16d9580f69c08896cc7f2bde6ef31fb0140efc55e25eb6e7cf8e7fd99abf390f4609f51989264391a459be525b4b9f869c707f09f7f8958763cc6dfd53b8676a61d21e4e8ea40829673ed34be3024c89426c31df11ce62343a209a00d1e0365e60707f8518dc105fdba940a21aa3f1e6e8144664465145ca175c3cf3375ca9dc538e96bec1579bb83cb8151a023a639c62240a8297de57ca701804ae6882c6bcb90e0abd40825f53a563caf596e68d2fdbbaf74ae4dbf8ee4ee1e7a6a866c26ac2f8a4d050c109d78acb20ef565bc84f8cfcc4279a864232343e2b0e7f10f8db31fd33d0ffe3c3fece45d7171c1b05c603e6bfb1e47a514465b83429c18f885287a68d1af39ed2f3988cb903c4c7ae63cccfb2bcac12a262fcfc849901c854a6898667a6e78124cf24fad106239b6d376d72b95503f144a5a2937b4afcd77ebd15fe11c5249a96e5ca7e5d619b863ab96298134d8e91b9727499874cd0801a547a81340405952689a44a59013b366b7598d17529c5b39e6fcac001b6950a12adaaf83922a92f8cb6ebbb2156091fa73209bf8f194ce2a4ea8dec91f57625fbaf2809883fc781b74489644ee4120dd54c8df9977b6c1a478ca72a7b4601b4d9173cc4cc6f4d1e66e222b27f287e4d9028e89fd4732c012143eb3ebd6849638345f6ed8cf88bfcdf2b410c58e89c311b09869c556626c75610d3eecea294f26fa866c8698ab61b8d8354f96924d48246541b8be6a612652abf18f8883462e7ecdb379629bf24d8eb0aa43f06d0ba72414c1d813c1c17c8eb3035d809fe6bca7d1b3bf60ac0bda8f8bb0cd8cdceeda19362682957ae89b407e1d7b2251d2bf2ecd6504896c6af58b387532bc9d278a4d6eea146a834aae0e2eeb16bd132760531f7c06e2d5bd2511078b70a233ab1a2250d1b5cdf6373b9215cd2522c8e7d36522bd19286624dedd6b0162dc771b5dcf68866215ad250acd23d7a8942b4cce5f2e2de83d25b034adaf25cb05bcb4ab01cd95709644770cbf25961fafb9599ed42f951673eeacc479df9a8331f75e6af5c673eb2f47bb3f48fec4d3f52d8470afb4861ffa71466524e4c7c118970594e64249ad52236a31e34ea1d17e612bb5a82edb0ae9e42bbd6b12f4876721d63de988a88698afdee207f50b10737f8559e42ff97e171abe141f3bcedc051ef183549166392ab824908e6168d9acc86ad71769d76c6227a38a33e55d06effe4402a3116f0cf66e3a71f387e1b507f4e38da3311b349cf7f7533f8e905dd401f722973ce4db86635864426716c6e419690f577abe3ea5373a9c0a64c2b88d348b324a25012f7975a2c0c7f5055008914416a9c2984c3087bb5fc56ce9ce3a1508ce2d21684d5dbec6ae09d79333fbd9d510c954fcb7ba01bfa829ae3042b4affee124cf9625a536a8eef87662fc27c0a67698475807155bbc3d0507304aa1c1857ec9057521ef4716a5c6c110c0827213567a47099b28046d6ff999050286284d72e979c5abe3185f0dda6f1944a3869387041a732455240b3d1e87a901d3522ac501c793be34aae0b722d8e1576c075dd83260c35b855efb8d5a9b58febf075984e073400b7db3cea9e74bb8fe876760d0b07fefac2b90a5fcdbecd97184f1e9a300a5c1106eac73afa24a3a990220de70e0c7a1e8c522e9e0c13f2854353936922756a44fd399ae376ebff63224304249be0229424999b2918ee19952269481cb8e3b82964c201ccc458cb2c0a92fc078bba4ff277a7f099f01c27b753371dc062ce247d227073ebc0676150fff9c68111125a7f838103881741a8c6298ef0735c1199fc381abe285a82d9d2f1c2f602d9ded6b12303f80cabc36a1374b88e6344238b41cbc4a07d7054f55a8da3dac906fa6db775d276db8fc6508dfd01874f0efc4c644223f86c1cc52e88c2c396951bbf08807b9aad1e3da7704b51a7e594592ba3ec866ce5813dc987217a852454f06f86dbf211c514441d18e28e0d1967d89921b072aa6fda1deb032627b77972d0aa7aaedb69d7ba9d4d2fdadd56a3d1412ffaf39861a7f4ac16c460db5b60b37433a8c3f952257353b580282590ea1ac79993796b778a168af55d64f9425ed5a19f4af4294127ee74deff89084c43832e630f304a655837116f9d42f3c8e0dc6cb56acdd606d2cd56b7db39e9b4d0c673b3fa03216770b5027495e84d56c2a96d8c57ef82252731be1b4a811b5b44cffec661f5a3838d50ac89600950140f0b5fc781e3ce41bbea75bacddac91abaceb1dbec364f1edf9bc7be7fff2f1af3d04b', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136878, 13865, 320.0, 320.0, 'mcg', NULL, NULL, 'Pediatric', X'789cf34dacb05230363250c84d4ed74f49ac040026d904da', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136879, 13865, 80.0, 80.0, 'mcg', NULL, 2, 'Pediatric', X'789c33d4355228284d4b2b56d0b03050c84d4e5728482d52282e284aacd45470f27401009ad209aa', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136880, 13865, 640.0, 640.0, 'mcg', NULL, NULL, 'Pediatric', X'789cf34dacb05230333150c84d4ed74f49ac0400270e04df', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136881, 13865, 160.0, 160.0, 'mcg', NULL, 2, 'Pediatric', X'789c335228284d4b2b56d030343350c84d4e5728482d52282e284aacd45470f27401009608097b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136882, 13865, 640.0, 640.0, 'mcg', NULL, NULL, 'Pediatric', X'789cf34dacb05230333150c84d4ed74f49ac0400270e04df', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136883, 3320, 0.25, 2.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c33d03332d535ca4dd7cf4e57f00c532834d33534ca280200401505ea', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136884, 3320, 10.0, 10.0, 'mg/kg', NULL, NULL, 'Adult', X'789cf34dac5048c92f4e553034c84dd7cf4ed74f49ac0400458006b5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136885, 5175, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136886, 6795, 1.0, 2.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c33d43552c84dd7cf4e57f00cd35148cbcfc9c92f4f4d5148aa5430d033d53584cb290404f901001f190cbd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136887, 6795, 4.0, 5.0, 'mg/kg', 'IM', NULL, 'Adult', X'789c33d13555c84dd7cf4e57f0f45578d43649a128b52035b144c148d704219e9856925aa46068a0909b99a79099a6909659545ca290925f9caa509a575c9a9c9c5a5c9c569a0300aa7319b7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136888, 6795, 0.1, 0.3, 'mg/kg', 'IV', NULL, 'Adult', X'789c33d033d435d03356c84dd7cf4e57f00c530808f2030030c90512', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136889, 6795, 4.0, 6.0, 'mg/kg', 'IM', NULL, 'Adult', X'789c33d13553c84dd7cf4e57f0f455c82f523084f1c2005f090749', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136890, 6795, 1.0, 2.0, 'mg/kg', NULL, NULL, 'Adult', X'789c0bc82f2ed1cdcc2b294d4a2cc9cccf53284e4d81324a128b4a14124b140c758d1472d3f5b3d3f5338a0097b61079', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136891, 6795, 0.5, 0.5, 'mg/kg', NULL, NULL, 'Adult', X'789c0bc92c294a2c495548aa5430d03355c84dd7cf4ed7cf28522804b233f30099be09b4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136892, 6795, 4.0, 6.0, 'mg/kg', NULL, NULL, 'Adult', X'789cf34dac5048c92f4e55c84f5330d13553c84dd7cf4ed7cf2802005ff4079c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136893, 6795, 500.0, 500.0, 'mg', 'IN', NULL, 'Adult', X'789c0bc8494c4e5530353050c84d57c84e2d49cccdcc4b55c8cc030b25272ba4e5172918e6a6ebe7e6000019920d23', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136894, 6795, 10.0, 20.0, 'g', NULL, NULL, 'Adult', X'789c0b2e49cc4b492c4a51c84dacc8544829ca2c50284e2d2956484a2d294f4dcd533034d0353250484f2fd1cfcd0100663f0f33', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136895, 6795, 20.0, 20.0, 'g', NULL, NULL, 'Adult', X'789c0b2d2e4dccc9a954303250482f290100260b04e1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136896, 6795, 60.0, 60.0, 'g', NULL, NULL, 'Adult', X'789cf3cdcccb544829ca2c50284e2d51c8482c56303350484f2fd1cfcd010081ea0915', X'789ced5adb6e1b3912fd15c2c06265409225f9928cb0f3a0b133897762c7b09dbc448640b1a96ec66cb243b2256b06f9f73dc5d6ad654f9c0413ec5cfce08bd864f1d4a90babd8fa6d2771653a323c973b7db6f38b0c3c5746ee34d94ee9340d652114bebfb73753b7326f5b97d27f6a6f73a6178e173219f1400b7a9dde51abd36d753bd79d67fdc3a37e67bf7dd47ddefd613fce9522286b3c66feb6f3521ae9b88eff077917975fcf0bd91f9a13e5bd158a0735958c1be94326831278603d4f25fbd9badcf759b7d36487f8e9763a79ba97eba1b9b465909ed909e309002a1f1ca71dfbecf45d939d9ee1e77c688e6d9e5bc3ae1d4f243b87f690452a69ee22ca72bc09f41386021f6b499fdedfe09356e6367e5803ff1dc48f537925938870d4c8b932bb3b9f6e68bf4152ea3082b6caa435821ec0b773e1ac9049092e472b69d68d4e4d52c65935016f8ab81024775b3d06da6ed3c8cdc46a6d673261e339ebb40f5bddd533767109ce0e5a87cb9133362c7bdd1f7accc942f2c07aad83f5233e09d2c1220cf433356113e57c6089f59295c6974248ef27a5dea9934a3a5f95e36483c5d1c0709d4aaf780d7fa7dd6d75dafb5be8de776ff0ab7743b6355e258090aa29c8ab760614f808cb5fb3f32b36e629b3530279184106cbf8d4aa84199956f6f30b16194962723201db1ef2f76f1e800d671a57800bfc91268cb849f6c0ff8b3ba1020223915a3955e635350e5a476bce2cb0ac14c23e070fedb38c39d87552fa6db35e581f5aca8472bc40be5221701718acb432f75ee686e65a5164c885b5570fd8c7c8c9d09cf1bb8a3a84d20a6b5cf9b3923a69325e7a185ab2c4a902908f40fd85e64222204174ca6e1770897b1a12022e063d17817a15c0127709cbf99d8a42003978369661262599abd5ebb0340d71f65b5f72ade78c8642003a84f66a11cbb86747ebc9480eec63a9c4ed7ac64c858cd5e449b6b0d6bf3d9b4995668180c2008d671dfa4358e51dcf0b2d7791764810b94a06e740be60a6ccc7f0209093385b7856e003f95263bf2293feff91f5280c22ad3fb2fd1585bbdbc6fd4c828996ffabc6f7769e7a0af0a7007f0af00702fcaf1218db01fd14194f91f17d23e3bb79d8b62b3fb9d83fd5c59e2cff77b2fc97f7ee55692d139cb94e893faad71ef56a22baa8b47b1bd9e7cd65bdd286859fdd54c3fbeba445c7faf338fc47b70adf01de57327e554894397a74618b52f335b1ab80733235dc8839bbc453930e4d9ffd3434afb90855e039e56f6910e1ca4d881f99e0c6d8002767aed4e8716c0967be9428a328d820a5cfe8792227889c64685e49f252b17ae8c019428c02d337e190c2498e4867c464dc942e94aa5eeb1bef87b6d57afc62e884aee6aac97ea4cc682561071bae05d789795cec6afe88e68f0492556a9d02f84f8b13d72083299328f18075065a4b97cea972149a7bbf4717880fc5c960ecad2e83acadfe0f8215e23366358cf08bb13343c7b32f3d9c02a739f32253bfda2273d228de64722a638f294a87918044e523d1b448104ef4b45815b3502ed788ef57909752c732a206e78c7f80a0621132d2c3f053ab63ed5c58cac28a1e67dccdcd1d6bc876da66d2c047842de6485ed7f3023b6aca4f98f7e204a86c353b9518de90cb91cfed2d9f0fcd40b9199f632352446915e60bc1e05c64b40cfb1a7825dc703d54ba543ada722062958ec8018fd809822615ebd16b759910f8b797a7c410f721cb396b94064cf89879d5320f40d6f1e0a4c9b239322c76f451c4f1ab9f318e462187692912b279425a402b5d7ad6009a846095104bfa40ca4bcd4b6173bec705accd526dc774347d281db4bdcee68eda0b3437d65167020896b27d35bc36d9d7a6b9ffb7776d7bfb937bfdaddcebc99c7f7a737e65d53148a6d27939ba945cdc3fd55e4733585f709f0f4da3d3deffd7eeba38e68b9b99652ed01c0457b5024174bc00bad377e0d967d002a543c8914ffa43f35f3e037c878a7e59c41730300c244931eceaad419d8cd24460e5e9847d582d6028e3d7b3c925a880f1e564a20495d7cd789933e51a0606ffb715b48b172f2ea2203eb653c21857418aa5797a43cd66d5c960b1a56643ca029a36e085859d58cd948f3539ac9728e20b7e2532ab846c525b13ebc0ddb811ad84a9566d5162a5ffcca60547693af732aab768ab243cb530924732a52f146a2e0b6f4d64d49fa4c224cfc924832d53dce39ec337c10e2a3c7255cfb59a56b81a0e1c921f7343b406b252943134a8ff6d81ba7088c01c9a54cf29621db27f84f6bedb41a9fb229731caca854fcca4d684df02b1a02b3590f7bc7d40182f97033c5555a585a6ee963399a37292064ee0164ec81ab9d244033b82c7355151a1fd1251beca0beb02d5b774815709be071db924e1bf02670ea3742aabb046af7590577d566ec98fe84da2df2545e8a6f0acf40275b75bc4b2c5869456c81c202fb164a3d221a1c9980672a842ce8c7016f1a529e1d0d69414ee4a8812c4a5cd78cc6600dc02dfb08d2187a1421125b6e33ea3f27942ee4fdb18296e1f3a434fa9ee140041ddc1d2f347805159b016b0c7e890c78ed2a67455d3be8e95c6f1c5c52e9ba17705623874aea892b78658ad3acd4587ea2b12b1b025ef94a7429b4cba02514b7711ba1dfbe0aa94481530c99a683b23f5c41211fc97a265a24b95b429a92194d048832e3b43c5e19a8c8a8ac56af25145399c7a17ade404a330eebac7f75525b2acc765f4963afe2ac3523713136ecca628e7dbec2a20c1231a130b4991ed8f6555e7649cae7a01c86cc08a3b13a8c5ad2f69b5020285571a665ce636991b3c113ef2727a7c115314b0c1cc0169c9a95849d14384b124ee0c1b5b829b55593046427c4fbfca30dcf0e57b73044fd490045cf0e3373d4a7525b4223fa6cbee33206b6101920948e2da5ba898a658ef2b4d96d73aeb8cb46ceb2ab831bddaa94af074c2a7d645c0d9866a71af07df089dcb12e9c1c2bdd159d3e1552f14b0f30a19dda144a62b54b30c35e7a6794b5fd9749b968d0214656a509a2fcf6d7af4a1349517460fd8e00d3e81b0cc960dedca6639b61c5bad7c0e9af01ca85e0e7e1a50f69245a0e33fb5f46d09df4456073daa4e19eae9c8c6fddbf92f6a7e37cfd72fe9503766d77add65a67e5cc66039b3b6be9edb1f97f2b23ebf6a909ff2d4539efab3e6a9ed33f529517d71cff70fa7ea6befcdd1b9e65c106175a25e713d411538917dd66b1f226a4be7ab28a8a0f6d9e2ee1535f51d80545fce7beb62fd7d264586940685c0d64054cfcecf4e36753261a1d637a0a6effd51b8d610bf8cdfd8436c324f3972d14c200950131bdf961f1cb68e3a687160a4c45327414d47f57c49a6afeea1a9eae6b197a1b8dd6c7da85b7a47de3091ce519e27c1a767ac31e17477b06a2328eda2ee96b1dfc0a2f3397aff34a7ade074f40687a09a45f2239ec8cbd6bd31b50925e1f1f31c3c57492a71a4a346daa5b30339fdde8911b8c8e682bb44f128213a6274617a57153df2d5f579bc27086b558f0727e44187dfe24157528e064887355b2cdf59b0c6197d19125df3ea7d065b3e039174d218ee6b832752f3395df2c5d34348b67e69373448b2d4d67eebe5fd16acaff95267b5a056853ca0d3e3121f78b15397fa00298f4b5d2ffa1da99f61f50bde60548b47cbc5a38dc5b55d36ccf3e8f78ee34454629f3efd0f5f238764', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136897, 6795, 20.0, 20.0, 'g', NULL, NULL, 'Adult', X'789c73cb2f52282ccd4cce564829ca2c50284e2d5128cf2cc950303250484f2fd1cfcd0100c6630b68', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136898, 6795, 3.5, 3.5, 'mg', 'IN', NULL, 'Adult', X'789c7329ca2c50c8cc5328c94855284ecc4d55c82bcd4d4a2d52c84f534829ca2f285628007272810a348cf54c1572d3f5416c5b052343031027a308c83606b1b2411c4d0000191888', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136899, 6795, 1.5, 2.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d433d53552c84dd7cf4e57f00c030018df03a8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136900, 6795, 4.0, 5.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c33d13555c84dd7cf4e57f0f4050013e20342', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136901, 6795, 3.0, 6.0, 'mg/kg', 'IN', NULL, 'Pediatric', X'789c33d63553c84dd7cf4e57f0f4030013e10343', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136902, 4736, 3.3, 3.3, 'g', 'IN', NULL, 'Adult', X'789c33d6334e57d0305428292ed05448c92c2ececf294b4d51c8cc53b0c8af52c8c92c2ccd4c5130d4355628c9cc4d2d5628482d524849ac0400ceb1119a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136903, 4736, 1.65, 1.65, 'g', 'IN', NULL, 'Pediatric', X'789c33d33534aab45230d4333355485748c92c2ececf294b4d51c8cc53b0c8af52c8c92c2ccd4c5130d4355628c9cc4d2d5628482d524849ac0400c9c71170', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136904, 13982, 125.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333432d5353530c84d5708f0572834cb50d030cc50484a4dcb2f4a55c82f5230ca50484c2b492d52c84d4dcc29d6040029c40dd9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136905, 13982, 250.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333235d0353530c84d5708f0572834cb50d030cc50484a4dcb2f4a55c82f5230ca50484c2b492d52c84d4dcc29d60400299d0dd8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136906, 13982, 12.5, 25.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cb3313150c84eb7523034d233d53532cd4dd7cf4ed74f49ac5408f05748c92ccb4c494d512834cb0000d0310b70', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136907, 13982, 125.0, 500.0, 'mg', 'PO', NULL, 'Pediatric', X'789cb33331c84eb752303432d5353530c84d5708f0572834cb000043de05eb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136908, 13982, 50.0, 100.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cb33131c84eb7523035d0353430c84dd7cf4ed74f49ac5408f05748c92ccb4c494d512834cb0000c2c30b19', X'789ced596b6f1b3716fd2b8480020e6acb92376eb642b180ecda499038112cb748b10a048a7335c38a434ef9503c2dfcdff790b26ccb522d7b92a08bee7e30e09921cf7df0dc17f5472bb3211f6b5e52abc75a3f4aa1cc25175229a95bbbac15ac8aef0bef2bd7dbdfff246754b68dcde37f727f6db9139657948db98fbb0e3a07dfed75ba7bddce45e745efb0db3b3c681f3e3f7cf1fd615a4bc24ba31d56fed17a499a2c57e97f4f9769fb455d518f0d48cb8500ee68cf9293ce73ed47babaf930d23f1ac77362a7c696aec70e0e3bbb879dce481f9bb2349a5d589e117b071b5d2f490e93bbc2aff0caf389a2f8f4ef8f7802e62c3ddc2a732b6dbb5b6e556e5d7d8ce8fd2c283f869252e72b266ed0a6359c493d967a7afd6e770c7baba256461821eeb9a87b70b8074bcb9c0ddeb3dfbe2bd84eb760139a1a4bcc587650303ef56459495cb967ad5543a366ef9d2753d6a4a4976e051a4efc0ce8077c9ae47e5d23efbbf4afb2f24bca7d3c6993e80165927b2bc517a2ddf86005e187e71d36cb7bac8b88de3b382cf3fd59be9ff13a9a93c9b9cc288b668df4bf9e7716eb56cf701b15d7c5451438ad1b41b608bbefdc2f4cceafe08a0709fb97fae2eb6af244520f2b12120730305550fcd65d4b85069672cdb5a899956e36d23d76c476b46114b5d102a1354d5f9e8df45b2e7c42e831c7a7e46b16f44c9b4f2826e7a4b9628bb019e994bb7b0c283cfb35385f522c3e37e1b5f6e51555c015ebfb3dcb682a3565f776dfbc6f5a9a56ad7e44d58e15bf5a6e1a0bee29375642c6a25a1d1bed2d973a9362838ffb4a91cd6be60d138a3bb71f1b8891163cc4b54c6ac69d2f4abef2ca91fc3d20b565d2199b915df96893bf65597169a30f1b10a39fcdc93a1a9f1317eb2a6f4c7764a509abebb84e61ce2fa51b69473694cc4931d3e4dc9e820fa1e9021e5f430580658a40a7b197c9e974a40b2a8daae3f9734da5841714859989dd03fee7b9e53a208fd41eec80104dc1dbe5575f58534ed2c7eb37e44c55f03c86decd030a020b4a90dd904217fdce8a4d9a07477c7f6e4aa0443e8279d61614d12b99e3ac404306d7c38860a138b751726583953e40ec94e6f1bc2c7708658aa4861a52c545ce9b120c49da4d14173356e0082335741e0831767ae118299a8361d99393f0dfe280eed3eeef7442ffedb63cb5632ab82db930cae4f58a51afb89a825e530c239df68b6297c9297b797ace7e60dd0ef30569d66dff13ea9e11e08d92aeec31a6240c81a530922b558ff4c9a5b0b428383056532c9b2f3adfb09dcaca126e50b1028982eb9cb267bb6c221501ff9b081bdf023556afbe5840485dc889f48e09528a7d82085606015a561ea58eb91a648da352935caa3da00d0e673c24ede0f039fe687b4a7d43ab7e1bc6287422aa0469fbee1a8cd84e70213a0565f8f5484b8d46b74c15119fe691111338e3eed69ba90f3bcec18ee523db41af1c2b284d53a0035bc018d06a813efc162ad4982c73ac07f13e495fdcf118bfb11494fa296694a586e8c3d94f17af99d1d0041d042a588d46a804c64d4e01fe872e32846119f7e0e78703e48f8512286af0993538c6e09382088bec8e6e58fd8f0756df2ebc6359d4e9a535a1627d8638a28a21dbd85aa7ec138786db8e95658162813e69b3292700c598f9f0bc89c46b49c8838875c91fce11684a9286f1f45f5a5eb2815938346e7b6ff344e3448d88da5e9ab3cb8e76d9f12e7bd94a797fc9b93aad6c41c41dd83f411a2c15a406183f4b2b330eb725633700bc7e9c12885de42b1097e59b50b6a971120321cd1840589edb069cf3a7e2c8503680391b0efb0dac383bdfb86d9bb4e3fe5ec39dc3389cb5d94985c4674b996df4d936ad8fdbec574207d1cc556fdb0ce44b8d414ee8031e0191c2e31de53c8687bb0ff8aecd7200a2741ada48e96d1a0100adb44cc961b347b61ebfb1fc12a992334c01b1883764e3ab764c4c2a90febd9125c861a8c9b2c1ce378a264e4613dca6707ca4e0fd5b1876323c7afb6d13a835a43783e3464029b42748e31877aa5dd62fab63a629ff5250956972c468d52d78dccccdcbcd0c4d9020d47cbd49850fdd6d305c21041b1ff6b09079e3cd036b3c21d796d272f46d8dc26489310f2a470bd4106271cf0167baaadd2ce6f19008da0ce03876150b4eb1a9a580febf49e4de85c962238d9afa9930cdece92344402b8ed6a00931fa028dbeff3c15068e4276ad04c7c89b5a0cde00e828d85961148a24f881d69a0bd90466e8090d2366e2e25aa9922b7f3da43580fb05878bd69333baee5ae245a36882748ad15d4897d8eb83e2366e6f944b8e6c100f04c1d6fd6f2997e673c268804199824d0865807b05fad326b59753998e26c49100f367bd291ab7daf3b39c5869626ad2722ac5c6585c0339934eac0564a17859674925de2ca4ce6a4cb9c8d3e5ed4cd2a4ab38976246de3bf9276a6cf549d46311d76819199f6f6e1cd760fa9ac7aabbdef1c5c15e9bb2168fea1ed7189b3431c8fee8f82dcf1b17219aa30c25da91c26b1dfbd966e178ac4cbcedc9a27be2d55bfc4574d3496df5f45da09d745dbe447bd604ee34b83b07a749a454661f777c6b0ea3ca9b3435fae5c0b539e2317f7c5cbf6af9ff8dc9ffc68dc9537fe6221af795332bdcb8bd96736ce78c4bfdc45f85b7213dfc9bd19d3de3eb3d571fafaeaefe03bc765e22', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136909, 13982, 250.0, 500.0, 'mg', 'PO', NULL, 'Pediatric', X'789cb33331c84eb752303235d0353530c84d5708f0572834cb000043d505ea', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136910, 21016, 0.02, 0.06, 'mg', 'IV', NULL, 'Adult', X'789cf3c94f4cc9cc4b5748c92f4eb55230d03330d20512660ab9e90a9e613a0a69f93939f9e5a9290a49950a997969a5c599f9790097741076', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136911, 21016, 2.0, 20.0, 'mcg', 'IV', NULL, 'Adult', X'789c33d2353250c84d4ed7cfcdcc53f00c53c8cc4b2b2dcecccf0300568307d6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136912, 21016, 0.02, 0.06, 'mg', 'IV', NULL, 'Adult', X'789c73cc29492dca4b2cc92c4bcda9d45148cacf292d5630d03330d20512660ab9e90a9e613a0a2519a979205143a0a81144502120c80f00587911b4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136913, 21016, 0.1, 0.1, 'mcg/kg', NULL, NULL, 'Pediatric', X'789c4dcac10d80200c05d055fe002a3a0237d72050b0114a0225c6edd59ba7777976b768e46b2924a18385955d7e8da37315d48875d9507c3267328565c2c57a40599b530a684e1261f4e172bebf3bfff7033f9020d9', X'789cc556516fdb3610fe2b073f6d801dcb6e9d151ef6e024dd12ac4d0dcf2b3054814093679933751448aaae50f8bfef28358e9d78306a0cd80b219eee8ef77d3c7da7af1de5aa3c235160670c9d3b6f4b67033a246b3a5de854ce44fb2a84d28ffbfd8d5e6371615d1e9f74ff85bb974e94a8321162d430195ef692416f90cc939fc6a3d178f4ea22793378935c36be2883b6e4d9f36be7372474c234cf01bf34e1f3bac4315c611020724bda879f539a50d0c2b9551d5685963ea51beb458ef0ab75851fc3dd47b00eeede83a6bfdbfc295ddba2b004732714c23d238d7eb17224613461977715ef5a04d562bfb02d9b8258188cbb4f0fbce38875b3792af4594da7797b1eb07d88e74c546542c67834e50744bcb342b10d94f54c4872910c7bbc5c429133de2e2cad3176830a1635c35e56be41fd69f0c0cb9097616f984021f37ea12912f4e433d7c18980102cdcce409082ab29536cf8464904fd194ddd858535957f796a582145eb80adc3d608d3d9fdf771d8e09ea2d222382d8f61bfb7b04163405a0a8e81324c1f2aa5d1336e07a2e4062c9d8e285413cdf5df4ec0a1e45b47529ee16a66dbec60835d72dd83869175434a17363aac20b46c287082b8a32a5f0963eae8dbdbf766565f3d9c01f38f1225d7914d6d5919f1d4fa8f48a70e7312246b98f1db08640cd729bd133234dee0b45f47e39fb426bbe13a66b181a1250d7a5091c225f7b34ae9164b8e9147de9ddbe3cfab3bdde43751585a679f69ca76193a7ce05e731fe03b9d76e79f45ff4cf28de5d6713f7cfb8aee48697984de192e1d875a57a7c4ab6731f091c2472bf8ba28832d226f292d582c6a291c77e6be534a689839ee5526deb3a548e98a710a25389e94b3aca36732fc58d4690ae68f9e0744ee957c3ac5d59ef34196e7f84ea77abb8bc8da88837cc7d839555a1391ed22da7bbd8e0220f4bfdcee8495c1e57554326984f7fd38d6cef84827ea333a8fd90c857c79ca8d134d7fb0964887c2233fc08721282c583c53fad80b42aee0878adf4449f6a1d16c28adf79a0ffdf11c755c095708698dcdeb83626e8559f68c5ef24818f28885569a5eb3e0bfe791c9aaad7d3106c32aeeba70fdd7f4f52849e9ed172e3c9e3d86cab11e006b67219c36750c932bc163b6880a3991ad573b7e958bf33967e4df26f111209ddf395f88e36cbfca0fe431c4842d9ff00b0c7aa3b6d69bcab51ffee1db21ac5ce79094ed2992fee3a3bf57d911b389f1f6b0235ffe14fc5fff16dbed3fc8b35ac9', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136914, 51, 1.0, 2.0, 'g', 'IM', NULL, 'Adult', X'789c33d4354a57f0f4d5f70c53283432c900001cf603db', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136915, 51, 1.0, 1.0, 'g', 'IM', NULL, 'Adult', X'789c73cb2c2a2e5170755170c92f4eb552304c57f0f4d5f70c53a850300400749c07bc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136916, 51, 4.0, 4.0, 'g', NULL, NULL, 'Adult', X'789cf34dacb0523049d73732c9000013690319', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136917, 51, 4.0, 4.0, 'g', 'IV', NULL, 'Adult', X'789c334957f00c5348c92ccb4c494d51283434d23532c950a85030d73532544849ac2c0600a3d30993', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136918, 51, 2.0, 2.0, 'g', 'IM', NULL, 'Adult', X'789c73cb2c2a2e5170755170c92f4eb552304a57f0f4d5f70c53a85030040074a807bd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136919, 51, 250.0, 250.0, 'mg', 'IM', NULL, 'Adult', X'789c0bcd4bcecf2dc8c94c4e2c494dd151c8cccb2cc94cccb152303235c84d57f0f455a850300400f2690be3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136920, 51, 500.0, 1000.0, 'mg', 'IM', NULL, 'Adult', X'789c0bcd4bcecf2dc8c94c4e2c494dd151284a4d2e2d2a4acd2b51c84f5328482d2ace2c2e01f2ac144c0d0c740d0d0c0c72d3153c7d152a140c0160f11325', X'789ced5b6f6fdb3613ff2a445ea5989dd86ed316de30c071d3365bd21a711674785c08b444cb6c245225a534dad0effefc48498e252b91a3ee0f8af94d6349bce3f1777f787764ffdcf354e23b82866c6f48f6c66c112b4e6fa5607b1db297a8c0bc5dc671a48787875ff8350b0fa4f2cd2f7e5819ac5d4523e63934363483dee079b7d7eff67b97bd17c3a3deb07774d0efbd7cfab26fc73237e652688cfc73ef0d134cd1c0fe8ed9ad25bf4c2336244f95477cfbd58c9e89318b9634903a928ae3f195d4d467e4b554a11e122e3e812b9d078c68192486a24322f9c5638a2ca4cabf5b3e39e134564cf8f1b29e7848fafee1512f3ceb9041f6e3c75a764332c047bf438e7af64fdf3704f8dbb3fff4fc99b89049cc34910b32f2422eb88eb3150dc9e955879c9e6365320ca520978a7a8cbc833620d38574b15e2e2c60c97c1db3af7865a5354ffffb88a7808b6bfb70876109ad6dd4b93efceb4733c7c84b82d8015c5cf825fdd4c854e8d1199446f6bb031f4b3c3cbd229f07cf9633f19a2b1d939357046c990139ff7a4bfa33714e6f87e4997f88917be5351a718ea91b33985ce09c33019178cc7569b2676076453c7ec33de691cffd41178cc0f94577d0271e4df5c6f483b5e96b667c238574a5eb56ccf337e1ca300ab84b63e675600b908406b9258061b69851a025818dd1d85a8cbb0c68987a9c12c57caa3ccc636d02a611e39506d490afc25a31375130d3d88c8c98d2301e3c0d8db5c1b97aebf3bde25a33d897a15c033683fd9ca6447fe1b1bb24b1242e5bf05b1e3232794fe802a092c1b3eeb3974bc217c4852d61fa80f03052f2868598cf58a8f89408a8fbc6a09eb3cfe69d28192dd380de724df635bb4d404bb5a65810b9e12009f5939958c7a606e9c9e9ab12c465287fd38c40f825f1e46deaa64644467e38ec9290c54a0aeed13f64c06ad84eb948b491b8e34cd90d53acc638af4a96d2ef594ba9e175223ce942711b6657b6e1a7bdeef31e811ec89c41ef8c0045977989aa930fd801202bdf49c43deea561f6345e52e12ac9bd075079c36f3661a9032151bed1a8b3a6a98d055cadf1ec1d1c75074b08ce6454c30fd17909c99cd706d112a3e710eff03ac3340374f0e5fa41b77e2094651ef8d747956ae0da85955d58d98595ff5658f9077c7e233fda39fdcee9774eff6fe6123b0ffcbb3cb01aec762eb873c13a17fcabeca26a6f3bc3f8ce0de39b1458b5869d06ff050dfe25a06fec233bd41b02eadf02d04678fd8e11fa66d9ab60fc93c27feb5cdb1f1c64d6c490d1c68abb8f6dfaeffff4c2798568ecbc0fbc2725aaa342ce8d6e5d563697bfdfd32f2b66c927e93a7de75c8a78599eeaa741cf9eb73c7aca99f87945da7d71d4445d19d220f3cfb9ac90da9ea754e13189ff3abb4acf6163f2caf02dce4d466e1233e7bd0d13ceb951b1b33fc884b2580e9cdf1955fa21bddd79c726b8f8f8d46ec5b630baab71b85814276e90cf1ca77958c396e73a9586efcbf5756fd597c91bc16b445b2035112c09916852c44f1986094ac1b43b723f275c310faa7c9aa376af0e0f2142bd1ecdf4bd4d097389069672264ec5420e49b9bc4355f765c90489a4d6dc1c519a92cf94952c66f891a84d50dbb4bffe21c43776f8ff08e4d388b906f0898c9280deadbf58d144315f60cb4ec905be0ac4a221399e8933682a3f2cc6fe35c70490932ed84c5c3081d23c8bd33361434bf172417980846a48dec9a29d41a8f729d1b129ff3bc4e01dc3573553494802ec2d01207acb4289d810a4dab4047ce3ecc661f39642f1a54384243a898045d64b98c090622998116645fdc2e619d0c3d20cc837959918ab71407eeaf772f659702dcf5bc4177cdb6eaa8708deb208e0b955948ad75478885706318f6b468df986885499657448226c57c70d800260cf5103a30a706b0b3466a4d8e744c17a73f456b8937912136dcc6081b93d2b12048e89c716c8bbbcb607fd55cb693eeb7f652e7d6483b5c385b3e2909ffb8fe1718a72e199c6d586a58e8280293fb53e1150ad0fcd1d12d32bc262032d2bf734c858c189ba8ad1acdd048f7b02c8c01790681883c11519a80c3c28268d989af320e02a990393905338e81541fae67220ee6228e432c0a16cf01217ca3c5d105ab92a42dc92045c5b9d9880d2312c3437b738128bff1845484c6df78c0b1d33da5a0d0faffa9117309c0dfae24606f240cd9c0bfba1aa99dad41d3e23938a06052d32e199385652b89896ea7026a6316c5ae8ee2f722934809ca6c2533244b8b994b7b05a53633015c263de315417d60567e244a5f192859484702f8e2cc0104cad8f68ee5e0b7811549e07fad850bc63498c741c9b0f147cc692ebe2b70906419a3967a6fecb2504984b378d5763d24842fdb1fd5058c9c8575424811d67859a26b0a5b51c640c6ce1a49eb1238f2fe0833c60a6151a64221d1bb3a32a3df46910cc03ea1923d141e2f918f50b4d8c373063b928ab188d33a229e37f20d2da15459007bc969cdaf9cf1281b8c43dc1d295fda2a67079c411d119d9174c9aee2e76b6cd4424bb105452da99b46ddc624140164c546e07d08189272870785001cd0a730970340d790e3fa2a7524b56c2fe111b5aad25355bf8fa6070bfe3729fd535b3ac503a2bca12fffb6db779064bebac689d35daf21c1533dd827395a2c4afd65cb788227764ce1d59897361cbcdcc56234bf4eb1ed0cca334baacf5dc77b6d07231b2445ff1b86636558212b7c225b6d83d8b915948de05d8ef22c056f7c55d84dd45d85d84fd2e22ecbfe4aa6d8a80d66b9c2c298cdf9581f4d3d24adfd260d10df8c234ff0e5e765f1ebc587648ff6849f66d317dd4ed1fa19e3a67100dc0eb7048c6bf4f9e1df500c22dcca2681df0902a8e221695a96066bcbba402c3edadf4fc22fb3ceb0ab9dca3c18f0077c9e71c259acb82807c41cc263a45a5c6724b78646b792462b093d8789c29e209cfee1eb0e602e6575606643a133ad1a8f062d39939d43933c4fb44279032051ca733d488584b682b737cbac1eab3dec91aa9324b89a98841713113ab47b22f952dccd9c2da177817d7282cf7e90f102145b1e9633cc29e3d41b94389ae566a6e8060e84a42d31ffdedf294480149f685b1db143567081e2b5306ff0ffd9910927834864d7e18cc04cd84405909cc94ecd84e821130d1cc5b930da39f3e30fa6ee0daca8c4c6f944c223222886b2c222843559af50489fd9f0eb9649a7889ed849d1c9005656064bce7c3b33633e63315bdbf877746f89795d068ff8da22199c80c5043f65ef9d690b35d0e5c0f8ae574c871878c3be4cd9ecdd20a9b4bedc82c34add8dec369d59c642d785c71ec128834d962db0b41a10b2161b8c4afe3f2a1dfc0e6c47882bdf8041685e26a185d3c960f76c036f29c4fa7a316689c5fd49235493d1e755b524e632453074552830dbf0eb4d3a6e90fc82786c85f8f5593086707a63b66772ed3ddda466bd641de319f1a07d15586ef0e880f86d87924ab35eaa6f58041581c19d423d2a847a9e82d822545d21e9b3df01e736ce2f3f6c084a62061e28f56ee892886ed96b7a0fc356073cdcd12741bb7ce273ebc63434ea6c7673fb471c90d4ebf4ec6ad1859dfce12001d75c8288cc64430bfcdf2ea5845b24dc441856b1abaed602e8809321f9761d71775223446ab290de082ad953d5d72bf35f104353843b00db9a273dece4d0a1e3749e023096ac9c29cab091760eae8a09dcfe3c11a683b06639357643645168a99a2a98de7aeb3f1b869a5276d005967d36e3d23b808cc8a22396863182317597cfcb0084dce35d12cf172212853894d32680b46c789ba5ecac03307cae6e485babc8e4dd3ce328d195246734727172aa4419cd7702da4fadd5caf46e646589eb6982e945bc7a909ecd728175daeadf5c6494095216f154b8e55e23ee0048df467cce7f221376ad43945b9813adf7030ad44696abd367b2f65a1554d628a029499691b6fbce273c5a5894cc21c89d6bae20626e75cbb1bfe985dc6b712d17a8f6ace4a53574688d3e15d5552975534f2b9e0ee358b63cdbf4590bc124f42426fb6ccb247829a6d7733e533d5bd9061ead6a68f4d3aca6e8a48847fe4fc8afaf7ec428d86a7d80df6216b772cc06b6112da7a7f6c4ca9efebdb3d16e97546fbf620bee0f6a44d9848f49ade8469622294a97635d28445b1b475635c545cf76e341f379b2dbb9ec97fa367f2c81edc9431c7fc3fa6bdf259d50a7ab27f4eb9a83b2ed9f2a8a28e53d389c58ac6c969be7efcfaf5ebff010ccbbf95', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136921, 51, 1.0, 1.0, 'g', 'IM', NULL, 'Adult', X'789c73c92c2e4ecdcdcc4b2c494db152304c57f0f4d5f70c53283432c90000849508b0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136922, 51, 1.0, 1.0, 'g', 'IM', NULL, 'Adult', X'789c73cecfcb2acd4b2ec92ccb2cc92cb652304c57f0f455a8503004007a6c086e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136923, 51, 250.0, 250.0, 'mg', 'IM', NULL, 'Adult', X'789c333235c84d57f0f455a8503004001408030b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136924, 51, 250.0, 250.0, 'mg', 'IM', NULL, 'Adult', X'789c333235c84d57f0f455a8503004001408030b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136925, 51, 1.0, 2.0, 'g', 'IV', NULL, 'Adult', X'789c33d4354a57f00c53283434d23532c950a85030d73534504849ac2c06005a8906f4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136926, 51, 1.0, 1.0, 'g', 'IM', NULL, 'Adult', X'789c334c57f0f4d5f70c53a85030040014040306', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136927, 51, 250.0, 250.0, 'mg', 'IM', NULL, 'Adult', X'789c333235c84d57f0f455a8503004001408030b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136928, 51, 1.0, 1.0, 'g', 'IV', NULL, 'Adult', X'789c334c57f00c53a8503004000b970241', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136929, 51, 60.0, 60.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c3333c84dd7cf4e57f00c53283432c950a850302acf060042780626', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136930, 51, 4.0, 4.0, 'g', NULL, NULL, 'Adult', X'789cf34dacb0523049d73732c9000013690319', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136931, 51, 50.0, 50.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3335c84dd7cf4e57f0f4d5f70c53283432c9000030de051e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136932, 51, 50.0, 50.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523035c84dd7cf4e57f0f4d5f70c53a8503004008cb308b5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136933, 51, 2000.0, 2000.0, 'g', NULL, NULL, 'Pediatric', X'789cb331323030480700047f0166', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136934, 51, 50.0, 50.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3335c84dd7cf4e57f0f4d5f70c53283432c9000030de051e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136935, 51, 50.0, 50.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523035c84dd7cf4e57f0f4d5f70c53a8503004008cb308b5', X'789ced5b6f6fdb3613ff2a445ea5989dd86ed316de30c071d3365bd21a711674785c08b444cb6c245225a534dad0effefc48498e252b91a3ee0f8af94d6349bce3f1777f787764ffdcf354e23b82866c6f48f6c66c112b4e6fa5607b1db297a8c0bc5dc671a48787875ff8350b0fa4f2cd2f7e5819ac5d4523e63934363483dee079b7d7eff67b97bd17c3a3deb07774d0efbd7cfab26fc73237e652688cfc73ef0d134cd1c0fe8ed9ad25bf4c2336244f95477cfbd58c9e89318b9634903a928ae3f195d4d467e4b554a11e122e3e812b9d078c68192486a24322f9c5638a2ca4cabf5b3e39e134564cf8f1b29e7848fafee1512f3ceb9041f6e3c75a764332c047bf438e7af64fdf3704f8dbb3fff4fc99b89049cc34910b32f2422eb88eb3150dc9e955879c9e6365320ca520978a7a8cbc833620d38574b15e2e2c60c97c1db3af7865a5354ffffb88a7808b6bfb70876109ad6dd4b93efceb4733c7c84b82d8015c5cf825fdd4c854e8d1199446f6bb031f4b3c3cbd229f07cf9633f19a2b1d939357046c990139ff7a4bfa33714e6f87e4997f88917be5351a718ea91b33985ce09c33019178cc7569b2676076453c7ec33de691cffd41178cc0f94577d0271e4df5c6f483b5e96b667c238574a5eb56ccf337e1ca300ab84b63e675600b908406b9258061b69851a025818dd1d85a8cbb0c68987a9c12c57caa3ccc636d02a611e39506d490afc25a31375130d3d88c8c98d2301e3c0d8db5c1b97aebf3bde25a33d897a15c033683fd9ca6447fe1b1bb24b1242e5bf05b1e3232794fe802a092c1b3eeb3974bc217c4852d61fa80f03052f2868598cf58a8f89408a8fbc6a09eb3cfe69d28192dd380de724df635bb4d404bb5a65810b9e12009f5939958c7a606e9c9e9ab12c465287fd38c40f825f1e46deaa64644467e38ec9290c54a0aeed13f64c06ad84eb948b491b8e34cd90d53acc638af4a96d2ef594ba9e175223ce942711b6657b6e1a7bdeef31e811ec89c41ef8c0045977989aa930fd801202bdf49c43deea561f6345e52e12ac9bd075079c36f3661a9032151bed1a8b3a6a98d055cadf1ec1d1c75074b08ce6454c30fd17909c99cd706d112a3e710eff03ac3340374f0e5fa41b77e2094651ef8d747956ae0da85955d58d98595ff5658f9077c7e233fda39fdcee9774eff6fe6123b0ffcbb3cb01aec762eb873c13a17fcabeca26a6f3bc3f8ce0de39b1458b5869d06ff050dfe25a06fec233bd41b02eadf02d04678fd8e11fa66d9ab60fc93c27feb5cdb1f1c64d6c490d1c68abb8f6dfaeffff4c2798568ecbc0fbc2725aaa342ce8d6e5d563697bfdfd32f2b66c927e93a7de75c8a78599eeaa741cf9eb73c7aca99f87945da7d71d4445d19d220f3cfb9ac90da9ea754e13189ff3abb4acf6163f2caf02dce4d466e1233e7bd0d13ceb951b1b33fc884b2580e9cdf1955fa21bddd79c726b8f8f8d46ec5b630baab71b85814276e90cf1ca77958c396e73a9586efcbf5756fd597c91bc16b445b2035112c09916852c44f1986094ac1b43b723f275c310faa7c9aa376af0e0f2142bd1ecdf4bd4d097389069672264ec5420e49b9bc4355f765c90489a4d6dc1c519a92cf94952c66f891a84d50dbb4bffe21c43776f8ff08e4d388b906f0898c9280deadbf58d144315f60cb4ec905be0ac4a221399e8933682a3f2cc6fe35c70490932ed84c5c3081d23c8bd33361434bf172417980846a48dec9a29d41a8f729d1b129ff3bc4e01dc3573553494802ec2d01207acb4289d810a4dab4047ce3ecc661f39642f1a54384243a898045d64b98c090622998116645fdc2e619d0c3d20cc837959918ab71407eeaf772f659702dcf5bc4177cdb6eaa8708deb208e0b955948ad75478885706318f6b468df986885499657448226c57c70d800260cf5103a30a706b0b3466a4d8e744c17a73f456b8937912136dcc6081b93d2b12048e89c716c8bbbcb607fd55cb693eeb7f652e7d6483b5c385b3e2909ffb8fe1718a72e199c6d586a58e8280293fb53e1150ad0fcd1d12d32bc262032d2bf734c858c189ba8ad1acdd048f7b02c8c01790681883c11519a80c3c28268d989af320e02a990393905338e81541fae67220ee6228e432c0a16cf01217ca3c5d105ab92a42dc92045c5b9d9880d2312c3437b738128bff1845484c6df78c0b1d33da5a0d0faffa9117309c0dfae24606f240cd9c0bfba1aa99dad41d3e23938a06052d32e199385652b89896ea7026a6316c5ae8ee2f722934809ca6c2533244b8b994b7b05a53633015c263de315417d60567e244a5f192859484702f8e2cc0104cad8f68ee5e0b7811549e07fad850bc63498c741c9b0f147cc692ebe2b70906419a3967a6fecb2504984b378d5763d24842fdb1fd5058c9c8575424811d67859a26b0a5b51c640c6ce1a49eb1238f2fe0833c60a6151a64221d1bb3a32a3df46910cc03ea1923d141e2f918f50b4d8c373063b928ab188d33a229e37f20d2da15459007bc969cdaf9cf1281b8c43dc1d295fda2a67079c411d119d9174c9aee2e76b6cd4424bb105452da99b46ddc624140164c546e07d08189272870785001cd0a730970340d790e3fa2a7524b56c2fe111b5aad25355bf8fa6070bfe3729fd535b3ac503a2bca12fffb6db779064bebac689d35daf21c1533dd827395a2c4afd65cb788227764ce1d59897361cbcdcc56234bf4eb1ed0cca334baacf5dc77b6d07231b2445ff1b86636558212b7c225b6d83d8b915948de05d8ef22c056f7c55d84dd45d85d84fd2e22ecbfe4aa6d8a80d66b9c2c298cdf9581f4d3d24adfd260d10df8c234ff0e5e765f1ebc587648ff6849f66d317dd4ed1fa19e3a67100dc0eb7048c6bf4f9e1df500c22dcca2681df0902a8e221695a96066bcbba402c3edadf4fc22fb3ceb0ab9dca3c18f0077c9e71c259acb82807c41cc263a45a5c6724b78646b792462b093d8789c29e209cfee1eb0e602e6575606643a133ad1a8f062d39939d43933c4fb44279032051ca733d488584b682b737cbac1eab3dec91aa9324b89a98841713113ab47b22f952dccd9c2da177817d7282cf7e90f102145b1e9633cc29e3d41b94389ae566a6e8060e84a42d31ffdedf294480149f685b1db143567081e2b5306ff0ffd9910927834864d7e18cc04cd84405909cc94ecd84e821130d1cc5b930da39f3e30fa6ee0daca8c4c6f944c223222886b2c222843559af50489fd9f0eb9649a7889ed849d1c9005656064bce7c3b33633e63315bdbf877746f89795d068ff8da22199c80c5043f65ef9d690b35d0e5c0f8ae574c871878c3be4cd9ecdd20a9b4bedc82c34add8dec369d59c642d785c71ec128834d962db0b41a10b2161b8c4afe3f2a1dfc0e6c47882bdf8041685e26a185d3c960f76c036f29c4fa7a316689c5fd49235493d1e755b524e632453074552830dbf0eb4d3a6e90fc82786c85f8f5593086707a63b66772ed3ddda466bd641de319f1a07d15586ef0e880f86d87924ab35eaa6f58041581c19d423d2a847a9e82d822545d21e9b3df01e736ce2f3f6c084a62061e28f56ee892886ed96b7a0fc356073cdcd12741bb7ce273ebc63434ea6c7673fb471c90d4ebf4ec6ad1859dfce12001d75c8288cc64430bfcdf2ea5845b24dc441856b1abaed602e8809321f9761d71775223446ab290de082ad953d5d72bf35f104353843b00db9a273dece4d0a1e3749e023096ac9c29cab091760eae8a09dcfe3c11a683b06639357643645168a99a2a98de7aeb3f1b869a5276d005967d36e3d23b808cc8a22396863182317597cfcb0084dce35d12cf172212853894d32680b46c789ba5ecac03307cae6e485babc8e4dd3ce328d195246734727172aa4419cd7702da4fadd5caf46e646589eb6982e945bc7a909ecd728175daeadf5c6494095216f154b8e55e23ee0048df467cce7f221376ad43945b9813adf7030ad44696abd367b2f65a1554d628a029499691b6fbce273c5a5894cc21c89d6bae20626e75cbb1bfe985dc6b712d17a8f6ace4a53574688d3e15d5552975534f2b9e0ee358b63cdbf4590bc124f42426fb6ccb247829a6d7733e533d5bd9061ead6a68f4d3aca6e8a48847fe4fc8afaf7ec428d86a7d80df6216b772cc06b6112da7a7f6c4ca9efebdb3d16e97546fbf620bee0f6a44d9848f49ade8469622294a97635d28445b1b475635c545cf76e341f379b2dbb9ec97fa367f2c81edc9431c7fc3fa6bdf259d50a7ab27f4eb9a83b2ed9f2a8a28e53d389c58ac6c969be7efcfaf5ebff010ccbbf95', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136936, 51, 2000.0, 2000.0, 'g', NULL, NULL, 'Pediatric', X'789cb333323030480700048b0168', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136937, 51, 50.0, 75.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3335d03537cd4dd7cf4e57f0f4d5f70c53283432c900003cca05b7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136938, 51, 50.0, 75.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523035d03537cd4dd7cf4e57f0f4d5f70c53a850300400a42d094e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136939, 51, 50.0, 100.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3335d0353430c84dd7cf4e57f0f4d5f70c5348c92ccb4c494d51283434d23532c900009a590965', X'789ced5b6f6fdb3613ff2a445ea5989dd86ed316de30c071d3365bd21a711674785c08b444cb6c245225a534dad0effefc48498e252b91a3ee0f8af94d6349bce3f1777f787764ffdcf354e23b82866c6f48f6c66c112b4e6fa5607b1db297a8c0bc5dc671a48787875ff8350b0fa4f2cd2f7e5819ac5d4523e63934363483dee079b7d7eff67b97bd17c3a3deb07774d0efbd7cfab26fc73237e652688cfc73ef0d134cd1c0fe8ed9ad25bf4c2336244f95477cfbd58c9e89318b9634903a928ae3f195d4d467e4b554a11e122e3e812b9d078c68192486a24322f9c5638a2ca4cabf5b3e39e134564cf8f1b29e7848fafee1512f3ceb9041f6e3c75a764332c047bf438e7af64fdf3704f8dbb3fff4fc99b89049cc34910b32f2422eb88eb3150dc9e955879c9e6365320ca520978a7a8cbc833620d38574b15e2e2c60c97c1db3af7865a5354ffffb88a7808b6bfb70876109ad6dd4b93efceb4733c7c84b82d8015c5cf825fdd4c854e8d1199446f6bb031f4b3c3cbd229f07cf9633f19a2b1d939357046c990139ff7a4bfa33714e6f87e4997f88917be5351a718ea91b33985ce09c33019178cc7569b2676076453c7ec33de691cffd41178cc0f94577d0271e4df5c6f483b5e96b667c238574a5eb56ccf337e1ca300ab84b63e675600b908406b9258061b69851a025818dd1d85a8cbb0c68987a9c12c57caa3ccc636d02a611e39506d490afc25a31375130d3d88c8c98d2301e3c0d8db5c1b97aebf3bde25a33d897a15c033683fd9ca6447fe1b1bb24b1242e5bf05b1e3232794fe802a092c1b3eeb3974bc217c4852d61fa80f03052f2868598cf58a8f89408a8fbc6a09eb3cfe69d28192dd380de724df635bb4d404bb5a65810b9e12009f5939958c7a606e9c9e9ab12c465287fd38c40f825f1e46deaa64644467e38ec9290c54a0aeed13f64c06ad84eb948b491b8e34cd90d53acc638af4a96d2ef594ba9e175223ce942711b6657b6e1a7bdeef31e811ec89c41ef8c0045977989aa930fd801202bdf49c43deea561f6345e52e12ac9bd075079c36f3661a9032151bed1a8b3a6a98d055cadf1ec1d1c75074b08ce6454c30fd17909c99cd706d112a3e710eff03ac3340374f0e5fa41b77e2094651ef8d747956ae0da85955d58d98595ff5658f9077c7e233fda39fdcee9774eff6fe6123b0ffcbb3cb01aec762eb873c13a17fcabeca26a6f3bc3f8ce0de39b1458b5869d06ff050dfe25a06fec233bd41b02eadf02d04678fd8e11fa66d9ab60fc93c27feb5cdb1f1c64d6c490d1c68abb8f6dfaeffff4c2798568ecbc0fbc2725aaa342ce8d6e5d563697bfdfd32f2b66c927e93a7de75c8a78599eeaa741cf9eb73c7aca99f87945da7d71d4445d19d220f3cfb9ac90da9ea754e13189ff3abb4acf6163f2caf02dce4d466e1233e7bd0d13ceb951b1b33fc884b2580e9cdf1955fa21bddd79c726b8f8f8d46ec5b630baab71b85814276e90cf1ca77958c396e73a9586efcbf5756fd597c91bc16b445b2035112c09916852c44f1986094ac1b43b723f275c310faa7c9aa376af0e0f2142bd1ecdf4bd4d097389069672264ec5420e49b9bc4355f765c90489a4d6dc1c519a92cf94952c66f891a84d50dbb4bffe21c43776f8ff08e4d388b906f0898c9280deadbf58d144315f60cb4ec905be0ac4a221399e8933682a3f2cc6fe35c70490932ed84c5c3081d23c8bd33361434bf172417980846a48dec9a29d41a8f729d1b129ff3bc4e01dc3573553494802ec2d01207acb4289d810a4dab4047ce3ecc661f39642f1a54384243a898045d64b98c090622998116645fdc2e619d0c3d20cc837959918ab71407eeaf772f659702dcf5bc4177cdb6eaa8708deb208e0b955948ad75478885706318f6b468df986885499657448226c57c70d800260cf5103a30a706b0b3466a4d8e744c17a73f456b8937912136dcc6081b93d2b12048e89c716c8bbbcb607fd55cb693eeb7f652e7d6483b5c385b3e2909ffb8fe1718a72e199c6d586a58e8280293fb53e1150ad0fcd1d12d32bc262032d2bf734c858c189ba8ad1acdd048f7b02c8c01790681883c11519a80c3c28268d989af320e02a990393905338e81541fae67220ee6228e432c0a16cf01217ca3c5d105ab92a42dc92045c5b9d9880d2312c3437b738128bff1845484c6df78c0b1d33da5a0d0faffa9117309c0dfae24606f240cd9c0bfba1aa99dad41d3e23938a06052d32e199385652b89896ea7026a6316c5ae8ee2f722934809ca6c2533244b8b994b7b05a53633015c263de315417d60567e244a5f192859484702f8e2cc0104cad8f68ee5e0b7811549e07fad850bc63498c741c9b0f147cc692ebe2b70906419a3967a6fecb2504984b378d5763d24842fdb1fd5058c9c8575424811d67859a26b0a5b51c640c6ce1a49eb1238f2fe0833c60a6151a64221d1bb3a32a3df46910cc03ea1923d141e2f918f50b4d8c373063b928ab188d33a229e37f20d2da15459007bc969cdaf9cf1281b8c43dc1d295fda2a67079c411d119d9174c9aee2e76b6cd4424bb105452da99b46ddc624140164c546e07d08189272870785001cd0a730970340d790e3fa2a7524b56c2fe111b5aad25355bf8fa6070bfe3729fd535b3ac503a2bca12fffb6db779064bebac689d35daf21c1533dd827395a2c4afd65cb788227764ce1d59897361cbcdcc56234bf4eb1ed0cca334baacf5dc77b6d07231b2445ff1b86636558212b7c225b6d83d8b915948de05d8ef22c056f7c55d84dd45d85d84fd2e22ecbfe4aa6d8a80d66b9c2c298cdf9581f4d3d24adfd260d10df8c234ff0e5e765f1ebc587648ff6849f66d317dd4ed1fa19e3a67100dc0eb7048c6bf4f9e1df500c22dcca2681df0902a8e221695a96066bcbba402c3edadf4fc22fb3ceb0ab9dca3c18f0077c9e71c259acb82807c41cc263a45a5c6724b78646b792462b093d8789c29e209cfee1eb0e602e6575606643a133ad1a8f062d39939d43933c4fb44279032051ca733d488584b682b737cbac1eab3dec91aa9324b89a98841713113ab47b22f952dccd9c2da177817d7282cf7e90f102145b1e9633cc29e3d41b94389ae566a6e8060e84a42d31ffdedf294480149f685b1db143567081e2b5306ff0ffd9910927834864d7e18cc04cd84405909cc94ecd84e821130d1cc5b930da39f3e30fa6ee0daca8c4c6f944c223222886b2c222843559af50489fd9f0eb9649a7889ed849d1c9005656064bce7c3b33633e63315bdbf877746f89795d068ff8da22199c80c5043f65ef9d690b35d0e5c0f8ae574c871878c3be4cd9ecdd20a9b4bedc82c34add8dec369d59c642d785c71ec128834d962db0b41a10b2161b8c4afe3f2a1dfc0e6c47882bdf8041685e26a185d3c960f76c036f29c4fa7a316689c5fd49235493d1e755b524e632453074552830dbf0eb4d3a6e90fc82786c85f8f5593086707a63b66772ed3ddda466bd641de319f1a07d15586ef0e880f86d87924ab35eaa6f58041581c19d423d2a847a9e82d822545d21e9b3df01e736ce2f3f6c084a62061e28f56ee892886ed96b7a0fc356073cdcd12741bb7ce273ebc63434ea6c7673fb471c90d4ebf4ec6ad1859dfce12001d75c8288cc64430bfcdf2ea5845b24dc441856b1abaed602e8809321f9761d71775223446ab290de082ad953d5d72bf35f104353843b00db9a273dece4d0a1e3749e023096ac9c29cab091760eae8a09dcfe3c11a683b06639357643645168a99a2a98de7aeb3f1b869a5276d005967d36e3d23b808cc8a22396863182317597cfcb0084dce35d12cf172212853894d32680b46c789ba5ecac03307cae6e485babc8e4dd3ce328d195246734727172aa4419cd7702da4fadd5caf46e646589eb6982e945bc7a909ecd728175daeadf5c6494095216f154b8e55e23ee0048df467cce7f221376ad43945b9813adf7030ad44696abd367b2f65a1554d628a029499691b6fbce273c5a5894cc21c89d6bae20626e75cbb1bfe985dc6b712d17a8f6ace4a53574688d3e15d5552975534f2b9e0ee358b63cdbf4590bc124f42426fb6ccb247829a6d7733e533d5bd9061ead6a68f4d3aca6e8a48847fe4fc8afaf7ec428d86a7d80df6216b772cc06b6112da7a7f6c4ca9efebdb3d16e97546fbf620bee0f6a44d9848f49ade8469622294a97635d28445b1b475635c545cf76e341f379b2dbb9ec97fa367f2c81edc9431c7fc3fa6bdf259d50a7ab27f4eb9a83b2ed9f2a8a28e53d389c58ac6c969be7efcfaf5ebff010ccbbf95', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136940, 51, 50.0, 100.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523035d0353430c84dd7cf4e57f0f4d5f70c53a850300400ab780973', X'789ced5b6f6fdb3613ff2a445ea5989dd86ed316de30c071d3365bd21a711674785c08b444cb6c245225a534dad0effefc48498e252b91a3ee0f8af94d6349bce3f1777f787764ffdcf354e23b82866c6f48f6c66c112b4e6fa5607b1db297a8c0bc5dc671a48787875ff8350b0fa4f2cd2f7e5819ac5d4523e63934363483dee079b7d7eff67b97bd17c3a3deb07774d0efbd7cfab26fc73237e652688cfc73ef0d134cd1c0fe8ed9ad25bf4c2336244f95477cfbd58c9e89318b9634903a928ae3f195d4d467e4b554a11e122e3e812b9d078c68192486a24322f9c5638a2ca4cabf5b3e39e134564cf8f1b29e7848fafee1512f3ceb9041f6e3c75a764332c047bf438e7af64fdf3704f8dbb3fff4fc99b89049cc34910b32f2422eb88eb3150dc9e955879c9e6365320ca520978a7a8cbc833620d38574b15e2e2c60c97c1db3af7865a5354ffffb88a7808b6bfb70876109ad6dd4b93efceb4733c7c84b82d8015c5cf825fdd4c854e8d1199446f6bb031f4b3c3cbd229f07cf9633f19a2b1d939357046c990139ff7a4bfa33714e6f87e4997f88917be5351a718ea91b33985ce09c33019178cc7569b2676076453c7ec33de691cffd41178cc0f94577d0271e4df5c6f483b5e96b667c238574a5eb56ccf337e1ca300ab84b63e675600b908406b9258061b69851a025818dd1d85a8cbb0c68987a9c12c57caa3ccc636d02a611e39506d490afc25a31375130d3d88c8c98d2301e3c0d8db5c1b97aebf3bde25a33d897a15c033683fd9ca6447fe1b1bb24b1242e5bf05b1e3232794fe802a092c1b3eeb3974bc217c4852d61fa80f03052f2868598cf58a8f89408a8fbc6a09eb3cfe69d28192dd380de724df635bb4d404bb5a65810b9e12009f5939958c7a606e9c9e9ab12c465287fd38c40f825f1e46deaa64644467e38ec9290c54a0aeed13f64c06ad84eb948b491b8e34cd90d53acc638af4a96d2ef594ba9e175223ce942711b6657b6e1a7bdeef31e811ec89c41ef8c0045977989aa930fd801202bdf49c43deea561f6345e52e12ac9bd075079c36f3661a9032151bed1a8b3a6a98d055cadf1ec1d1c75074b08ce6454c30fd17909c99cd706d112a3e710eff03ac3340374f0e5fa41b77e2094651ef8d747956ae0da85955d58d98595ff5658f9077c7e233fda39fdcee9774eff6fe6123b0ffcbb3cb01aec762eb873c13a17fcabeca26a6f3bc3f8ce0de39b1458b5869d06ff050dfe25a06fec233bd41b02eadf02d04678fd8e11fa66d9ab60fc93c27feb5cdb1f1c64d6c490d1c68abb8f6dfaeffff4c2798568ecbc0fbc2725aaa342ce8d6e5d563697bfdfd32f2b66c927e93a7de75c8a78599eeaa741cf9eb73c7aca99f87945da7d71d4445d19d220f3cfb9ac90da9ea754e13189ff3abb4acf6163f2caf02dce4d466e1233e7bd0d13ceb951b1b33fc884b2580e9cdf1955fa21bddd79c726b8f8f8d46ec5b630baab71b85814276e90cf1ca77958c396e73a9586efcbf5756fd597c91bc16b445b2035112c09916852c44f1986094ac1b43b723f275c310faa7c9aa376af0e0f2142bd1ecdf4bd4d097389069672264ec5420e49b9bc4355f765c90489a4d6dc1c519a92cf94952c66f891a84d50dbb4bffe21c43776f8ff08e4d388b906f0898c9280deadbf58d144315f60cb4ec905be0ac4a221399e8933682a3f2cc6fe35c70490932ed84c5c3081d23c8bd33361434bf172417980846a48dec9a29d41a8f729d1b129ff3bc4e01dc3573553494802ec2d01207acb4289d810a4dab4047ce3ecc661f39642f1a54384243a898045d64b98c090622998116645fdc2e619d0c3d20cc837959918ab71407eeaf772f659702dcf5bc4177cdb6eaa8708deb208e0b955948ad75478885706318f6b468df986885499657448226c57c70d800260cf5103a30a706b0b3466a4d8e744c17a73f456b8937912136dcc6081b93d2b12048e89c716c8bbbcb607fd55cb693eeb7f652e7d6483b5c385b3e2909ffb8fe1718a72e199c6d586a58e8280293fb53e1150ad0fcd1d12d32bc262032d2bf734c858c189ba8ad1acdd048f7b02c8c01790681883c11519a80c3c28268d989af320e02a990393905338e81541fae67220ee6228e432c0a16cf01217ca3c5d105ab92a42dc92045c5b9d9880d2312c3437b738128bff1845484c6df78c0b1d33da5a0d0faffa9117309c0dfae24606f240cd9c0bfba1aa99dad41d3e23938a06052d32e199385652b89896ea7026a6316c5ae8ee2f722934809ca6c2533244b8b994b7b05a53633015c263de315417d60567e244a5f192859484702f8e2cc0104cad8f68ee5e0b7811549e07fad850bc63498c741c9b0f147cc692ebe2b70906419a3967a6fecb2504984b378d5763d24842fdb1fd5058c9c8575424811d67859a26b0a5b51c640c6ce1a49eb1238f2fe0833c60a6151a64221d1bb3a32a3df46910cc03ea1923d141e2f918f50b4d8c373063b928ab188d33a229e37f20d2da15459007bc969cdaf9cf1281b8c43dc1d295fda2a67079c411d119d9174c9aee2e76b6cd4424bb105452da99b46ddc624140164c546e07d08189272870785001cd0a730970340d790e3fa2a7524b56c2fe111b5aad25355bf8fa6070bfe3729fd535b3ac503a2bca12fffb6db779064bebac689d35daf21c1533dd827395a2c4afd65cb788227764ce1d59897361cbcdcc56234bf4eb1ed0cca334baacf5dc77b6d07231b2445ff1b86636558212b7c225b6d83d8b915948de05d8ef22c056f7c55d84dd45d85d84fd2e22ecbfe4aa6d8a80d66b9c2c298cdf9581f4d3d24adfd260d10df8c234ff0e5e765f1ebc587648ff6849f66d317dd4ed1fa19e3a67100dc0eb7048c6bf4f9e1df500c22dcca2681df0902a8e221695a96066bcbba402c3edadf4fc22fb3ceb0ab9dca3c18f0077c9e71c259acb82807c41cc263a45a5c6724b78646b792462b093d8789c29e209cfee1eb0e602e6575606643a133ad1a8f062d39939d43933c4fb44279032051ca733d488584b682b737cbac1eab3dec91aa9324b89a98841713113ab47b22f952dccd9c2da177817d7282cf7e90f102145b1e9633cc29e3d41b94389ae566a6e8060e84a42d31ffdedf294480149f685b1db143567081e2b5306ff0ffd9910927834864d7e18cc04cd84405909cc94ecd84e821130d1cc5b930da39f3e30fa6ee0daca8c4c6f944c223222886b2c222843559af50489fd9f0eb9649a7889ed849d1c9005656064bce7c3b33633e63315bdbf877746f89795d068ff8da22199c80c5043f65ef9d690b35d0e5c0f8ae574c871878c3be4cd9ecdd20a9b4bedc82c34add8dec369d59c642d785c71ec128834d962db0b41a10b2161b8c4afe3f2a1dfc0e6c47882bdf8041685e26a185d3c960f76c036f29c4fa7a316689c5fd49235493d1e755b524e632453074552830dbf0eb4d3a6e90fc82786c85f8f5593086707a63b66772ed3ddda466bd641de319f1a07d15586ef0e880f86d87924ab35eaa6f58041581c19d423d2a847a9e82d822545d21e9b3df01e736ce2f3f6c084a62061e28f56ee892886ed96b7a0fc356073cdcd12741bb7ce273ebc63434ea6c7673fb471c90d4ebf4ec6ad1859dfce12001d75c8288cc64430bfcdf2ea5845b24dc441856b1abaed602e8809321f9761d71775223446ab290de082ad953d5d72bf35f104353843b00db9a273dece4d0a1e3749e023096ac9c29cab091760eae8a09dcfe3c11a683b06639357643645168a99a2a98de7aeb3f1b869a5276d005967d36e3d23b808cc8a22396863182317597cfcb0084dce35d12cf172212853894d32680b46c789ba5ecac03307cae6e485babc8e4dd3ce328d195246734727172aa4419cd7702da4fadd5caf46e646589eb6982e945bc7a909ecd728175daeadf5c6494095216f154b8e55e23ee0048df467cce7f221376ad43945b9813adf7030ad44696abd367b2f65a1554d628a029499691b6fbce273c5a5894cc21c89d6bae20626e75cbb1bfe985dc6b712d17a8f6ace4a53574688d3e15d5552975534f2b9e0ee358b63cdbf4590bc124f42426fb6ccb247829a6d7733e533d5bd9061ead6a68f4d3aca6e8a48847fe4fc8afaf7ec428d86a7d80df6216b772cc06b6112da7a7f6c4ca9efebdb3d16e97546fbf620bee0f6a44d9848f49ade8469622294a97635d28445b1b475635c545cf76e341f379b2dbb9ec97fa367f2c81edc9431c7fc3fa6bdf259d50a7ab27f4eb9a83b2ed9f2a8a28e53d389c58ac6c969be7efcfaf5ebff010ccbbf95', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136941, 51, 4.0, 4.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dacb0523049d73732c9000013690319', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136942, 51, 50.0, 50.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3335c84dd7cf4e57f0f4d5f70c53a8503004002bae04a8', X'789ced5b6f6fdb3613ff2a445ea5989dd86ed316de30c071d3365bd21a711674785c08b444cb6c245225a534dad0effefc48498e252b91a3ee0f8af94d6349bce3f1777f787764ffdcf354e23b82866c6f48f6c66c112b4e6fa5607b1db297a8c0bc5dc671a48787875ff8350b0fa4f2cd2f7e5819ac5d4523e63934363483dee079b7d7eff67b97bd17c3a3deb07774d0efbd7cfab26fc73237e652688cfc73ef0d134cd1c0fe8ed9ad25bf4c2336244f95477cfbd58c9e89318b9634903a928ae3f195d4d467e4b554a11e122e3e812b9d078c68192486a24322f9c5638a2ca4cabf5b3e39e134564cf8f1b29e7848fafee1512f3ceb9041f6e3c75a764332c047bf438e7af64fdf3704f8dbb3fff4fc99b89049cc34910b32f2422eb88eb3150dc9e955879c9e6365320ca520978a7a8cbc833620d38574b15e2e2c60c97c1db3af7865a5354ffffb88a7808b6bfb70876109ad6dd4b93efceb4733c7c84b82d8015c5cf825fdd4c854e8d1199446f6bb031f4b3c3cbd229f07cf9633f19a2b1d939357046c990139ff7a4bfa33714e6f87e4997f88917be5351a718ea91b33985ce09c33019178cc7569b2676076453c7ec33de691cffd41178cc0f94577d0271e4df5c6f483b5e96b667c238574a5eb56ccf337e1ca300ab84b63e675600b908406b9258061b69851a025818dd1d85a8cbb0c68987a9c12c57caa3ccc636d02a611e39506d490afc25a31375130d3d88c8c98d2301e3c0d8db5c1b97aebf3bde25a33d897a15c033683fd9ca6447fe1b1bb24b1242e5bf05b1e3232794fe802a092c1b3eeb3974bc217c4852d61fa80f03052f2868598cf58a8f89408a8fbc6a09eb3cfe69d28192dd380de724df635bb4d404bb5a65810b9e12009f5939958c7a606e9c9e9ab12c465287fd38c40f825f1e46deaa64644467e38ec9290c54a0aeed13f64c06ad84eb948b491b8e34cd90d53acc638af4a96d2ef594ba9e175223ce942711b6657b6e1a7bdeef31e811ec89c41ef8c0045977989aa930fd801202bdf49c43deea561f6345e52e12ac9bd075079c36f3661a9032151bed1a8b3a6a98d055cadf1ec1d1c75074b08ce6454c30fd17909c99cd706d112a3e710eff03ac3340374f0e5fa41b77e2094651ef8d747956ae0da85955d58d98595ff5658f9077c7e233fda39fdcee9774eff6fe6123b0ffcbb3cb01aec762eb873c13a17fcabeca26a6f3bc3f8ce0de39b1458b5869d06ff050dfe25a06fec233bd41b02eadf02d04678fd8e11fa66d9ab60fc93c27feb5cdb1f1c64d6c490d1c68abb8f6dfaeffff4c2798568ecbc0fbc2725aaa342ce8d6e5d563697bfdfd32f2b66c927e93a7de75c8a78599eeaa741cf9eb73c7aca99f87945da7d71d4445d19d220f3cfb9ac90da9ea754e13189ff3abb4acf6163f2caf02dce4d466e1233e7bd0d13ceb951b1b33fc884b2580e9cdf1955fa21bddd79c726b8f8f8d46ec5b630baab71b85814276e90cf1ca77958c396e73a9586efcbf5756fd597c91bc16b445b2035112c09916852c44f1986094ac1b43b723f275c310faa7c9aa376af0e0f2142bd1ecdf4bd4d097389069672264ec5420e49b9bc4355f765c90489a4d6dc1c519a92cf94952c66f891a84d50dbb4bffe21c43776f8ff08e4d388b906f0898c9280deadbf58d144315f60cb4ec905be0ac4a221399e8933682a3f2cc6fe35c70490932ed84c5c3081d23c8bd33361434bf172417980846a48dec9a29d41a8f729d1b129ff3bc4e01dc3573553494802ec2d01207acb4289d810a4dab4047ce3ecc661f39642f1a54384243a898045d64b98c090622998116645fdc2e619d0c3d20cc837959918ab71407eeaf772f659702dcf5bc4177cdb6eaa8708deb208e0b955948ad75478885706318f6b468df986885499657448226c57c70d800260cf5103a30a706b0b3466a4d8e744c17a73f456b8937912136dcc6081b93d2b12048e89c716c8bbbcb607fd55cb693eeb7f652e7d6483b5c385b3e2909ffb8fe1718a72e199c6d586a58e8280293fb53e1150ad0fcd1d12d32bc262032d2bf734c858c189ba8ad1acdd048f7b02c8c01790681883c11519a80c3c28268d989af320e02a990393905338e81541fae67220ee6228e432c0a16cf01217ca3c5d105ab92a42dc92045c5b9d9880d2312c3437b738128bff1845484c6df78c0b1d33da5a0d0faffa9117309c0dfae24606f240cd9c0bfba1aa99dad41d3e23938a06052d32e199385652b89896ea7026a6316c5ae8ee2f722934809ca6c2533244b8b994b7b05a53633015c263de315417d60567e244a5f192859484702f8e2cc0104cad8f68ee5e0b7811549e07fad850bc63498c741c9b0f147cc692ebe2b70906419a3967a6fecb2504984b378d5763d24842fdb1fd5058c9c8575424811d67859a26b0a5b51c640c6ce1a49eb1238f2fe0833c60a6151a64221d1bb3a32a3df46910cc03ea1923d141e2f918f50b4d8c373063b928ab188d33a229e37f20d2da15459007bc969cdaf9cf1281b8c43dc1d295fda2a67079c411d119d9174c9aee2e76b6cd4424bb105452da99b46ddc624140164c546e07d08189272870785001cd0a730970340d790e3fa2a7524b56c2fe111b5aad25355bf8fa6070bfe3729fd535b3ac503a2bca12fffb6db779064bebac689d35daf21c1533dd827395a2c4afd65cb788227764ce1d59897361cbcdcc56234bf4eb1ed0cca334baacf5dc77b6d07231b2445ff1b86636558212b7c225b6d83d8b915948de05d8ef22c056f7c55d84dd45d85d84fd2e22ecbfe4aa6d8a80d66b9c2c298cdf9581f4d3d24adfd260d10df8c234ff0e5e765f1ebc587648ff6849f66d317dd4ed1fa19e3a67100dc0eb7048c6bf4f9e1df500c22dcca2681df0902a8e221695a96066bcbba402c3edadf4fc22fb3ceb0ab9dca3c18f0077c9e71c259acb82807c41cc263a45a5c6724b78646b792462b093d8789c29e209cfee1eb0e602e6575606643a133ad1a8f062d39939d43933c4fb44279032051ca733d488584b682b737cbac1eab3dec91aa9324b89a98841713113ab47b22f952dccd9c2da177817d7282cf7e90f102145b1e9633cc29e3d41b94389ae566a6e8060e84a42d31ffdedf294480149f685b1db143567081e2b5306ff0ffd9910927834864d7e18cc04cd84405909cc94ecd84e821130d1cc5b930da39f3e30fa6ee0daca8c4c6f944c223222886b2c222843559af50489fd9f0eb9649a7889ed849d1c9005656064bce7c3b33633e63315bdbf877746f89795d068ff8da22199c80c5043f65ef9d690b35d0e5c0f8ae574c871878c3be4cd9ecdd20a9b4bedc82c34add8dec369d59c642d785c71ec128834d962db0b41a10b2161b8c4afe3f2a1dfc0e6c47882bdf8041685e26a185d3c960f76c036f29c4fa7a316689c5fd49235493d1e755b524e632453074552830dbf0eb4d3a6e90fc82786c85f8f5593086707a63b66772ed3ddda466bd641de319f1a07d15586ef0e880f86d87924ab35eaa6f58041581c19d423d2a847a9e82d822545d21e9b3df01e736ce2f3f6c084a62061e28f56ee892886ed96b7a0fc356073cdcd12741bb7ce273ebc63434ea6c7673fb471c90d4ebf4ec6ad1859dfce12001d75c8288cc64430bfcdf2ea5845b24dc441856b1abaed602e8809321f9761d71775223446ab290de082ad953d5d72bf35f104353843b00db9a273dece4d0a1e3749e023096ac9c29cab091760eae8a09dcfe3c11a683b06639357643645168a99a2a98de7aeb3f1b869a5276d005967d36e3d23b808cc8a22396863182317597cfcb0084dce35d12cf172212853894d32680b46c789ba5ecac03307cae6e485babc8e4dd3ce328d195246734727172aa4419cd7702da4fadd5caf46e646589eb6982e945bc7a909ecd728175daeadf5c6494095216f154b8e55e23ee0048df467cce7f221376ad43945b9813adf7030ad44696abd367b2f65a1554d628a029499691b6fbce273c5a5894cc21c89d6bae20626e75cbb1bfe985dc6b712d17a8f6ace4a53574688d3e15d5552975534f2b9e0ee358b63cdbf4590bc124f42426fb6ccb247829a6d7733e533d5bd9061ead6a68f4d3aca6e8a48847fe4fc8afaf7ec428d86a7d80df6216b772cc06b6112da7a7f6c4ca9efebdb3d16e97546fbf620bee0f6a44d9848f49ade8469622294a97635d28445b1b475635c545cf76e341f379b2dbb9ec97fa367f2c81edc9431c7fc3fa6bdf259d50a7ab27f4eb9a83b2ed9f2a8a28e53d389c58ac6c969be7efcfaf5ebff010ccbbf95', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136943, 51, 50.0, 50.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c73cf2c4b553035c84dd7cf4e57f0f4d5f70c53283432c950a85030564849ac2c5648cb2f52284a4d2e2d2a4acd2b51c8cc4b4b4d2ec9cccf0300f07d12c5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136944, 51, 1.0, 1.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dac50304cd74fc92f4e0500153003b9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136945, 51, 80.0, 100.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cb330d0353430c84dd7cf4e57f00c5348c92ccb4c494d51283434d23532c950a85030d73532544849ac2c0600fc090bf3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136946, 51, 100.0, 100.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb552303430c84dd7cf4e57f00c53a85030040079e0081c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136947, 51, 4.0, 4.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dacb0523049d73732c9000013690319', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136948, 51, 50.0, 100.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3335d0353430c84dd7cf4ed74f49ac54f0f4d5f70c5348c92ccb4c494d51283434d23532c950a850303450004a17030042a80dbc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136949, 51, 2.0, 2.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dacb052304ad74f49ac0400145e0387', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136950, 4490, 13.0, 13.0, 'mcg', 'IV', NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65208494cca492d513034ce4d4ed75130320553a60660ca1cc2b3b0005386061051434323080d556c686c0ea1a1ba0ca1da8cc0eaf5143cc3e05a8da0b429980600c0d02654', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136951, 4490, 300.0, 500.0, 'mcg', 'IV', 1, 'Adult', X'789cb352303630d035353050c84d4e57f00c53a830d45128c948cd533035d0353430808aa62466e6542a94e69564e6282426e5a42a94e403514e6a516249aa42803f00a9651538', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136952, 4490, 1.7, 15.0, 'mcg/kg', 'PO', NULL, 'Pediatric', X'789cb35270c92f4e2d56284b2caad45130d433d7353455c84d4ed7cf4ed74f49ac5408f00700b25a0a34', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136953, 3728, 0.5, 1.0, 'mg/kg', 'IV', NULL, 'Adult', X'789cf3cc4b294d2ec9cccf53b05530d033d53554c84dd7cf4e57f00c53c82f4b2d52303428d65148cbcfc9c92f4f4d5148aa0429822a4905ca572a18e91a2be466e69596a4162b24162be4a5a6a6a4a600008eaa1b86', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136954, 3728, 10.0, 30.0, 'mg', NULL, NULL, 'Adult', X'789c05c1510a83500c04c0abeca7fd28283d4a4f10f35609e4256022d2db77e63bc51d167a71325a1c238b85655bdf9f15f37c4125509e8fffb01332a68555f3e24027781cd48666945ade85e290b68c3f97c92059', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136955, 3728, 0.1, 0.2, 'mg/kg', 'IV', NULL, 'Adult', X'789c0dcb310e83301044d1abcc050007c91d17a0204229d26ff060acc03ac22b216e1fb74fff4f92d4a8a20b117221d67ca23088a5acf8d02e52e1da47e3da1e47ecbeb13b92a256bd6fbcab84f18df9f544d58db2db76e35777aa150cf01e37e52cc82b24f20f4bdd24c2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136956, 3728, 10.0, 20.0, 'mg', 'IV', NULL, 'Adult', X'789c73cc2bc94ccd4d2dc94c5648c92fcecc4bd7513034d0353250c84d57f00c53c82f027215ceed49d7cf4ed7cfcdcc53c8cc4b2b2dcecccf030016801329', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136957, 3728, 5.0, 50.0, 'mcg/kg', 'IV', NULL, 'Adult', X'789c33d5353550c84d4ed7cf4ed7cfcdcc53f00cd351c8cc4b2e4a4d2c4e55304596293434005200662f0f3e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136958, 3728, 65.0, 65.0, 'mcg/kg', NULL, NULL, 'Adult', X'789c25cd610a02410840e1ab78806021aa9f7b17716c467235d421ba7d437b80efbd991355bf80994e82c50d3e5203f6c71d0eeadbab6f87183c3d60bfde46e405d01a504809fda5a8c21b4bd82a4f2b46c1982bc5d6bcb3f94ce83ac9c9633197966765fd68b8e25a70fe00c9a13391', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136959, 3728, 2.0, 10.0, 'mg/kg', NULL, NULL, 'Adult', X'789cd34829ca2c5030d23534c84dd7cf4ed7cf28d20400390205bf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136960, 3728, 2.5, 3.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cf3cc4b294d2ec9cccf53d030d6353453a8ccd754482c5130d233d535d63355c84dd7cf4e57f00c0300eaa90b0f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136961, 3728, 1.0, 1.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c3354c84dd7cf4e57d0c84dac50303100f23475144a3252f3140cf44ca17201417e107923b03c0074300e36', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136962, 805, 100.0, 100.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65208494cca492d51303430c84d07007a3b08b6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136963, 805, 100.0, 100.0, 'mg', 'PO', 2, 'Adult', X'789c333430c84d5708f05770f27451a85030564849ac2c06003b1a05d0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136964, 805, 100.0, 100.0, 'mg', 'PO', 2, 'Pediatric', X'789c7bd4b9d4a832df4ac1d0c020375d21c05fc1c9d345a142c1582125b1b2180098620954', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136965, 15738, 50.0, 50.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f55082e294acd4b2fc928b6523035c84dd72fcb4cccd1513087310104180d06', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136966, 15738, 50.0, 150.0, 'mg', 'IV', 1, 'Adult', X'789c3335d035343550c84d57f00c534849cccca9040028bc050f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136967, 15738, 50.0, 70.0, 'mg', NULL, 1, 'Pediatric', X'789c3335d0353750c84dd7cfd530d2544849cccca904002dde0540', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136968, 11770, 50.0, 50.0, 'mg', 'IV', NULL, 'Adult', X'789c3335c84d57f00c53283434ca50a830d53534514849ac2c06004a820685', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136969, 11770, 100.0, 100.0, 'mg', 'IV', NULL, 'Adult', X'789c0b2e492c2ab152303430c84d57f00c53a8300400360e0556', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136970, 11770, 50.0, 50.0, 'mg', 'IV', NULL, 'Adult', X'789c3335c84d57f00c53283434ca50a830d53534514849ac2c06004a820685', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136971, 11770, 100.0, 100.0, 'mg', 'IV', NULL, 'Adult', X'789c0b2e492c2ab152303430c84d57f00c53a8300400360e0556', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136972, 11770, 50.0, 50.0, 'mg', 'IV', NULL, 'Adult', X'789c3335c84d57f00c53283434ca5048cb2f52482c51c8494d2c2e5130554849ac2c06009cae0a10', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136973, 11770, 100.0, 100.0, 'mg', 'IV', NULL, 'Adult', X'789c0b2e492c2a51303430c84d57f00c53a8300400310d051c', X'789ced5a6b6fdb3816fd2b448002292676e26432d3f1ec17c74d9b6c9bac11a74517ebc2a0a96b89138ad490521aed20ff7d0fe977a24689b62d6630fd6649bc8797f7792e933fb6225bc463cd53daeab2ad4b19932885929ab676d85661957f9be479e6babbbb9fe415a56d6363ff4beede59ec84e51945639e7b99fdbdfd9f5a7b9d5667ef72ef4577efa07bf04bfba717fb9d83bdb096442e8d7658f9c7d66bd264b90abf73ba09e2976546dd917ead4a51aaf92623bd3dd297945b3e7fe146faf948bf348ec7c45e199bba2e3b7d3fd27d93a646b34bcb2362e7381ade5f9631175285cd8bc9fafeb77895f38922fff49f8f7802f6557858d3677ddb47986663f9ed47bf472f2a543e86b652c71b67add069eb5403a0d59b4426959aabf1a99eae7f5e881eeea5318ecc7eefec27ece6b0d5f99145bc845d8639b7799775f6e60b6e3a5b9bc7f41a0dafa45e43de190b93664a0a9e53f405b719682ae00fc977c6de3385967939e6e2f742da87f6991acb78ce147197b3c3f50dd7f71be9335eb297bb7dc6a739d9f94226a778a689958ad88f2f5a3fef2777157bc0ed41ebafe381bb7efeee82075cf0b58c73d7097f4debfc79b47e7c419d294e91e4b995e269c59057a4e2787f43f845abd329cd4877dafb2c8d77af96a7f6c7b9e9b2c33dff3a3c77f65b9d9f995fbcb04ea773df073541f80db6aff4726feee5afbdffe36ae4b772cc536ae7dfdd33dfda368f2aa97f16e37c73e59e582087190989741a98ac50fc3ee77809cace2c3ee89849cd324bb1e65a9423dd652f47fa2d1779906256ba2be67d1e1b1bbe0e8c7372a24af64e3b14f25f9900b68c50e0b94299d710bbf6b4fa8290ce6c569e473a30d72e3b378c47bf152e4f49e723bd2ce3f7be9c50062071471ebc3c912a6a0d8a38617dc59d637de84bc2a215114bb9d439f973108b0c5e1cee3d5bdf64a4cf4dce229a8252473b6c52e41029d98498a599e7da6c480445b09947c0d6eda674ff7316ae67fe5e727c1124dd183938588a62e3d5069ff1513dfe5270ec05c77341b99c32fac6d764a9239febf722a7a714d9b864b961c27b60d74f7fb0f22a827a18a5fef18295c42de2e0c4b84ce65cb516bc82658bdcc1e025f984bc9fa7069e918b62033ff3c2ff58781c3ee2d65b323370708ec85e85884c332ead0f9b0679d28baec93a1a5f10af60e6952d83ac34c5e6ba4b689fb0483a6194b133a708afb725bd3405332a829d129323349132c813140d9c0373aa5d7b8360e4732bf812bcf6f89e3b51282c733eaa11d1dc46b3a75e911be9cb10b1249825bc0d16c2763752849dce294becdaf3b13359c263bf78b750822c60e1426c3807b8c4f2746244999b8c82c3cea9c8ede2e18452a34aef03ae29f56f068e8ac8e470af65c0f3346fa48f0a157bdf4d11575888f801f43fe14f2792d609d99b84648afab13ae82b42c0b084dbb4a269ce46f30dfb9f108fb84830de9ff3c2910facd2659439af53cfe689e55061166fd6267ec10577495886c031f377f77df3be50d7e61a26f2b54c70a4046a89f3a609aed9f038eca9e8da774776f4eefc090d65758e75ebd7e7f1c6ea8dd270d76f8fb86db82bb181b7e6f57aa8f5c51b2815c1f18843ae84c60ba10dd4854b1f5157172b6765ee7b227feb44be5b4abf67f2f74cfe1299fcd789a34644b2a959063eefb857272e378dc3d5b4a5e494ba20f157da7c82a667c8d48951d2a55d7626b54c3dc53abe4158061ec68ea4a25dd03372acc50e7f79f62b7b074246ece0e099171609d7906566ca7a622e8122e04bacf3645334e166207a1369203c1e2e5d20a99ea2bda1cdf30e47da154e50063c9c62e14f62db852bb852e5f3913e1d693f3c8047fa69019fae51d7b89f73d6452dc1d5a87d39242e467af9c8b691091a1496a681c202db5fdca3b0cfd0873f4085528338633dcaec278936235041d927ac40d55d9c1471f40e4b971afaabb67797a7cc6868b2add18e5ce972d468b162cbc0ffd019696d58c47304ed87fd91e633251091b09935b361c72b886488d674c3ea830756af16ae9dccebf4da9a22633de6724b1943f3b1a50efd87e1e35233c7a282fca470dc66534e00f289f2e1c7263bce775acc0e0f5765a44fd0d07bffb5e5a99f5a8341bdd8bf6c1c82358486476d2f8eb3c38e76587f87bdde0afc6099f661e5ac582d613f83b4bc18a00618efa5951187d9c2612b003e741ea7058733b441e4b2b811ccb14f05238c10805878aec181eee1c8226d0073361cf69a885d3412ebf75a0d258739cf92363bcefc7d488aced0c466fd36fb8d50d89b99ea6d9b21fc42fb8f69fe87c61a889020e714cf6e6eee029eb7596c4243345419d41ff66b5402025aaa0cf5a1da24b5f178868e7a8372c9fd35876f720de3f1a4ed8b932a48ffb75182a28ea19fca06926f144d9cf447705519f9c88d775730ec7878f4f6872650f790de0cfa8d8042724f429b77d90eeba5599f698abf1454669ab818639d675fd566aeaf9f736996720bae2320de4407ae90848d9d3d4c64dc587880c190506d5369f94456a749ad191620d798f8fc7c5781715a0f718d32a8058ce9b276c3ac8fc39cd918a1efc9c52cacd8d45201ba5e95bc4fc289a4bf322c1ad9751da7e1917a4814041707496814e13d01da9e3fac44ad6fc32837d382932d02d9e015401735404785bd4a8c42b7449480657321ab60eaf419e618d9fca89acc95c2f482f13741f857c1d5a5d0bfe15fb050ce684e5ffc558da842aab5f62b8bd15eba10c379a1b8f5f28d42e7c816e2ff4985b7144bf36032d5f5f101c7e451d800911630b000596da2ca09a73478a7f0030246ccb25152be97138c97be46693995e27119798601fd5e56268aa7651454e2d569554b354b613254ec7435a134e11717525c519e3bf91935ea4b26f498a536e823e3d7d524f26e5af634f7edf73ef9f3b3bc3669292a89647dcc064d0cda00d8bfe5f167da517d4ba36bf4a31077a4f05a7b6e5b9d91b5ec5a190c57e0a1304f24a7881ba92a596d6d295f03daf693eb12ed7903b55e156ecd6f9a442866b6d10830a02c376182cc17a35775c603e8e3fd6b97efb7277f8fdb93a7fe4701d1b8a79cd9888dd5159d63db675ceae74d6f39ab911ebeef5c9319cf656e3fdededefe0f1668dc2a', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136974, 11770, 1.2, 1.2, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d43352c84dd7cf4e57f00c53283434ca000027d504a2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136975, 11770, 50.0, 50.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb052303550c84dd73734ca00001d7803d4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136976, 11770, 50.0, 50.0, 'mg', 'IV', NULL, 'Pediatric', X'789c3335c84d57f00c53303434ca0000143f0315', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136977, 11770, 1.2, 1.2, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d43352c84dd7cf4e57f00c53283434ca000027d504a2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136978, 11770, 50.0, 50.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb052303550c84dd73734ca00001d7803d4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136979, 11770, 50.0, 50.0, 'mg', 'IV', NULL, 'Pediatric', X'789c3335c84d57f00c53303434ca0000143f0315', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136980, 11770, 1.2, 1.2, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d43352c84dd7cf4e57f00c53283434ca000027d504a2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136981, 11770, 50.0, 50.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb052303550c84dd73734ca00001d7803d4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136982, 11770, 50.0, 50.0, 'mg', 'IV', NULL, 'Pediatric', X'789c3335c84d57f00c53303434ca0000143f0315', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136983, 14130, 500.0, 500.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db652303432d551303235d05130353050c84d5748c92c2e482d2a4e5528494c020017b30cfb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136984, 14130, 20.0, 30.0, 'mg/kg', 'PO', 1, 'Adult', X'789c3332d0353650c84dd7cf4e5708f057087401002517045c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136985, 14130, 20.0, 20.0, 'mg/kg', 'PO', 1, 'Adult', X'789c0b2e492c2ab152303250c84dd7cf4e5708f0570874010048620634', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136986, 14130, 40.0, 40.0, 'mg/kg', NULL, NULL, 'Adult', X'789cf34dacb052303150c84dd7cf4ed74f49ac04002cd00547', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136987, 14130, 5.0, 10.0, 'mg/kg', NULL, NULL, 'Adult', X'789c734cc92a2d2e5148c92f4e5548aa5430d5353450c84dd7cf4ed74f49ac542834d635cbcd57484a2c4e4d51c8cf53284e2d2acd55484b2d2aca2cc9cc030058181465', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136988, 14130, 10.0, 10.0, 'mg/kg', NULL, NULL, 'Adult', X'789c73494d2e4a4d2c4e5548c9071286060ab9e9fad9e9fa2989950a99690ace450a76c6c6aa0a8949f965a90a494075399979a90a15460ae5a9a9d9c50067b31411', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136989, 14130, 500.0, 500.0, 'mcg', NULL, NULL, 'Adult', X'789cf3c8cf49b152704b2d2aca2cc9cc53b031353050c84d4ed7f701006bc207e8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136990, 14130, 10.0, 20.0, 'mg/kg', 'PO', 1, 'Adult', X'789c3334d0353250c84dd7cf4e5708f0570874010024f8045a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136991, 14130, 10.0, 10.0, 'mg/kg', 'PO', 1, 'Adult', X'789c0b2e492c2ab152303450c84dd7cf4e5708f0570874010048540633', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136992, 14130, 20.0, 20.0, 'mg/kg', NULL, NULL, 'Adult', X'789cf34dacb052303250c84dd7cf4ed74f49ac04002cb80545', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136993, 14130, 5.0, 5.0, 'mg/kg', NULL, NULL, 'Adult', X'789cf3cc2b492d2a2a2d285128294a4d2cc94dcd2b51c84c5348cc01f2522a15124b144c1572d3f5b3d3f553122b018923105f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136994, 14130, 300.0, 300.0, 'mcg', NULL, NULL, 'Adult', X'789cf3c8cf49b152704b2d2aca2cc9cc53b031363050c84d4ed7f751c82f52c8c92c4b2d52c82cca074928e4a603d5e9a703009cfb0fe5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136995, 14130, 20.0, 30.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c3332d0353650c84dd7cf4e5708f057087401002517045c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136996, 14130, 20.0, 20.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c0b2e492c2ab152303250c84dd7cf4e5708f0570874010048620634', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);